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The theeie consists of txiro separate studies on two 
eng;ymos which have potentially useful applications in the 
biochemical study of various human diseases*
In Part 1 , the activity of the enisyrae, isocitrate 
dehydrogenase, in aerum of patiente with diseases involving 
the liver or biliary tract » was studied and compared with 
established biochemical tests of liver function, in order 
assess its application to the differential diagnosis of 
jaundice* Particular attention was paid to results on 
patienta xjith obstructive jaundice as previous authors have 
reached differing conclusions of the ultimate usefulness of 
this enzyme, due to the equivocal results shown in those case 
Very high value© were found in severe, acute breakdown 
of liver cells* These coincided with large increases In 
activity of two other enzymes used in the diagnosis of acute 
he%)atic damage - serum glutamic^-oxalacetic transaminaso and 
scrum glutamic-pyruvic transaminase• The serum isocitrato 
dehydrogenase was extremely sensitive in detecting liver coll 
damage, even at a subollnical level, and was comparable and 
perhaps slightly superior to the serum transaminases in this 
respect, while all three enaymes if ere very much more 
sensitive than other conventional tests of liver fi^nction*
Xn chronic liver damage, variable values for serum 
ioocitrate dehydrogenase were found, with only small to 
moderate increases which could not be related to the clinical 
state of the patient # Higher values were found in biliary
cirrhoais than in portal cirrhosis. Tli© ©njsymo roaults 
were significantly correlated with the transaminase results, 
but not with the other liver function teste.
In obstructive Jaundice, the engyme was elevated in 
the serum of over of the cases, and particularly high
values were associated with secondary involvement of the 
liver in malignant cases, and acute inflammation of the 
biliary tract in benign obstructive jaundice. The enzyme 
could not be used to difforentiato malignant from non- 
malignant oases, and was not related to the severity or 
duration of the biliary retention. Xn these cases, the 
enzyme was not closely related to serum transaminase values.
It was concluded that the enzyme did not offer great 
advantages in the differential diagnosis of jaundice due to 
the abnormal values which may be found in obstructive 
jaundice. However, it was an easily estimated enzyme, very 
sensitive for detecting and assessing acute damage to liver 
cells, and could be a useful adjunct or alternative to the 
serum transaminases.
Part H Involved the study of the enzyme, p-glucuronidas© 
in various biological material taken from patients with 
carcinoma of the cervix uteri*
Biopsy specimens of cervical carcinoma were obtained and 
fractionated by homogenisation and differential centrifugatio 
into three cytoplasmic fractions - mitochondria, microsomes 
and soluble supernatant. (3-Glucuronidase activity was
meaauroci in each fraction and the résulta compared with 
spocimono of nosi-mnligsiasit cervix treated in the same way.
The activity of the oarclnoiua apocimena was,found to be 
coiisidorabiy higher than non-maligmant apooimons in the 
majority of caaoa. Increasea in ^-glueuronidaao activity 
wore mainly in tSie soluble supernatant fraction and not In 
particle enzyme, even thoiigh the enzyme had previously been 
descrihod as located mainly within cytoplasmic particles. 
There was no correlation with the enzyme activity and dogpreo 
of malignancy of the cervical lesions.
Bamples of cervical ccarcinoma were taken before and 
after treatment of the lesion by irradiation from radiwa 
irfipXante, and their p-glucuronldase activity compared,
Tlioro was net a uniform change in enzyme activity following 
radiation due to large tanoxplained inoîi'oaees and decreases 
being observed.
The excretion of 0-glucuronidaso In urine of patients 
with cervical carcinoma receiving radiotherapy was followed 
over the full course of treatment. Pronounced increases 
in ©xorotion of the enzyme following radium treatment were 
observed in the majority of patients studied, and the pattern 
of p«*-gluouronida80 e^ecreticn could be related to the enzyme 
activity of the tissue being irradiated. There was also 
increase:-, in p-gluoia37onidaae activity of the aermm in those 
patients, and the results indicated that radiation of the 
lesion caused mobilisation of the enzyme into the patient * s 
circulation-, which v/as thon cleared by the kidno^^s into the u.i
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STATISTICAL CALCULATIONS.
In both Farts 1 and 2, the Mean and Standard Deviation 
(S .D.) on a group of results were calottXated by the formulae ;
SsMean x ss ™  B*î). sa J n
n— 1
where x individual values, and n number of observations 
in the group.
i
Student * 8 t Test of Signifloanoe between groups of 
unpaired samples was applied by the formula{«
_  _  , ______  8%^. (S^f- ■*• s / .  (Sxf-
t = ^ “ y ' / y  where
® 4  «X* »y- 2 ,e
S and y are the means of the two groupsi and n^ and are
the number of samples in each group4
Degrees of Freedom n -s- n - 23c y
In groups with pairedaamplea. a t value was obtained
from the differences of the paired samples by the formulas-
«__2
y_ Sx ( Sx)
t = (î - 0_) Vn where 8"^ =   n,.._,
S n - 1
X ^ the difference between paired samples, x the mean 
difference* and n the number of paired samples*
Degrees of Freedom n - 1
P value© corresponding to the t values were obtained 
by reference to Bocumenta Geigy Scientific Tables (1962)* 
Results were considered signifioantXy different when P was
less than. 0.05«
Correlation Coefficients (r) between two groups of 
results were obtained from, the formula?-
a  _______S-Üf-lK.*,).......... X S(x'y')g O O
(S % )
n n
where S ( :c * y * ) ss S(x % y ) - 8x x Sy
n
The signifloanoe of a correlation coefficient was 
given by the formula?-
t r x/n
where n S3 nuwiber of paired results, and n - 2 Degrees of 
Freedom (Fisher, 1954)
P values corresponding to t were obtained from the Student 
t tables.
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are organic catalysts produced in, or through, 
the agency of* living cells of both animals and plants.** 
(Chambers Encyclopaedia, 1953)♦ Investigations which 
eventually led to this definition were initiated in the 
1 9th Century by Th^nard, Schwann, Eutzing, Pasteur and others. 
Their studios on the fermentation of sugars by yeasts led to 
the concept of biological catalysts, present in living cells, 
which could promote a wide range of naturally occurring 
chemical reactions. Further work showed that these 
substances could be extracted in an active form from cells 
(Buchner, 1897)# Parallel studies on the digestion of food 
in the stomach led to the conclusion that this was also a 
process governed by enzymes (Schwann, IB361 Bernard, I8 3 6).
From these early beginnings, the study of enzyme 
activities in biological materials progressed rapidly, and 
has culminated in the last three decades in the recognition 
and description of individual enzymes which mediate in the 
various steps of intermediary metabolism in living tissues.
It was Inevitable that these enzyme studies should be 
extended to pathological processes as well as no3?mal 
physiological ones. Early work in this direction was 
concerned mainly \flth digestive enzymes, and the first 
important diagnostic enzyme assay to emerge was the estimation 
of amylase in the urine for the diagnosis of aout© 
pancreatitis ( Wohlgemuth, I9IO). Studies on f eirmentation 
indicated that enzymes were involved in the formation and
-3-
hyciroiysi© of sugar phoe%)hates, and this led to Robison 
(1 9 2 3) finding high concentrations of an enzyme in growing 
bone which hydrolysed glucose-phosphate g he called this 
enzyme alkaline phosphatase. Subsequent"investigations 
were then directed to studying the activity of this enzyme 
in the serum of patient© with'various bone diseases (Kay,
1929).
Since the birth of clinical enzymelogy, the number 
ami 'complexity of enzymes being used as routine clinical 
diagnostic tests, or as research tools, in the study of 
pathological condition© has increased enormously. The 
subject ha© grown to such an extent that textbooks have 
been written entirely devoted to this one aspect of clinical 
biochemistry (Abderhalden and Oesper, 1 9 6I 5 King, 1965)*
Xn a recent attempt to assess the ezctent to which enzyme© 
were being used by clinical biochemists, mainly in the 
British Isles, no less than 46 enzymes were being utilised 
for routine or research purpose© (Gowenlook, 1 9 6 5)*
The activit^r of enzymes may be measured for clinical 
purposes in the patient*© serum, urine, cerebrospinal fluid, 
digestive juices, abnormal body fluids or tissue biopsy 
specimens. By far the majority of diagnostic enzymes are 
determined in blood serum. Bodanaky (1 9 6 2 ) ha© listed 33 
serum enzymes which have been reported to have diagnostic 
potentialities § the most widely used and ivell-established 
of these are acid and alkaline phosphatase, amylase,
ret) 4 —
ohollneateraae, glutamlo=^oxalap@tic transaminase and
glutamie^pyruvic transaminase.
Enzymes are infrequently measured In urine, the only 
established ones being amylase and, possibly, laropepsin. 
Various enzyme activities have been measured in cearebro- 
spinal fluid (Delank, 1963; Mellisk and Bassett, 1964), and 
in abnormal body fluids, e.g. malignant and benign effusions 
(Brauer, West and Zimmerman, 1 9 6 3 )•
The investigation into enzyme activities in specimens 
of tissue from normal and pathological material is still in 
its infancy. Histochemistry, which involves the localisation 
of enzymes within tissues by staining of hlstologioal . 
preparations, has progressed forward to include many enzymes. 
Results from these techniques, however, must be viewed with 
caution as many factors, e.g. permeability of the tissue to 
the enzyme substrate, tissue autolyals,, or naturally occurring 
activator© or,inhibitor©, may influence results in an- 
unpredictable way. It is only recently that results of 
detailed investigations into the quantitative measurement 
of enzymes in various human tissue© have appeared, e.g.
Shank, Ko van, Majima and Bowser, 1964. Little work has 
been carried out on the distribution of enzymes among intra­
cellular component8 - nucleus, mitoohoaidria, mlcrosomes and 
cell sap - in normal and diseased human tissues.
The clinical use of enzymes covers a broad spectrum of 
disease states, but there are two fields of human disease
which have attracted a vast amount of investigation© on 
many different enzymes. Firstly, there are diseases 
involving the liver*• Hepatio cells are a rich source of 
many enzymes due to their diverse metabolic oaxmbilitiee, 
and^ consequently, damage to these cells in liver disease 
ha© led to studies on the appearance of abnormal amounts 
of these enzymes in the blood stream of Jaundiced patients 
(Baron, 1963). Secondly, enzymology has emerged aa one of 
the foremost inatrmnents in the search for the cause, 
diagnosis, prognosis and cure of the numeroia© forms of 
cancer* The concept that malignant cells ©how changes in 
their metabolism compared with normal cells has been 
proposed by Warburg (1936), and many investigations since 
then have indicated that neoplastic cells can have 
pronounced differences from normal cell© in various enzyme 
activities*, This subject has been extensively reviewed 
by Doug 3. a a (1 9 6 3) • Besides studies on enzymes In malignant 
tissues, intensive investigation© have been, and are being, 
undertaken into their activities in other biological 
material from cancer %)atienta, e*g* serum, blood cells, 
urine, cerebrospinal fluid and other body fluids* These 
studies are directed mainly towards asaeasing the enzyme 
as a diagnostic and prognostic aid, and it© us© a© an index 
of the ^progression of the disease during treatment.
The present Investigation consists of two separate 
studies, each on© being an example of the clinical use of
an enzyme In the two fields of human disease mentioned 
above.
In Part 1, the activity of the enzyme^isooitrate 
dehydrogenase^ha© been studied in the serum of jatmdioed 
patient©, in order to asseo© its potential as a diagnostic 
aid in the differential diagnosis of Jaundice.
Part 2 consista of a study into the p-glucuronldase 
activity of tissue specimens, urine and serum of patients
- v ir v '
with carcinoma of the cervix uteri, some of who received 
radiotherapy, again.with a view to assessing It© diagnostic 
or prognostic application©.
-7-
PAHT 1.
STUDIES ON ISOCITRATE DEHYDROGENASE IN HEPATIC DISEASE.
INTRODUCTION.
- 8
Many biochemical tests have been devised for assessing 
the functioning and integrity of the liver in patients with 
suspected hepatic disease* Some of these tests have 
involved the determination of the activity of enzymes 
present in venous blood. Three of these enzymes have 
become established as useful tools for the differential 
diagnosis of Jaundice. Firstly, serum alkaline x^hosjjhatas© 
(E.G. 3#1.3.1.) has become one of the standard tests for 
diagnosing jaundice due to obstruction of the biliary tract. 
Gutman, Olson, Gutman and Flood (l94o) found raised values 
for this enzyme in 98^ of patients with obstructive jaundice. 
A value of over 30 King-Armstrong (K-A) units/100 ml. for 
the alkaline phosphatase in a Jaundiced patient is one of 
the surest guides of an obstruction to the flow of bile.
Two other enzymes, serum glutamic-oxalacetio trans­
aminase (S-GOT, E.G. 2,6.1.1.) and serum glut ami c-pyruvic 
transaminase (S-GFT, E.G. 2.6.1.2.), have now become widely 
used as sensitive indices of acute hepatocellular necrosis 
( V^roblewski, 19581 Agross, 1959) • Very high values are 
found in conditions causing acute breakdown of liver cells, 
e*g* infectious hepatitis, homologous serum Jaundice, and 
toxic liver damage caused by chemicals (Molander, Sheppard 
and Payne, 1957» Wroblowski and LaDue, 1956a,b). The
determination of these two enzymes also has a prognostic 
and epldemilogica.1 value In acute hepatitis (¥ro"blewski,
A
Jervis and LaDue, 1956? Goldberg and Riddell Campbell, I962).
-9"
Both the B-GOT and S-GPT may be raised to varying degrees 
in chronic liver damage and obstructive jaundice (Molander 
©t alè t 1957s Chinsky, Wolff and Sherry, 1957), but not to 
high values found with acute liver coll damage*
Isocitrate Dehydrogenase*
The activities of other enzymes in the serum of 
jaundiced patients have been studied by many investigators * 
One of these is isocitrate dehydrogenase (E*C* 1*1.1*42.)* 
This is one of the enzymes concerned in the aerobic break­
down of carbohydrate in the citric acid cycle, and catalyses 
the reactions-
1-iso citrate j- NADP x— 2«oxoglutarate -f* NADPH^ f 00^
(Colowick and Kaplan, 1955)• It ia widely distributed in
animal tissues and found in high concentrations in heart, 
liver, kidney and adrenal g3.ands, moderate amounts in ovary 
and intestine, and smaller amounts in muscle, brain, lung, 
testis and spleen (Adler, Euler, Giinther and Plass, 1939) * 
It also has measurable activity in sera taken from 
apparently healthy people (Wolfson and Williams-Ashman, 
1957a)i
Serum Isooitrate Dehvdrofrenase (S~ICP) in Liver Disease,
Values of S-XCD to be found with most types of hepatic 
disease have been described*
- 1 0 -
a) Acute Damage to Liver Celia.
White (195B) stated that the highest concentrations 
of the enzyme in mouse tissues were to be found in liver 
cells. Liver homogenates from rats have also been found 
to have the highest isocitrate dehydrogenase activity with 
more activity than the next highest tissue- heart - 
which, in turn, was very much more active than other rat 
tissues (Nachlas, Davidson, Goldberg and Seligman, I963)# 
These facts are reflected in human disease where greatly 
abnormal amounts of isocitrate dehydrogenase in serum are 
found in conditions causing acute damage and breakdown of 
liver cells. Wolfson and Williams-Ashman (1957b) showed
that very high values for S-XCD were obtained in acute 
hepatitis, e.g. infectious hepatitis and homologous serum 
jaundice. Since then, all other authors reporting on 
S-XCD have stated that the highest levels of activity were 
encountered in these conditions. Sterkel, Spencer,
Wolf son and Wi H i  ams-Ashman ( 1958) stated that in cases of 
infectious hepatitis, high S-ICD values of approximately 
15 times the normal mean were found within 10 days following 
the onset of jaundice? these returned to normal values 
approximately 10 days later* Okumera and Spollberg (i960) 
investigated 20 patients with acute hepatitis, 12 due to 
infectious hepatitis, 6 with homologous serum jaundice and 
two with toxic hepatitis due to the drug, iproniazid. They 
stated that the highest S-IGD values were to be seen early
- 1 1 -
in the disease, but that the S-ICD had no direct relation­
ship to the patient’s clinical condition or to the duration 
of the illness. There was no correlation with the S-XCD 
and other tests indicating hepatocellular damage. Boll, 
Shaldon and Baron (I962) showed that in 48 cases of 
infectious hepatitis all had raised S-XCD values at some 
stage of the disease. Xn general, peak values occurred 
5-10 days after onset of symptoms and usually returned to 
normal by the third to fourth week of illness.
In some instances the S-ICD has been compared with one 
or both of the serum transaminases in acute hepatitis. 
Sterkel et al. (1958) indicated that S-GPT showed similar 
changes to S-ICD, the rises in S-GPT activity often being 
of greater magnitude than those of S-XCD. Kerppola, 
Nikkila and Pitkanen (1959) showed that S-ICD mirrored the 
S-GOT in acute liver cell damage. Hargreaves, Janota and 
Smith (1961) showed an incidence of abnormal values of 85^ 
for S-XCD and both transaminases in acute hepatitis. They 
demonstrated that the S-XCD tended to return to normal 
rather more quickly than the transaminases. Bodansky, 
Schwartz, Krugman, Giles and Jacobs (i960) undertook a 
sequential study of S-ICD activity in children submitted to 
inoculation with viral hepatitis and compared the results 
with S-GOT. They found that in 9 cases which developed 
clinical evidence of hepatitis, 8 showed elevations in 
S-XCD and S-GOT on the same day. They expressed the rise
- 1 2 -
±n enzyme activity as Maximal activity recorded and showed
Upper limit of norma].
that the S-GOT rose correspondingly higher than the S-ICD.
The above ratio for S^ -XCI) varied from 11-38, while for S-GOÏ
the corresponding values were 16-50* The authors concluded
that the S-GOT was to be preferred to the S-XCD* Franken,
Braunsj Storck and Kazmier (i960) claimed that the S-ICÏ)
was not 90 significantly raised as the transaminases in
acute hepatitis. Cohen, Potters and Bowers (1961) stated
that S-XCD was raised on average to I6 times the upper
limit of normal and that the S-GPT was a slightly more
sensitive indicator of acute hepatic damage than the S-ÏCD
and 8-GOT, these last two being comparable in sensitivity.
Bell et al. (1962) showed that in acute liver damage 
caused by hepatotoxlc drugs, the S-ÏGD was e3.evoted in many 
oases before the 8-GOT and both enzymes showed abnormal 
results before the other standard tests of liver function* 
They concluded that the S-XCB was a very sensitive test for 
detecting liver damage caused by drugs.
b) Chronic Liver Damage.
Variable S-ICB values are found in chronic diseases of 
the liver* Wolf son, Spencer, Sterkel and V/llliams-Ashman 
(1958) stated that normal S-XCI) activities were usually 
found in portal cirrhosis* Okumera and Spellberg (i960) 
found normal or slightly elevated values (up to twice the
"13-
upper limit of normal) in a group of 18 patients with portal 
cirrhosis* Two cases of hepatic coma had normal values.
Xn 10 oases in the series of Kerppola et al * (1959)»
4 showed abnormal S-XCl) values and all of these were stated 
to be in the 'active* phase of the disease, characterised 
by considerable jaundice and inflammatory changes in the 
liver. Cohen et al * (196I) supported this by stating that 
the majority of 19 * active * cases had raised 8-XGD values 
which agreed with the clinical impression of the activity 
of the condition, whilst 3 * inactive * cases showed normal 
S-ICD values. Opposed to this, Sterkel et al * (1958) 
found 5 raised S-XCD values in 27 results on 19 patients 
with portal cirrhosis and stated that there was no relation­
ship between the S-XCD, S-GPT and the degree of hyper- 
bilirubinaemia or clinical evidence of activity of the 
cirrhotic process. Franken et al. (i960) stated that the 
S-XCD was variable in cirrhosis and not related to the 
clinical state of the patient. Bell et al. (1962) found 
the S-XCD elevated to varying degrees in 28 of 39 oases 
and divided these into compensated and decompensated 
patients, defining a 'decompensated* case as one with a 
serum bilirubin above 2.0 mg./lOO ml. and a serum albumin 
of less than 3*0 g./lOO ml. They found that no correlation 
existed between the 8-ICD and degree of compensation of the 
patient, nor with the severity of the cirrhosis as judged 
by the presence of ascites or hepatic coma.
—14—
There are few i-ne-ldenooe of the S-XCB being compared 
with transaminases in chronic liver damage. Hargreaves et al *
(1961) found abnormal values for S-XCD and S-GPT in 50^ S 
of cases compared with 6^ jo for S-GOT. Cohen et al, (1961) 
claimed that the S-GOT and S-GPT gave essentially the same 
results as S-XCD in their 'active' and * inactive' cases.
0) Malignant Disease in the Liver.
In patients with neoplastic diseases, increases in 
S-XCD activity have been associated with secondary involvement 
of the liver (Wolfson and Williams-Ashman, 1957b), White 
(1958) showed that 13 cases of metastatic cancer with no 
hepatic secondaries had normal S-XCD values, while 4 patients 
with metastatic invasion of the liver all had high S-XCD 
values - up to three times normal. Sterkel et al♦ (1938) 
stated that elevations of S-XCD in an Individual with 
malignancy appeared to indicate liver métastasés. Cohen 
et al. (1961) found raised S-XCD values in 70^ of cases with 
carcinoma of the liver, compared with abnormal transaminase 
values in 64^ G of the oases. They stated that the S-ICD 
approached the alkaline phosphatase in sensitivity as an 
index of liver métastasés. 'Tan, Cohen, West and Zimmei'iaan 
(1963) in a very large series of metastatic liver cases 
(284 patients), found that the S-XCD was raised in the 
majority of cases up to twice the upper limit of normal, and 
above this in 20^  ^of the cases. The S-ICD was elevated in
—15“
a higher proportion of cases than wore the transaminases.
d) Obstructive Jaundice.
Conflicting reports have been published concerning the 
significance of S-XCD in obstructive jaundice. Wolfson
et al. (195B) claimed that the S-XCD was seldom raised in 
extra-hepatic obstruction of the biliary tract. Sterkel 
et al. (195B) claimed that the enzyme could be used to 
differentiate between Intra-hepatic jaundice and extra- 
hepatic obstructive jaundice, basing this on 12 S-XCD 
déterminâtions on 6 cases of extra-hepatic obstruction, 
three benign and three malignant, which showed normal S-XCD 
values. The S-GPT showed 5 abnormal results in 12 
determinations and they claimed that the S-XCD would yield 
more specific information than the S-GPT in the differential 
diagnosis of intra- and extra-hepatic jaundice. Bell et al.
(1962) supported this statement, saying that S-XCD was 
normal in 19 of 20 oases of uncomplicated obstructive 
jaundice of short duration, whereas the S-GOT was raised in 
of these cases. They stated, however, that long­
standing obstruction leading to liver cell damage resulted 
in raised S-XCD values up to three times the upper limit 
of normal#
In opposition to this, Cohen et al » (1961) found raised 
values in k of 6 cases of extra-hepatic obstruction, the 
average of the 6 cases giving a rise in S-XCD of 1.6 times
-16-
tlio upper limit of normal. Kerppola et al. (1959) found 
normal S-XCD in 7 cases of cholelithiasis, but stated that 
increased S-XCD in obsti'uctive jaundice pointed to malignant 
disease. Okumera and Spellborg (i960) found S-XCD values 
ranging from 2-4.5 times normal in 4 of 5 cases of malignant 
obstructive jaundice, these cases being classed separately 
from those with liver métastasés, Xn data presented by 
Saad, Steigman and Dubin (1963), only one case out of 12 
with benign obstructive jaundice, and only 4 of 19 malignant 
cases had normal S-XCD values. Norberg (196I) noted a 36^ t 
incidence of increased S-XCD values in patients with symptoms 
of acute cholecystitis, with or without accompanying* 
jaundice. Okumera and Spellberg (i960) showed high S-XCD 
in two out of 17 cases of acute and chronic cholecystitis. 
Hargreaves et al> (I96I) claimed that the S-XCD was raised 
in 30% of 25 cases of obstructive jaundice, while the S-GPT 
was raised in 60ÿG and the S-GOT in BO^, but their series 
included 6 cases with biliary cirrhosis. Bell et al. (1962) 
found raised S-XCD values in 21 of 27 cases of biliary 
cirrhosis.
Xt is of interest to not© that Okumera and Spollberg* 
(i960) reported that three cases of extra-hepatic neonatal 
jaundice (two with atresia of the common bile duct, and one 
caused by a cholodochal cyst) had S-ICD values 1.5"*5 times 
normal. The S-XCD fell to normal 5 days after surgical 
removal of the cyst and relief of the obstruction. Komiya
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(1963), studying S-ICD in infancy and childhood, found that 
10 of 13 oases of common bile duct atresia and one case of 
choledochal cyst had moderate elevations of S-ICD•
Wolfson and Williams-Ashman (l95?b) stated that an increase 
in S-ICD activity followed bile duct ligation in rats, and 
Okumera and Spollberg (1960) found moderate elevations 
after ligation of one hepatic duct in dogs and also 
following an experimental biliary fistula.
O u t l in e  o f  th e  P re s e n t I n v e s t ig a t io n .
This present work was undertaken to assess the rôle 
that S-XCD can play in the diagnosis of hepatic disease, 
and compare the results, wherever possible, with the two 
serum transaminases, alkaline phosphatase and other 
biochemical tests of liver function. S-ICD was determined 
in a large group of patients with various diseases affecting 
the hepatic and biliary system. Particular attention was 
paid to cases of extra-hepatic biliary obstruction in the 
hope of clarifying the B-ICD results which are found in this 
condition, since the overall status of the enzyme as a test 
in the differential diagnosis of jaundice depends to a 
large extent upon its response to biliary retention as 
opposed to liver cell damage.
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PAHT 1.
MATERIAL AND METHODS.
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All serum S-ICD and other enzyme analyses were 
estimated on unhaemolysed serum specimens. The analyses 
were carried out with minimal delay after witlidrawal of 
the specimen, hut material that could not be handled 
immediately was stored at -20^ and the analysis completed 
in less than two weeks* The serum could bo kept at -20^ 
for this period with minimal loss of B-ICD, transaminase 
and alkaline phosphatase activity.
Estimation of Isocitrate Dehydrogenase in Serum.
The enzyme was estimated in serum by the colorimetric 
method described by Bell and Baron (1960), which depends 
upon measurement of the coloured DNP-hydrazone of a-oxo- 
glutaric acid in alkaline solution.
Reagents
1. O.IM-Tris buffer, pH 7*5
2. Buffered substrate. 1.845g. of dl-trisodium isooitric 
acid were dissolved in 70ml. tris buffer, 15ml. N-NaOH 
added and the solution stood overnight. The pH was 
adjusted to 7*5 with N-HCl and the volume made to 100ml. 
with tris buffer; the solution was stored at -20?
3. 0.013M-NADP. lOmg. of NADP (Boehringer) dissolved In 
1ml. of 0.15M“NaCl. This was made up fresh for each 
batch of analyses.
4. 0 .03M"Mangan©se chloride. 0.597^* of MnCl^.411^ 0 
dissolved in 100ml. of 0.15M-NaCl.
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5* 0.19M-EDTA. ?.Xg. of the disodlura salt of EDTA
dissolved in 100ml. water.
6. 0 .OOlM-DNP-hydrazine. 19•Bmg. dissolved in 100ml. N-HGl
7. 0.4N-Na0H
8. a-oxoglutaric acid standard, A stock solution was made 
by dissolving 70mg. a-oxoglutaric acid (B.D.II.) in 100ml. 
water. This was made up fresh every two weeks.
Procedure
The following reagents were pipetted into test tubes 
placed in a 37^ water bath:
Serum test - 0.3ml. of 0.15M-NaCl, 0.1ml. of 0.03M-MnCl^,
0.5ml. of buffered substrate, 0.1ml. of 0.013M- 
NADP.
Serum control - 0.4ml. of 0.15H-NaCl, then as the serum test
but minus the NADP.
NADP blank - 1.0ml. of D.15M-NaCl, 0.1ml. of MnCl^, 0.1ml.
of 0.013M-NADP.
The reagents were allowed to equilibrate to 37^, then
0.2ml. serum was added to serum test and control, and 
incubated for exactly 60 minutes. The enzyme reaction was 
stopped by adding 1 ml. of 0.19M-EI)TA to complex the ,
followed immediately by 1 ml. of O.OOlM-DNP-hydrazine. The
tubes were shaken and left at room temp, for 20 minutes.
Ten ml. of 0.4N-Na0H were then added to each tube, left for 
15 minutes, and serum test read against control at 390 mji 
on a Unicam SP600 spectrophotometer. The NADP blank was
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read against a reagent blank and the extinction subtracted
from each test reading.
A calibration curve was made from different dilutions
of the stock a-oxoglutarat© solution. O.lml, of 0.03M-
MnCi^* 1 ml* of 0.19M-KDTA and 1 ml* of 0*OOlM-DNP-hydrazine
were added to 1 ml * volumes of the diluted standards, the
tubes left for 20 minutes, 10ml* of 0*4N-Na0H added and the
extinction read against a reagent blank at 390 m^ i* A new
calibration curve was made for each new batch of DNP-
hydrazino and NaOH solutions*
A unit of S-Ï01) activity was expressed aa the formation
of 1 m|imole of a-oxoglutarate/min./ml * at 37° * Enzyme units/
ml*serum were obtained from the calibration curve by the
equation ug# g-oxogluturate x 5 x 1000 == S-IOD units/ml*
146 X 60
These units may be converted to X*U./litre by dividing by 
a factor of 3 to allow for the change in reaction rate at 
25° instead of 37°*
Estimation of Transaminases in Serum*
B-GOT was measured by the method of Cabaud, Leopor and 
Wroblewski (1936), and S-GPT by that of Ur^blewski and 
Cabaud (195?)# These standard methods involve measuring 
the coloured DNP-hydrazone of pyruvate, which is formed 
directly by the enzyme S-GPT from the reaction:-
1-alanine  ^ a-oxoglutarate pyruvate -}■ glutamate
— —
and indirectly in the estimation of S-GOT from the reaction:- 
aspartate *?• a-oxoglntarate oxalacetat© 4- glutamate.
The oxalacetat0 is converted to pyruvate by aniline citrate. 
Those methods involve the precipitation of proteins to stop 
the enzyme reaction and the pyruvate DNP-hydrazone being 
extracted into toluene before colorimetric assay.
A unit of transaminase activity is defined as that 
amount of enzyme in 1 ml. of serum which forms 1 pg. of 
pyruvic acid in 20 minutes at 25° under the test conditions.
To convert these units to X.IT./litre, they should be 
multiplied by 0 .57#
Estimation of Alkaline Phosphatase in Serum.
This was estimated using the standard method first 
described by King, Haslex/ood, Delory and Beall (1942). Xt 
involves the colorimetric determination of phenol liberated 
by the enzyme from sodium phenyl phosphate.
A unit of enzyme activity is defined as that amount 
of enzyme contained in 100ml. of serum which will liberate 
1 mg. of phenol in 15 minutes at 37° under the test 
conditions. These units must be multiplied by 7*1 to convert 
them to I.U./litre (King and Campbell, I96I).
Other biochemical tests of liver function were estimated 
by standard routine methods. Serum bilirubin was measured 
by the method of Mal3-oy and Evelyn ( 1937 ) # thymol turbidity
— 2 3 “
and flocculation as described by Maclagan (1944) and zinc 
sulphate turbidity by the method of Kunkel (1947)*
-24.
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© Dehydrogena9e Bstimatiom 
Bell and Baron (i9 6 0 ), In t h e i r  original -publication 
on the colorimetric measurement of 8-lOD, undertook a 
detailed investigation into the effects of various réaction 
conditions, e.g. kinetics of the reaction with time and 
temperature, substrate and coenzyme concentrations, metal 
ion cofactor requirements, and quantities of test m a t e r ia l  
(serum) used.
Xn the present investigation, it was felt necessary to 
check on the reproducibility of the m ethod by performing 
duplicate analyses and also v a r y in g  the amount of serum  
and incubation time, in o r d e r  to cop© with specimens with 
high S-IOI) a c t i v i t y ,
A numbe'r of specimens were analysed in duplicate at 
-the commencement of the investigation and r e s u l t s  on 10 
sera covering a wide range of enzyme activity are shown in 
T a b le  1. Very good reproducibility occurred over the 
whole ra n g e  of activity studied.
Specimens with moderate to high activities ware also 
measured using reduced amounts of serum; results are shown 
in Table X where it can be seen that sreproduoibl© results 
were again obtained.
High activity specimen© were also analysed by varying 
the incubation time and it is shown by the data in Table 1 
that the reaction is linear with time over the 60 minute 
incubation period.
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TABLE 1.
DATA ON TilB ESTIMATION OP S-IGD TO SHOW THE HEPHODUCIBILITY 
OP THE METHOD. AMD VARIATION IN REACTION CONDITIONS.
Part AS“ S-ICD results of duplicate analyses
?cimen Serum 
ml.
Incubation 
t line 
min.
S - X C B  units/ml. 
Analysis Analysis 
no. I no. 2
1. 0.2 60 4 3
2. « # B 8
3 • Î9 SÎ 12 13
4. 19 t 13 14
5 . M SI 15 15
6. » 25 26
7 . 19 s 30 30
8. tî 33 34
9. 0.1 ÎÎ 55 53
10. SI 30 100 102
" S-IGD results u s X m c  different, .aliquots of serum.
ml •
0.2
of serum
0 . 1  0 , 0 5
IX. 60 21 22 20
7 o — tt 30 32 32
12. — 30 46 48 48
Part Os*- B-XCB result, Iwr different incubation times.
itfiTir-w<riifi''inMiV»i'i*‘iiff<i*'Tiriiii~ii"iir'ii'VirWfi<iiiii'>ïiiiii"'ii‘r i  jv w ii r, *i- rmii Aii m-TT-i,Tinni,iiwiinniPiii*i#wiii,m-n,i k i wiW* #.## 'wrf 1»iiww w  11 'i l 1 '■
8.
12.
13.
0,2
«
M
*
Incubation tlm©(mln.)
60 30 15
33 34 35
47* 46 48
32* 54 54
0 .Iml. serum used.
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Determination of a Normal Range for Serum ïsocitrate
i.as e #
Blood samples taîcen from 40 healthy people, aged from 
20-80 years, were used to determine a normal rang© for S-ICD 
activity* They included laboratory workea?©, medical 
students and pre-operative specimens taken from apparently 
healthy people admitted for minor surgery, e.g. repair of 
hernia. These gave a normal range of approximately 3-10 
units/ml. (mean 6.0, S.D. I.7)» which agrees almost exactly 
with the range quoted by Bell et al. (1962).
ISOCITRATE DEHYPHOGENASE IN HEPATIC DISEASE.
S-XCD activities in oases of various hepato-biliary 
diseases are classified in Fig*. 1. Each point represents 
on© S-XCB determination on a single case. The distribution 
of S-ICD values found in the various groups is shown in 
Table 2 v/here abnormal values are expressed as multiples of 
the upper limit of normal - 10 units/ml. 
a) Acute Hepatitis.
The patients were all suffering from infectious 
hepatitis and all had high values ranging from 33-224 units/ 
ml. Specimens were obtained within l4 days of the onset of 
symptoms except in two cases which gave S-ICD values of 104 
units/ml. at 22 day® in one case, and 54 units/ml. at 27 
days in the othex'.
“ 2 8 —
FIGURE 1.
S-ICI) VALUES XN DIFFERENT TYPES OF HEPATO-BILIARY DISEASE,
S-lCD 
u n its /m l. 
300n
200 -
100-
8 O ”
60-
40 ”
20 -
j
4
t
Acute
Hepatitis
Drug-
Induced
Jaundice
Portal
Cirrhosis
Biliary
Cirrhosis
Liver
Cancer
Obstruct. 
Jaundice
The normal ran^'© for S-IGD of 3-10 units/ml. is sliown by
the shaded area.
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TABLK 2.
DISTRIBUTION OF S-XOB RESULTS IN VARIOUS HBRM'IC DISEASES
Cases with Oases,with raised S^ -*XCD
* Hi_> 111 I i|i 11 A* a 'nii; iil~ni(i|i ■inr~i~iiM Oimwi '|Oi i>
normal S-^ XCp
,l»iôx 1.5-Zk 2-3x 3-4% >4x
upper limit of normal
Units/ml. 3-10 11-15 16-30 31-30 31-40 >40
Acute (1 3 ) 0 0 0 0 3 11
hepatitis
Portal (3 5 ) 7 11 4 2 0 1
cirrhosis
Biliary (?) 1 O 1 4 1 O
cirrhosis
Obstructive (53) 9 15 7 3 7
Jaundice
Subdivided
#5 i«a^W4^ meât/fCLis^ ittJtKiÆgitV* mKTVlULf .,* h ?»«*#
into S“
Malignant (11) O 3 2 3 1 2
with liver
secondaries
Malignant (14) 5 4 4 1 0 O
without liver
secondaries
Non-malignant (20) 4 8 5 3 0 0
without aci%t e 
inflammat ion
Hon-malignant (B) 0 0 1 O 2 5
with acute
Inflammation
Figures in parenthesis denote total no* of cases in each group.
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d Jatmdice.
There were three oases of jaimdioe attributed to the 
drug o h lo rp ro m a a ia e  # one due to promazine, and one case of 
poisoning by a phenolic disinfectant ( * Sa.nisial ® ) . 
Biochemical data on these cases are shown i n  Table 3,
The specimen on the first case (M.K.) was taken th r e e  weeks 
after commencing ohlorpromaisine therapy (50mg. t.i.d.)? the 
second (M.M.) was obtained 7 days after a single injection 
of 50mg. chlorproma^lneÇ and th e  third (H.G.) following a 
two week period of treatment with the drug.
The specimen fro m  patient H.N. was taken when jaundice 
If aa noticed approximately 10 days following a dose of 
promazine. Subsequent laparotomy showed no mechanical 
obstruction in the biliary tract, but liver biopsy produced 
histology consistent with obstructive jaundloe*
The jaundice caused by phenolic poiaoning in patient 
J»W. was found by haematology and subsequent post mortem 
to be haemolytic. Liver m orphology and histology was 
described aa n o rm a l. The high alkaline phosphatase was 
p ro b a b ly  due to the patient also having extensive bone 
f r a c t u r e s . The raised S«»XC1> i n  this case does not appear, 
therefore, to  be associated with liver damage or biliary 
retention.
The two highest S-IGl) values in this group ( 188 and 50 
units/ml.) were foxmd in two cases of liver necrosis 
caused, by a hyperseneitivity reaction to p-aminosaXleylic
31-
TABLIG 3
S-IGD VALUES AND OTHER BIOGKEMIOAL DATA ON
DRUG-INDUCED JAUNDICE CASES.
Case Sorura
bll.
Aik, 
pho s.
ZnSOr
Turb.
S-ttOT S-GPT B-ICD
(0.2-
1.7
4-12 0-2/0 3-12 5-50 0-50 3-10 )
ÏC—A 
unit 3^ 0
units units units/ml;
M.K.* 6.8 24 o/o 5 204 25
M.M.* 6.3 64 1/0 10 — 64 18
H.Ü.* 2.7 15 o/o 3 76 165 16
K.N. 6.8 44 I/o 2 - 13
9
J.W. 20.8 35 I/o 3 23
Normal range shown in parenthesis 
* Ghlorpromazine jaundice 
^ Promazine jaundice 
1 Phenol-induced jaundice
—acid. One of these cases was Investigated in detail.
This was a man, aged 20, who developed acute liver failure 
28 days after starting on 12g. p-aminosalicylie acid daily.
Ho was severely ill for two weeks, but eventually made a 
slow recovery. Biochemical tests showing the course of the 
acute hepatic upset are shown in Table 4. As can be seen, 
the patient became jaundiced and shoxved ample evidence of 
severe liver damage. The turbidity and flocculation tests 
were grossly abnormal and this was reflected by the changes 
in serum proteins where there xms an increase in the 
globulins (mainly Y globulin) giving an inverse albumin/ 
globulin ratio. The alkaline phosphatase showed a high 
value indicative of biliary obstruction. The transaminases, 
hoxfever, reached values found only xfith acute hepatocellular 
damage, indicating extensive liver cell damage. The S-ICD 
was also considerably raised, this fitting in very well with 
the other biochemical findings.
Once the patient had fully recovered, it xfas decided to 
confirm the diagnosis of a hypersensitivity reaction by 
giving a challenge dose of p-aminosalicylic acid. This 
offered the opportuniter for investigating, biochemically, 
the occurence of possible hepatocellular damage.
The patient x\ras given a 3g* dose of p-amino salicylic 
acid and serial blood samples wei^ e x^ithdraxm at time 
intervals shown in Table 3* There was an Increase in the 
activities of S-ICD and S-GPT to abnormal values, and the
T A B U S  4.
BIOCHEMICAL DATA ON A CASE OF L I W R  DAMAGE
CAUSED BY..._pra m i n o s a l i c y l i c AGID
Bili- 
rtab in
TT/TF* %nSOr
Turb.
Proteins
Alb./Olob
Allc. 
• phoa
S-GOT' S-GFi' S-I«
mg * io unit a unite K-A
units??»
unita/ml •
Normal 0 . 
Range 1.7 0-2/0 3-12 3.9-/1.7 
3.5 3.0
4—12 5-50 0-30 3-11
Dayst
28 2.3 2/0 3 3.4/2.0 34
33 8.3 4/I'l 8 4.0/2.6 53 432 728 50
4o 1.8 10/+4 24 3.3/4.2 23 214 500 18
46 0.5 3/+3 27 4.5/3.7 16 42 186 3
34 0.3 6/'}'3 15 5.0/2.7 11 20 44
76 0.4 4/0 14 4.7/3.7 9 21 25 —
138 0.5 2/0 9 4.8/2.3 7 13 16 5
^Thymol t'arbidlty/thymol flocculation
Days after commencing p-aisiinos alley lie acid therapy
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BIOCHEMICAL DATA ON LIVER CELL DAMAGE FOLLOWING A TEST
""   -     . i muMii w m ii II II iiirnu
DOSE OF D-AMINOSALICYLIC AGID.
Tim© Serum
bllitiubin
Alkaline S-GOT S-GPT S-XCD
(0.2-1.7
mg. fa
4—12 
K-A unitsÇS
5-50 0 - 5 0  
units/ml#
3-10
0 hours 0.5 7 13 16 5
2 7 21 18 5
6 ” 5 25 16 6
12 " 6 6 10 5
24 '* 0,4 5 11 14 7
2 days 0.7 6 42 43 14
3 - 6 38
4 « 0.6 6 25 11
y I — 6 32 là
9 0.6 6 22 31 7
Abnormal values are underlined.
Time following the administration of a 3g. dose of
p-aminosalicylic acid.
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S-GOT also seemed to show a slight rise, although never 
to abnormal values. Two other enzymes not reported here - 
sorbitol dehydrogenase and adenosine deaminase •» also 
produced abnormal values over this period (Watts and 
Griffiths, 1964). The serum bilirubin showed no evidence 
of subclinioal jaundice and the alkaline phosphatase did 
not increase. But the response of the enzymes coincided 
xflth symptoms of general malaise and liver tenderness and 
were believed to be conclusive evidence of subclinioal 
liver cell damage.
c) S-ICB in Cirrhosis.
Twenty-five cases of portal cirrhosis showed variable 
S-ICD results. Seven cases (2B?J) had a normal value, the 
majority of the abnormal results were only minimal rises 
(below 15 units/ml*), xfhile only three cases gave values 
above 20 units/ml. Bell et al. (1962) defined a 
decompensated case of cirrhosis as one x\rith a serum 
bilirubin greater than 2 .Omg./lOOml. and a serum albumin 
less than 3*0g./l00ml•, and attempted to correlate the S-ICD 
with the degree of compensation as assessed by these 
criteria* In the present series, the S-XCD values were 
not related to the compensation of the patient.
d) Biliary Cirrhosis.
All these oases were diagnosed xvith the aid of liver
— 36—
biopsy. Only one of the 7 cases had a normal S -IC D , and 
subsequent specimens ta k e n  from that case produced S -IC D  
values of 15 and 12 units/ml.
e ) M a lig n a n t  In v a s io n  o f  th e  L iv e r .
Fifteen cases of invasive cancer of the liver all 
gave raised S-XCD values ranging from 12-57 units/ml.
These included 11 cases with liver métastasés from different 
primaries, two reticulosarcomas and one lymphadenoma. One 
case of primary liver hepatoma had an S-ICD of 4? units/ml.
f) S-XCD in Obstructive Jaundice.
All analyses in this group wore carried out on pre- 
operative blood specimens. In no case was there clinical, 
biochemical or operative evidence of concomitant liver cell 
injury, although in the majority of cases liver biopsy 
specimens x^ rero not taken to confirm this. In those cases 
where biopsy specimens were obtained, the histology was 
compatible with uncomplicated biliary obstruction. Fifty- 
three cases xfere investigated. Of these, only 9 (17/?»^) had 
normal S-ICD activity. Fifteen cases had minimal
increases (up to 1.5 times the upper limit of normal),
19 cases {36fo) had moderate increases ranging from 3.6-30 
units/ml., and the remainder (19/0 had high values up to 
52 units/ml.
Gases of obstructive jaundice were divided into 4 groups
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as shown In Table 2 (p.29):-
1, Malig^nant obstructive .jaundice with metastatic spread 
to the liver* Those cases were classified with the liver 
cancer cases in Fi^, 1. They were diagnosed at operation 
and/or post mortem,
2, Malignant obstruction with no evidence of liver 
métastasés, Again the diagnosis was made at operation or 
autopsy.
3. A non"*malignant, non^inflammatory group comprising 
cholelithiasis and chronic cholecystitis with little or no 
evidence of an acute inflammatory process occurring at the 
time of blood withdrawal, when applying the criteria stated 
below.
4. Non-malignant obstruction accompanied by acute 
inflammation at or near the time of blood withdrawal. The 
criteria for inclusion in this group were^ operative or 
pathological evidence of acute inflammation of the gall 
bladder or biliary tract, or pyrexia over lOO^F or 
pronounced leucocytosis associated with jaundice when no 
other cause was apparent when the blood specimen was taken.
The distribution of S™ÏCÎ) values in these groups is 
shotm in Table 2, and statistical analysis of the data is 
presented in Table 6. It can be seen from the latter 
Table that secondary invasion of the liver in malignant 
obstructive jaundice gave significantly higher S-XCl) values, 
but this was not invariably so as there was some overlap
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TABLE 6.
SERUM ISOGXTïlATK DEHYDROGENASE IN OBSTRUCTIVE JAUNDICE.
Group No . of
S-XCD units/ml 
Mean ± S.D, t P
Malignant with 
liver secondaries
Malignant without 
liver secondaries
11
14
Non-malignant without 
acute inflammation
20
27 ± 14.7
13 ±  6,8
13 dr 3.8
3.244 <0.005
0.928 n.Q.
7.938 <0.001
Hon-malignant with 
acute Inflammation
8 42 ± 12,3
^ values were obtained by applying the Student t test 
between the means of the various groups.
between groups 1 and 2 (Table 2), There was no significant 
■difference between S-TGB values found in uncomplicated 
malignant and non-malignant cases (groups 2 and 3), and the 
spread of results was similar in the two groups. Although 
the group with acute inflammation was small compared with 
the non-inflammatory group, the S-XOB values in the fo rm e r  
group showed a high degree of significance from those of 
the latter (P <0*00l). As can be seen from T a b le  2 (p*29) 
there was very little overlap b etw ee n  these groups, only 
one case from the inflammatory group having an S-XGÏ) as low 
as 20 units/ml, and falling within the range of the non- 
inf 1 ammatcry group. It should be mentioned that three 
oases were not included in either of these groups as their 
classification was equivocal. Two had very high S-ICI) 
values (47 and 52 units/ml.) and also showed some evidence 
of acute inflammation, but not sufficient to satisfy the 
criteria for inclusion in the inflammatory group. When 
the blood specimens were taken, both had pyx'exia just below 
lOO^F and one also had a slight neutrophilia. There was 
no evidence of an acute Inflammatory process at operation 
l4 days later in one case and 5 days later in the other.
The third ease had an S-XOD of 8 units/ml,, and although 
there was no clinical evidence of inflammation when the 
blood specimen was taken, pus was found in the biliary 
tract at operation 8 days later.
Fig. 2 sîiows serial analyses of S-ICD, transaminases 
and alkaline phosphatase on on© of the cases in the non­
inflammatory gx'oup. This man had an operation for mild 
obstructive jaundice which proved to be due to multiple 
adhesions surrounding the gall bladder. There was no 
evidence of acute inflammation. He developed, post- 
operatively, an infection associated with jaundice which 
persisted for 8 days. The S-XCl) showed a very pronounced 
rise to 58 units/ml., whereas the tranaaiiiinaaos, whilst 
giving a sharp increase, remained within the range generally 
seen in obstructive jaundice (both below 400 units/ml.).
The alkaline phosphatase was also greatly elevated. The 
turbidity tests and serum proteins remained normal. It 
seems likely that this man developed a post-operative 
cholangitis•
Table 7 shows the S-XOB results on the non-inflammatory 
benign -cases and malignant obstructive Jaundice cases with 
no liver métastasés divided on the basis of duration of 
symptoms. The onset of symptoms was taken in its widest 
sense, i.e. the first indication of abdominal or biliary 
upset, however vague or non-specific. It seems obvious 
that the S-ÏCD results were distributed irrespective of 
duration of symptoms,
Xn some of those cases, the S-XCl) was determined 
post-operatively after successful surgical relief of the 
biliary obstruction. The B-XCD returned to normal fairly
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F X a U H I S  2 *
SERUM imzrms XH a oasis of POST^OPBHATIVE JAWDIOE 
ASSOCIATED WITH INFECTION.
S-ICD units/ml. 
K-A units/100ml.
601
50 S-GPT
S-GOT
units/mi.
r40040
-30030-
ALKALINE
PHOSPHATASE
20 -
\  S-CPT
10
S-ICD
S-COT 1-0
BILIRUBIN
c* 6i
2010
OPERATION
DAYS
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SylCD ÏN OBSTRUCTIVE JAUNDICE CASES WITH
VARYING DURATION OP SYMPTOMS.
Gyoup No.of 
cases
units/aiX • 
8-IGD Mean
Patients with ayniptoms of 
X wee It or less duration
Xk
Patients with symptoms 
of îi-3 weeks duration
9 XX-X6 l4
Patients with symptoms 
of X-3 months duration
XX 3-^9 x4
Patients with a long past 
history of biliary upset 
or abdominal symptoms
4*** s4 13
Cases included are those with malignant obstruction without 
liver métastasés and non-malignant without acute Inflammation.
"h 3“
quickly in those eases which showed a raised pre*»operative 
8-lGD.
SERUM TKAMSAMINASE RESULTS.
In many of the patients studied, either one or both 
of the transaminases were measured. The distribution of 
results for the S-0OT and S^CPT are shown in Tables 8 and 9* 
It can be seen that, as expected, both transaminases 
produced very high values In acute hepatitis with all values 
well above 400 units/ml. The S-GFT usually showed greater 
increases than the S<*UOT (Fig. 3» p#49) •
There was a wide scatter of results for both trans- 
aminases in portal cirrhosis. The S-GPT was normal in 60fo 
of cases and the S-GOT in 4o^L Elevations in activity 
were in general only moderate and values for both 8-GOT 
and S-GFT were usually well below 300 units/ml., except in 
two oases which produced S-GOT results of 304 and 312 
units/ml. These results in no way correlated with the 
clinical status of the patient.
In obstructive jaundice, the results were again very 
variable and were scattered fairly uniformly over the range
0-400 units/ml. A normal S-GFT was found in 13^ of the 
oases and normal 8-GOT in 21^ 4. There was a random 
distribution of abnormal results in the 4* groups of extra- 
hepatic biliary obstruction. Statistical analysis of these 
results is shown in Table 10 for the S-GPT and Table 11 for
TABLE 8.
DISTRIBUTION OF B-OPT RESUJ..TS XH VARIOUS HEPATIC DXSEASBS *
Cases with Oases with raised •GIYT
normal S-GPT
1 1^-2% 2-3% 3- 4x 4-8x
Upper limit of normal
Units/ral• 0-30 31-
73
76-
100
101-
130
131“
200
201-
400
>400
Acute (i3) 
hepatitis
0 0 0 0 0 0 13
Portal {20) 
cirrhosis
12 2 2 3 1 0 0
Biliary (?) 
cirrhosis
1 0 X 1 2 2 0
Obstructive (39) 
jaundice
3 4 7 8 3 10 0
Subdivided 
into)-
Mali gnant (9) 
with liver 
secondaries
1 3 0 3 1 1 0
Malignant (10) 
without liver 
secondaries
4 0 1 2 0 3 0
Mon-malignant(^3) 
without acute 
inflammation
0 1 3 3 1 3 0
Mon-malignant(7) 
with acute 
inf1ammatIon
0 0 1 0 3 3 0
Figures in parenthesis denote total no. of cases in each group
DISTRIBUTION OF S-OOT RESULTS IN VARIOUS HEPATIC DISEASES.
Oases with 
normal S-GOT
Unit e/ml • 3-“ 3G
Acute
hepatitis
Portal
cirrhosis
Biliary
cirrhosis
Obstructive
jaundice
Subdivided 
into 5-
(13)
(21)
(7)
(28)
Malignant (6)
with liver 
secondaries
Malignant (8)
without liver 
secondaries
Mon-malignant(9) 
without acute 
1nf1ammat ion
Hon-malignant 
with acute 
i n f1ammatIon
0
0
2
2
0
Caaes ^with raised S-GOT
1-1.3% 13“ 2-3% 3-4% 4-8% >Bx
upper limit of normal
31- 76- 101- 151“ 201- >400
75 100 130 200 400
0
4
0
0
2
2
0 0
2
0
1 2
2
0 2
2
1
1
0
C)
13
0
0
o
0
0
0
0
Figure© in parenthesi© denote total no. of case© in each group.
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TABLE 10.
SERUM GLUTAMIC PYRUVIC TRANSAMINASE IN OBSTRUCTIVE JAUNDICE.
Group
Malignant with 
liver secondaries
S-GFT unita/ml. 
No.of Mean ± S .D .
cases
qfcaaaKwiiHWimwiig'iU/»
9 112 ± 87
0.64-3 n.s.
Malignant without 
liver secondaries
10 143 ± 131
0*188 n.s.
Non-malignant without 13
acute inflammation
133 i- 71
2.108 n.s.
Non-malignant with 
acute inflammation
231 ± 123
^ values were obtained by applying the Student t test 
between the means of the various groups.
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TABLE 11.
SERUM GLOTAMIC 0XALACBÏ1C TRANSAMINASE IN OBSTRUCTIVE JAUNDICE.
Group
S-GOT im.its/ral.
No.of Mean ±  S * D.
cases
p
Malignant with 
liver secondaries
126 ± 104
0.377 n.s
Malignant without 
liver secondaries
8 124 4r 99
0.937 n.s.
Non-raalignant without 9 
acute inflammation
88 ± 49
1.700 n.s.
Non-malignant with 
acute inflammation
163 ± 124
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tli© S-GOT. Ho significant difference oould be detected 
between the groups for either of the transaminases. The 
S-GPT, however, Just missed sign!floanee at the level 
between the s^on-inflammatory and inflammatory groups and 
a difference may well have shown u%) with a great0$? number 
of inflammatory cases*
Fig. 3 shows the ratio of S-GOT to S-GPT in patients 
who had either one or both of the transaminases raised 
Eibov© normal. It shows clearly the diagnostic advantage 
of this ratio, over the absolute values for the transàminases 
In chronic liver damage where it is almost invariably 
greater than 1.0. Only one of 13 oases showed a ratio loss 
than this (0*92)* It can be soon that in the majority of 
cases of othax^  types of hepatic disease, the S-GPT was 
usually higher than the S-GOT*
ALKALINE PHOSPIIATASK RESULTS.
Serum alkaline phosphatase was determined in all the 
patients studied, and the results obtained are shown in 
Table 12* In all but two of the cases with acute and 
chronic liver cell damage, the alkaline phosphatase ivas 
below 30 K-A units/100ml. One case of viral hepatitis 
had an alkaline phosphatase of 42 K-A units/lOOml•, and 
one case of portal cirrhosis had a value of 54 K-A units/ 
100ml. Xn biliary cirrhosis, the alkaline phosphatase 
tended to be higher, with 4 out of 6 cases having values
— 4^ —
FIGURE
r a t i o  o f S-GOT TO S-Gl'T IN VARIOUS HEPATO-BILIARY UTSEAKES.
S-GOT
S-GPT
30-
20 -
1-0
Acute
%
<
u
:
Obstruct, J Liver
•  4*2
Biliary Portal
Hepatitis Jaundice Métastasés Cirrhosis Cirrhosis
TABLE 12.
DISTRIBUTION OF SERUM ALKALINE PHOSPHATASE RESULTS    iMvm f M l , w riwawMawmimn w ii i wiwiumuu*. ,*!« *««mw#
IN VARIOUS HEPATIC DISEASES.
Cases with 
normal alk.  ■ ■•■ -.     “ - " -iwwwMitmd»
ase
K-A units/lOOml. 4-12
Acute
hepatitis
Portal
cirrhosis
Biliary
cirrhosis
Obstructive
jaundioo
Subdivided 
into 3-
Malignant 
with liver 
secondaries
Malignant 
without liver 
secondaries
Mon-malignant 
without acute 
inflammation
Non- mal i gnant 
with acute 
inf1ammat ion
(12)
(%5)
(6)
( 53)
(20)
(8)
1
10
3
(11) 0
( 14) 0
Gases with raised
1- 10%  1^ - 2%  2- 3%  3“ 4x > 4x
upper limit of normal 
13-18 19-24 23-36 37-48 >48
0
0
1
2
2
0
0
2
0
0
26
8
12
2
0
0
0
0
12
2
Figure© in parenthesis denote total no. of cases in each group*
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above 30 K-A units/XOOml*, and three of these k had very 
high values of 80, 90, and X04 K-A imits/lOOml*
The enzyme had siormal activity in only 6fo of 
obstructive jaundice cases* Twenty-two cases ( had 
valu<^8 below 30 K-A unite/XOOml* g 11 of these, however, 
were between 23 and 30 K-A units/lOOml* Xn considering 
the different typo© of obstructive jaundice, it is clear 
that the presence of liver secondaries gave, in general, 
higher alkaline phosphatase values than in the other groups. 
This is'shown in Table 13 where statistical analysis 
between thé groups gave a significant difference between 
mallgmmt cases with secondary liver involvement and those 
without liver métastasés (P 0 ,02). Five of the cases 
with liver ©econdaries had extremely high values ranging 
from 63-152 K-A unite/lOOml*
GOMPARXSON OF S-ICD RESULTS WITH SERUM THANSAMINASES *
S-XGD values could be compared with one or both of 
the transaminases when these enzymes were determined in the 
same blood specimen§ this applied in the majority of cases* 
Acut e He pat i tis*
S-XGD was compared with both S-GOT and S-GPT in the 13 
cases of viral hepatitis. In all of them, high S-XGD 
values were invariahly accompanied by high transaminase‘ . 
activities* Xt can be seen from Fig# 4, however, that the 
correlation for S-XGD with respect to S™GPT - 0*49 (P<^0*02),
5 2 -
TABLE 13
 .........  n r f i> p
SERUM ALKALINE PHOSPHATASE IN OBSTRUCTIVE JAUNDICE.
No* of 
case©
K-A units/lOOmI*
Moan dt B.B. t P
Malignant with 
liver aeoondaries
11 67 ± 39
2,736 <0,02
Malignant without 
liver secondaries
14 33 i* 13
0,378 n.s.
Hon-malignant without 20 
acute inflammation
33 ± 15
0.391 n.s •
Mon-malignant with 
aout© inflammation
8 30 ± 25
^ values were obtained by applying the Student t test 
between the means of the variotis groups.
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PIGUHIS 4,
RELATIOMSHXP OF S-IÜP AMD SKRTM TRANSAMINASES
IN ACUTK HEPATITIS.
CASES O F INFECTIOUS HEPATITIS
S-G PT  
S-G O T  
units/ml.
3000-
2500-
2000-
1500-
1000-
OO
OO
500-
i6o 200 250
S-ICD units/ml.
•  S-ICD c o m p a r e d  WITH S-GPT 
O S-ICD COMPARED WITH S-GOT
and with respect to S-GOT », 0.35 (P < 0 .003) > was low.
On the other hand, Fig. 3 shows how the S-IGD can 
mirror the transaminase results. These sequential enayaie 
values were obtained from a young girl who had a severe 
attack of viral hepatitis with a very slow recovery period. 
The response of the S-XOI) and transaminases was almost 
identical. The first specimen was obviously taken early 
in the developement of liver damage, as the peaks of enzyme 
activity had not been reached. The initial rise and fall 
of S-XCD was very similar to that of the transaminases, and 
this is also shown very clearly in the period 20-30 days, 
when there was a secondary rise in enzyme values due to the 
premature ambulation of the patient. All the enzymes were 
markedly elevated after 70 days and indicated the probable 
onset of chronic liver damage.
The extent to which each enzyme rises may be expressed
by the ratio - M » maximum activity measured after Bodansky
upper limit of normal
et al. (1962)• This was determined for S-ÏCD, S-GPT and
S-GOT in all the infectious hepatitis cases. The
comparative rise in S-XCÏ) activity was then compared with
that of S-GPT and S-GOT; this is shown in Fig. 6 and
illustrates the fact that in all but two cases, both serum
transaminases produced a higher response than the S-XOP.
Xn the other two cases of acute hepatocellular damage, 
caused by p-aminosalicylic acid, high S-lCl) values again 
coincided with high transaminase results; this is shotm for
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SERUM EK2YMKS IN A CASE OF BEVICKK INFECTIOUS HEPATITIS •
S-GPT
S-GOT
units/m l.
3000-
2500-
2000-
1500-
1000 -
500-
0
BILIRUBIN
S-lCD
units/ml
-200
-150
-100
-50
S-tCD
30i
20
cft 10-
DAYS
— po—
FIOtJRB 6
COMPARISON BKÏWOEN THE RISE IN S-IC]) AND TRAWSAMINAS35
i ' i» iin ii>r r 3n>wiw r t f irtt4^t wiji3CU ji
ACTIVITIES IN ACUTE HEPATITIS•
CASES OF INFECTIOUS HEPATITIS
7*0'
6*0
5-0
4-0 ■
30-
2 0 -
10
#118
-
#
•
•
#
#
# #
•
# #
•
#
#
: *
•
# # I
#
#
M S-COT M S-CPT
M S-ICD M S-ICD
M for each enssyme =ï maximum activity measured
upper limit of normal
"py-
one of the cases In Table 4 (p# 33)* The S-XCD fell back 
to normal values much sooner than the S-GPT* Xn the 
subsequent experiment involving the test dose of p-amino­
salicylic acid, the S-XGD was probably slightly more 
sensitive than the S-GPT, and definitely more so than the 
S-GOT, in reflecting the subclinical hepatic dysfunction 
(Table 5 i P* 3 4 )# In the other case, the very high S -IC D  
value of 188 units/ml. corresponded to an S-GPT of only 
1035 units/ml* and an S-GOT of 573 units/ml* Eight days 
later, the 8-IGD had fallen to 32 units/ml*, the S-GPT to 
342 and the S-GOT to l40 units/ml*
Portal Cirrhosis*
In chronic liver damage, cases showing raised S-GOT or 
S-GPT activities usual3-y had an S-ICD above normal, the only 
exceptions being two oases with minimal rises in serum 
transaminases who had normal S-ICD values * The correlation 
between S-IGD and both transaminases is shown in Fig. 7* 
Statistical analysis of the data showed that there was a 
slightly closer relationship between the S-IGD and S-GPT, 
with a significant correlation coefficient of 0*79 (P<0*001), 
than between the 8-IGD and S-GOT with a significant 
coefficient of 0*65 (P ^  0*005)* None of these enzymes 
were related, however, to the clinical state of the patient*
Xt should be noted that the ratio of S-GOT to S-GPT 
was greater than 1*0 in all but one case, and gave a more
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li'IGOTîïï 7.
RBULTIONSHIP OF S-lCD AMP SERUM TRANSAMINASES
— ,1.   '      11**1" mwiinoiT n u Bihwii  ^ ii iw r iiW»mi i inr i m ; i n  ^ o # ' i * wm w r ; * iw#i %*iUiiii»’i» i u  ,WA —   .............................
XN POHTAL CIRMIOSIS.
CASES WITH PORTAL CIRRHOSIS
S-GOT 
u n its / m l .
r = 0 *6 5 (P < 0 -0 0 5 ) S-GPT 
units/ml
r=0-79 (P <0*001)
200 -
1 5 0 -
100-100-
— #- -«I--#-5 0 -5 0 -
e'o5 0 6 03 0  40
S-ICD units/ml.
5 0104 0 2030
S-ICD units/ml.
10 20
r =a correlation coefficient
Broken linos indicate the upper limit of normal for each 
ensymo•
consistent pattern than the wide variability of the 
individual S-XCÎ) and transaminase values #
Biliary Oirrhoaia»
The S-?XCB was closely related to both transaminases in 
all 7 cases of biliary cirrhosis. This is shown ±n Fi^. 8# 
which includes two sets of results from one patient. 
Statistical analysis gave very good correlation coefficients 
of 0.93 (F <^0.001) for S-ICI) with respect to S-GPT and 0.82 
(P <0*02) for S-ICD with respect to B-GOT.
Obstructive Jaundice.
The S-ICD could be correlated with the S-GPT in 20 
oases of benign biliary obstructionî 7 of these were in the 
acute inflammatory group. In the malignant cases $ the S-ICD 
and S-GPT were both estimated in 19 cases - 9 with liver 
métastasés and 10 without. The correlation between the 
two enzymes is shown in Fig. 9« and, as can be seen, is not 
very pronounced. In the cases of uncomplicated obstructive 
jaundice (the non-inflammatory benign group and malignant 
obstruction without liver métastasés), the correlation 
coefficient for S-ICD and S-GPT was 0.43 (P<0.05).
In the non-malignant group, the higher S-ICD values 
associated with acute Inflammation were reflected by the 
S-GPT in only two cases. In addition, no significant 
difference could be shown statistically between the S-GPT
-ou-
FIGURE 8,
RELATIONSHIP OF 8 -IG D  AND SICRUM TRANSAMINASES 
IN  B IL IA R Y  CIRRHOSIS.
CASES OF BIUARY CIRRHOSIS
S-GPi;
S-GOT
units/ml.
300-
200
100
3020
S-ICD units/ml.
•  S-ICD COMPARED WITH S-GPT 
O S-ICD COMPARED WITH S-GOT
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riGUI# Æ.
RICLATIONSHXP OP S-ICB AMD S~GPÏ VALUES   t i ;#»* i##' [w miiimiymumiiM#
IN OBSTiWOTIVB JAUNUXC35.
#<»m*  i * i i r iw « **  n^ wn— w n
CASES OF OBSTRUCTIVE JAUNDICE
NON-MALIGNANT CASES MALIGNANT CASES
S'GPT 
units/ml.
S-GPT 
units /ml.
400 -I 4001
300-
200- 200-
100 - 100-
) 30 40
S-ICD units/ml.
60 10 20 40
S-ICD units/ml.
50 60
•  WITHOUT ACUTE INFLAMMATION
O WITH ACUTE INFLAMMATION
•  WITHOUT LIVER METASTASES 
O WITH LIVER METASTASES
Broken lines indicate the upper limit of normal for each 
enzyme «
— O «C“
results obtained from the inflammatory and non-inflammatory 
groups (Table 10, p# 46), whereas the S-XCI) values in these 
two groups showed high significance (Table 6, p.38).
In the malignant cases# it can be seen from Fig. 9 
that S-XGD tends to give comparatively higher results than 
the S-GPT when there is secondary Involvement of the liver. 
There was not sufficient oases# however# to show a 
statistically significant difference between the regression 
coefficients for the two groups as shown under the malignant 
oases in Fig. 9*
There were fewer cases in which the B-IGI) and S-GOT 
could be correlated; these were 14 non-malignant cases 
(5 with acute inflammation) and l4 malignant cases# 6 of 
which had liver métastasés* The S-GOT and S-ICI) results 
on these cases are shown in Fig. 10. There were 
insufficient results to show a significant correlation 
between the two enzymes # but it can be seen that these 
results mirror those found for the S-XCD and S-GPT shown in 
Fig. 9.
SpICD HFSITLTS OOMPARICI) WITH ALKALINE PHOSPHATASE AND OTHIOR 
TFSTS OF LIVER FUNCTION.
a) Alkaline Phosphatase.
There was little point in considering these two 
enzymes in relationship to each other except in cases of 
obstructive Jaundice# where the alkaline phosphatase might
•6>
FXaUKE xo.
RELAX ? OF S-IC» AND S-G<yr VALUES .... —   ----------nstiattb«<eÆsàâ»s
OBSTRUC'JI'IVE JAUNDICE.
s-Gor
units/m l.
CASES OF OBSTRUCTIVE JAUNDICE 
NON-MALIGNANT CASES MALIGNANT CASES
S-GOT
units/ml.
400n 4001
30 0 -3 0 0 -
200- 200-
100- 100*
f -
30
S-ICD units/ml.
20 6010 5040 4 020 30
S-ICD unlts/ml.
50 60
# WITHOUT ACUTE INFLAMMATION 
O WITH ACUTE INFLAMMATION
•  WITHOUT LIVER METASTASES 
O WITH LIVER METASTASES
Broken lines indicate the tipper limit of normal fo3? each 
enEsymo •
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be considered ae a'possible index of severity of biliary 
retention. This is illustrated in Fig. 11 and shows that 
there is no correlation between the two enssymes. Although 
both ©nsaymes showed abnormal values in all oases with liver 
métastasést the alkaline phosphatase tended to give greater 
increases in activity than the S-XCD* Acute inflammation 
in the benign group did not affect alkaline phosphatase 
values in the same way as it did the activity of S-XCI)
(of. liable 6, p.38and Table 13, p.52),
b) Serum Bilirubin.
Xn the cases of acute and chronic liver damage there 
was no correlation between the S-XCD values and degree of 
hyperbilirubinaemia. Xn obstructive jaundice, the 
concentration of serum bilirubin may also be considered as 
another index of degree of biliary retention. Fig. 12 
shows that there is no corsrelation between S-XCD and 
bilirubin in the uncorai>licated cases of extra-hepatic ' 
obstruction.
o ) Thymol Turbidity and Flocculation Tests, and %ino. Sulphate 
Turbidity Test.
These teats of liver cell integrity depend upon 
quantity and quality of proteins produced by the hepatic 
cell and passed into the blood stream. They show up damage 
to liver cells when abnormal amounts of protein enter the 
circulation and cause turbidity when serum is added to 
certain buffered solutions. Consequently, these tests
—63**
FXGDHB :iX .
COMPARISON OF S-XCD AND ALKALINE PHOSPHATASE RESULTS
IN GASES wm-I UNCOMPLICAT3DO OBSTRUCTIVE JAUNUIC3C.
5iaeH|3M!Hnsie*rstiFp6iii
ALKALINE 
PHOSPHATASE 
K-A units/IOOmI,
80-]
70-
60 -
50 -
40 -
oo
30 -
#o
20
1510 20 30255
S-ICD  units/ml.
•  MON-MALIGNANT CASES WITHOUT INFLAMMATION 
O MALIGNANT CASES WITHOUT LIVER METASTASES
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COMPARISON OF S-XGD AND SI3RXM BXLXHIJBXN RESULTS IN
CASKS IfXTH UNGOMPLXCATKI) OBSTRUCTIVE JAUNDICE,
SERUM
BILIRUBIN
mg./100ml.
30-
25-
20 -
15-
10 -
3020 2510
S-ICD units/ml.
•  NON-MALIGNANT WITHOUT ACUTE INFLAMMATION  
O MALIGNANT WITHOUT LIVER METASTASES
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usuRlXy show abnormal values In conditions causing 
dysfunction of hepatic cells.
Eleven of the 13 cases of infectious hepatitis showed 
abnormaXitiea in one or both of the tiarbidity tests on the 
blood specimen taken for S-XGD estimation. However# the 
degree of upset of these tests was in no way related to the 
S-XCD value obtained. This also applied to the cases of 
chronic liver damage. Whereas the S-ICD showed variable 
results in portal cirrhosis and 289^  of the oases had normal 
values# all but one of the 2!5 cases had upset in the protein 
turbidity tests. The B-XGD was not# therefore, related to 
these indices of liver cell damage. This is also 
illustrated in Table 4 (p.33) concerning the patient with 
hepatocellular damage from p-aminosalicylic acid# where it 
can be seen that the maximal response of the S-ICD# S-GPT 
and S-GOT preceded that of the turbidity tests and upset in 
serum proteins# which remained at abnormal concentrations 
for a long period after the enzymes had returned to noinual.
By definition of obstructive jaundice without 
biochemical evidence of hepatocellular complications# all 
the cases in the obstructive jaundice group had normal 
turbidity tests# and the^ r could not# therefore# be compared 
with S-XCD results.
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PART 1.
DISCUSSION.
—In putting forward any new tost of llvor function# 
enzymic or otherwise * two factors are of prime importance 
for the test to be of real use as a diagnostic tool# a) 
that it should have epeoificity for oei^tain tyj^os of liver 
dysfunction# i.e. it can he used in the differential 
diagnosis of jaundice# and b) the test should preferably 
bo sensitive so that early diagnosis of the liver upset 
can be obtained.
The set of liver function tests now normally emplo^red 
in most clinical chemistry laboratories have been selected 
primarily for the above reasons* These tests consist of 
the determination of serum bilirubin for the diagnosis of 
Jaundice# gross or subolinioal, and for following the 
progression of the jaundice g protein precipitation tests# 
e.g. thymol turbidity and flocculation tests and zinc 
sulphate turbidity teats, which reflect changes in quantit^r 
and quality of plasma proteins which occur with chronic or 
acute liver cell damage 5 alkaline phosphatase because of 
its specificity in differentiating between Intra- and extra- 
hepatic jaundice.
These tests are not 100^ specific for a particular 
condition; this applies to the majority of biochemical tests 
in clinical use. Thus # increases in serum bilirubin can 
occur without damage to the liver or interference with 
biliary excretion# e.g. haemolytic Jaundice due to excessive 
breakdown of red blood cells ; the turbidity and flocculation
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tests may be abnormal In other conditions causing changes 
in plasma proteins without damage to liver cells, e.g. 
Hasiiimoto’s disease, long-standing infections ; alkaline 
phosphatase, which may be raised in any type of liver 
condition, but with a value above 30 ÎC-A units/l00m3-. in 
a jaundiced patient diagnostic of obstruction in the biliary 
tract, can show high values also in certain bone diseases, 
Big. Paget’s disease-or bone métastasés. However, in the 
jaundiced patient, the composite application of these tests 
can give a useful index of the probable type of liver 
pathology éxcept in complicated or atypical cases.
Adjuncts to these basic testa are the estimation of 
scrum transaminases, S-GOT and S-GPT, which have become 
widely used as testa of liver function. Their importance 
arises mainly from their great sensitivity in detecting 
acute necrosis of liver cells. This may be gross as in 
viral or drug-induced hepatitis where lÜOÿo diagnostic values 
for both transaminases will be found, or minimal where these 
enzymes can be used for detecting hepatic damage before the 
onset of jaundice, or abnormalities in turbidity testa, or 
clinical symptoms. The value of the transaminases in the 
differential diagnosis of jaundice is diminished somewhat 
because the enzymes are excreted into the bile and 
consequently raised values are seen in obstructive Jaundice. 
In addition, variable values may be encountered in chronic 
liver damage.
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In assessing the role of S-ICD in the diagnosis of 
different types of hepatic disease# the results to be found 
in the three main types of hepatic dysfunction# i.e. acute 
damage to liver parenchyma, chronic disease of the liver, 
and obstructive jaundice # must be studied in detail and the 
results compared with the information obtained from other 
liver function tests. It is obvious from previous 
publications that the enzyme should be compared closely 
with the transaminases, as their rôles as liver function 
tests will be very similar,
METHODOLOGY.
When considering a new analysis for introduction as a 
routine diagnostic test in clinical chemistry# it must be a 
method which will give reliable# reproducible results 
without presenting too many or severe practical i^roblems.
It is also desirable with enzymatic procedures that the 
conditions of analysis should be strictly adhered to and a 
check made against results obtained by other workers using 
the same procedure. It is quite po»aib3.e for an enzyme 
method to give varying resu3.ts from different establishments 
using the same procedure# due# perhaps, to differences in 
source or prepaaration of substrate or coenzymes, or 
apparatus used in the analysis.
The colorimetric determination of S-ICD# as described 
by Bel3. and Baron (1960)# was undertaken with no difficulty.
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Vevy reproducible results were obtained v/hich were 
comparable with Boll and Baron’s original, data on duplicate 
analyses# variations in incubation time# and volume of 
serum used* This was also reflected in obtaining an 
almost identical normal range as that quoted by Bell et ai. 
(1962) using the same method. Besides giving I'eliabl© 
results# the procedure pares anted no analytical problems.
The reagents were very stable# including the enzyme substrate 
when stored at 4^# except for the NADP solution which was 
made up fresh for each batch of analyses. A calibration 
curve using a-oxoglutaric acid was easily constructed and 
standards could be run along with tests as a check on 
reagents.
Serum enzymes could be stored at 4^ or -20^ for at 
least l4 days with negligible loss of S-ICD activity.
Wolfs on and Wi 11 iams Ashman (l95?u) stated that sera could 
be stored safely for many days at 4^# and Bodansky et al. 
(i960) stated that S-XCD was stable in a deep-freeze for 
21 days•
From a practical point of view# the estimation of S-ICD 
by the colorimetric method is comparable# and in some ways, 
better than that for the transaminases. The method was 
definitely superior to the colorimetric method used in this 
investIgation for both S-GOT and S-GPT# as the toluene 
extraction of the DNP-hydrazones was laborious and time- 
consuming. However # there are other improved methods for
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both transaminases which do not involve protein precipitation 
and toluene extraction (ReitEsan and Frankel, 1937) * The 
S-XCD determination has advantages over these methods as 
the calibaration curve is more linear and easier to construct, 
and very high enzyme activities are more accurately 
obtained by the S-XCD method using shorter incubation times 
and reduced sEumple size, than by equivalent procedure© with 
the transaminase methods* Bodansky et al. (i960) favoured 
the S-GOT in preference to the S-ICD, in part because the 
S-GOT was stable in the deep^freeze up to one year, whereas 
the S-IOI) was stable for only 21 days# This, however, is 
not a valid practical consideration as it is unusual and 
unlikely that periods of three weeks should elapse between 
v;ithdrawal and analysis of the specimen#
It can be stated from the outset, therefore, that when 
considering the S-ICD as a biochemical test of liver function, 
and particularly when comparing it with the serum trans­
aminases, the practical estimation of the enzyme present© no 
problem©, and, if anything, is somewhat superior to the 
transaminases in this respect#
ISOCITRATE DDHYBHO0XCNASB XM ACUTE HEPATITIS.
The highest S-XCD values recorded in this investigation 
all fell within this group and this confirms the findings 
of previous authors, e#g# Merten and SoXbach (1961) who 
found that acute hepatitis produced S-XCD values far in
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excGsa of thoso found in other disease states* In the 
infectious hepatitis group studied here # 9 of the 13 results 
were above 100 units/ml* The 4 lower ones, under 6o 
unit8/ml. (Fig. 1, p*28) were probably duo to the S-ICD 
having reached its peak prior to the blood specimen being 
taken, and the activity was probably falling back to normal. 
The initial rise of this enzyme takes place early in the 
disease, often before the onset of jaundice (Okumera and 
Spellberg, i960), and tends to fall fairly rapidly back to 
normal values * Bell et al*(1962) stated that the S-ICD 
returned to normal usually 3-4 weeks after the onset of 
symptoms.
S-ICD in infectious hepatitis gives very much the 
same information as the S-GOT and S-GPT* High values for 
one enzyme always coincided with high values for the others* 
As can be seen from the case which showed fluctuations in 
ensymo activity over a long period (Fig. 5, P«55), all three 
enzymes produced very similar results* Sterkel et a3. *
(1938) remarked on the similarity of the behaviour of S-XCD 
and S-GPT in acute hepatitis; Kerppola et al, (1939) 
commented on S-ICD and S-GOT, and Cohen et al * (1961) paired 
the S-ICD and B-GOT with having the same degree of 
sensitivity for reflecting acute hepatocellular damage, 
while the S-GPT was slightly superior to both of these.
From Fig* 4 (p* 33)# it is clear that there is not a 
good correlation between the S-ICD and both transaminases
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on direct comparispn of results* This can be explained 
by the fact that it has been reported that the fall from 
the initial pealt of S-XCD activity tends to be somewhat 
sharper than for the transaminases (Hargreaves et al*, 196I ; 
Cohen et al.. I96I)* It is probable, therefore, that in the 
cases of infectious hepatitis, the S-XCD activity may be in 
decline while the transaminases may still be rising, or 
falling at comparatively ©lower rates* Xn these 
circumstances, a direct comparison between these enzymes 
on Isolated specimens would be expected to give only a 
moderate or poor correlation*
Bodansky et al. (i960), in their study of S-XCD and 
S-GOT in experimentally induced viral hepatitis, commented 
on the superiority of .S-GOT over S-XCD because it rose to 
higher values. This has been shown in the present work 
(Fig. 6 , p.56), where in all but two cases, both trans­
aminase© showed higher increases in activity than the S-ICD. 
However, this is not a good way of expressing the sensitivity 
of an enzyme. The important factor in assessing the 
comparative sensitivity is to consider the time at which 
the enzyme starts to ©how detectable abnormal values in 
relation to symptoms and other tests of pathological xipset, 
and not so much the absolute peak value eventually reached. 
Thus, Bodansky et al. (1960) found that in 8 of 9 cases, the 
S-XCD and S-GOT became elevated on the same da^ r during the 
devolopoment of hepatitis. Okumera and Spellberg (1960)
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found in one of their cases that the B-XGB reached its peak 
activity before S-GOT*
Boll et al# (1962), commenting on the usefulness of 
S-ICD in detecting acute liver damage caused by hepatotoxic 
drugs, found that elevations in S-XCD activity occurred in 
many cases before elevation© in S-GOT activity, and both 
enzymes showed superior sensitivity over the commonly used 
liver function tests. The results on the patient with liver 
damage caused by p-aminosalicylie acid supports these findings 
The S-XGD and both transaminase© showed very high values 
during the initial liver upset ; the S-XGD fell to normal 
values more quickly than the S-GPT and i>o®sibly the S-GOT 
(Table 4, p.33)* However, when using these enzymes to 
detect Hiinimal liver cell damage following the test dose of 
p-aminosalicylic acid (Table 5, P*34), the S-XCD was the 
enzyme to show the first abnormal values and it was ©lightly 
more sensitive than the transaminases•
From these facts, it can be concluded that, while the 
tran®aminases produce,in most cases,values higher than the 
S-XGD in acute hepatitis., the sensitivity of those enzymes 
in detecting and following the course of acute hepatic 
damage is very similar, and although the results obtained 
from S-XCD estimation© do not ©how any definite advantages, 
they are very comparable and in no way inferior to those of 
the tran©amina©es.
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SKRUM ISOqlWHATB DBHYDROGENASE IN DRUG-INDUCED JAUNDICE.
The wid©ly-x3sed drug, chlorpromazine, is known to 
produce hepatic.dysfunction, with or without jaundice, in 
a small percentage of patients taking the drug (Sherlock,
195#)# The jaundice has been classed as oholangiolitiG 
due to intrahepatic choleatasie giving high alkaline 
phosphatase values. Promazine has been stated to produce 
a similar picture (Waitzkin, 195?)• Some reports have 
Indicated that there may be mild hepatocellular damage in 
this condition; Telman (1939) found increased transaminase 
values with histological evidence of mild liver cell necrosis 
in all of 9 patients. The S-ICB results on the patients 
with c111orpromazine and promazine jaundice in this present 
study, are in agreement with what would be expected from 
the histological description of the liver pathology*
The S-ÏC1) obviously does not have a diagnostic use in 
these cases, but its importance in other drug-induced liver 
conditions has been shown (p.32)^ and Bell et al. (1962).
In haemo lytic jaundice, normal S-ICD valxaes would be 
expected. Bell et al. (1962) found normal values in 10 
cases of chronic haemolytic jaundice. They stated, however, 
that high values might be found in haemolytic crises and 
this would explain the value of 23 iinits/Bil. found in the 
case of phonolie poisoning, where there was extensive 
breakdown of red blood cells.
SERUM XSOCXTHATE DEHYDHOCflQNASE IN CIRRHOSIS.
S-ICD values found in patients with portal cirrhosis 
wore, in all but one case, very much lowei' than those found 
in acute hepatic damage* Twenty-eight percent of cases 
had normal values, 6h^ p had minimal increases (below 20 
units/ml.) and of the remaining three cases, only one had a 
high value of 34 units/ml. These results agree with 
previously reported data, of which Wolfson and Williams- 
Ashman (1957b), Wolfson et al. (1958), and Sterkel et al »
(1958) all stated that the S-ICD tended to be normal in the 
majority of cases of cirrhosis, and increases when 
encountered, wore only moderate. Okumera and Spollborg 
(i960) found increases of up to two times normal; results 
in this report are similar to their findings.
The variation in S-XCD values in the cirrhotic patients 
was not predictable. Kerppola at al. (1959) and Cohen 
et al. (1961) stated that raised S-XGD values were associated 
with ’active* phases of the disease, where there was active 
breakdown or regeneration of liver cells. The former 
authors used criteria of severity of Jaundice and inflammatory 
changes in the liver seen in noodle biopsy specimens to 
assess the degree of activity ; the latter assessed their 
cases by the degree of jaundice, ascites and upset of 3.iver 
function testa, and histological evidence of active 
regeneration, inflammation or necrosis of tin© liver tissue.
Xn the cases investigated here, no liver biopsy specimens
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If ere taken and, therefore, no histological indication of 
the activity of the cirrhotic i>roc0ss in the liver could 
be obtained. The case with the high S-XCD value of 54 
unlts/ml. had amp3.e evidence of active cirrhosis, with a 
bilirubin of 9 .8mg./100ml., high transaminase activities 
and a very poor clinical condition. Xn the majority of 
other patients, however, S-ICD values could not bo 
correlated with certain indices of active cirrhosis.
There was no rolationship between S-XGD values and degree 
of hyperbilirubinaemia or the clinical state of the patient. 
This agrees with Sterkel et al» (l95B), who found no 
relationship with S-XCD and the amount of jaundice or 
clinical evidence of activity, and Bell et al. (1962) who 
found no correlation between S-XGD and the presence of 
jaundice and ascites in their patients. Franken et al. 
(i960) stated that there was no correlation between S-XCD 
values and compensation of the patient; Boll et al. (1962) 
agreed with this, defining a decompensated case as one 
with a bilirubin greater than 2.Omg./lOOml. and a serum 
albumin less than 3.Og./lOOml. On investigating the 
present series from this viewpoint, similar results were 
obtained.
On the other hand, if the serum transaminases are taken 
as indices of the activity of cirrhosis (Wroblewski and 
LaDue, 1956 ; Baron, 1964), then the S-ICD must also reflect 
activity, as results of these enzymes were significantly
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correlatod (Fig* ?, p.58), and, in the main, abnormal values 
for the transaminases coincided with raised S-XGD values* 
Cohen et al • (3.963.) stated that S-XCD, B-GOT and S-GPT were
all elevated in their ’active* cases* Stork©! et al* (1958) 
found 5 abnormal S-XCD values in 2? estimations on 19 
patients, compared with on© slightly elevated S-GPT ire suit 
in 20 estimations on „12 cases, and stated that S-GPT, along 
with S-XCD, was not related to biochemical and clinical 
evidence of active cirrhosis. Hargreaves et al. (1961) 
quoted an incidence of abnormal results similar for all 
throe enzymes in cirrhosis, but did not siilit their cases 
into ’active * and ’inactive* typos.
S-XCD det©rmlnations in portal cirrhosis appear, 
therefore, to give a picture similar to that produced by 
the transaminases, with variable increases which are in 
some cases unsi>ecific in nature. However, the transaminases 
do have a diagnostic advantage over the S-XCD in chronic 
liver damage. Wroblowski and LaDue (1956) found that in 
cases of pox‘tal cirrhosis which showed abnormal transaminase 
values, the S-GOT was a.lway© W g h e r  than the S-GPT. Thus, 
the ratio S-GOT/S-GPT would always be greater than 1.0,
They suggested that this fact might be of use in the 
diagnosis<of chronic liver damage. Baron (1964) has 
refuted this by saying that the ratio has not been proved 
to have a diagnostic value. Xn the.cases presented here, 
which showed abnormal values for the transaminases, the S-GOT
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was higher than the S-GPT in 11 of 13 cases (Fig* 3, p. 49) , 
the other two cases producing values of 1.0 and 0.92 for the 
5“GOT/S-GPT ratio. Therefore, although the transaminases 
can produce variable results, this ratio would appear to be 
a more specific indicator of chronic liver damage than the 
absolute values of either S-GOT, S-GPT or S-XCB.
Xt is not unreasonable to expect the S-XGD to show 
variable and unpredictable results in a liver condition 
such as portal cirrhosis where damage to, and regeneration 
of liver celle, and the progress o f  the disease, may 
fluctuate and make a true assessment of the changes taking 
place inside the diseased organ at a particular time very 
difficult.
SERUM XSOGXTHATIC DEHYDROGENASE XH OBSTRUCTIVE JAUNDICE.
The activity of S-XGD in patients with extra-hepatic 
biliary obstruction, whatever the cause, is important, as 
the overall statue of this enzyme as a useful factor in 
the differential diagnosis of jaundice stands or falls by 
its ability to distinguish jaundice due to extra-hepatic 
cause© from intracellular liver damage. Xn 1958, Sterkel 
et a l suggested that the S-XGD could be used to differentiate 
between intra- and extra-hepatic jaundice, and Baron (1963) 
stated that S-XCD had advantages over the tra n s a m in a s e s  
because of normal values seen in obstructive jaundice.
This has been reiterated by the same author (1964) in a
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textboolc in which he states that S-XCD is generally normal 
in biliary obstruction. Thei*e are, however, authors who 
have found variably raised activities in obstructive 
jaundice (Hargreaves et al.. I96I; Cohen et al.# I96I ;
S aad  e t  a l . ,  1 9 6 3 ) .
In assessing B-XCÎ) in acute and chronic liver cell 
damage, and comparing the results with serum transaminases, 
it has been found that the S-XCD is sensitive and comparable 
with the transaminases as an indicator of acute hepato­
cellular damage. Xn chronic liver damage, the S-ICD has 
little or no diagnostic use, whereas the transamixiaaes, with 
the S-GOT/S-GPT ratio, have. S-GOT and S-GPT also have the 
disadvantage of producing variable increases in obstructive 
jaundice and, therefore, the S-XCD would be useful as an 
adjunct to these enzymes if it produced more specific 
results in this pathology.
The S-ICD results found in this present series of 
obstructive jaundice cases, however, do not support Baron’s 
contention (1964) that the S-ICD gives essentially normal 
values with obstruction. In considering all the cases 
liZhioh had proven extra-hepatic biliary retention, only Ijfo 
produced normal S-ICD values (Table 2, p.29)» Admittedly, 
abnormal values in some of the cases could bo explained by 
secondary complications, e.g. the presence of liver 
métastasés in malignant obstruction and acute inflammation 
in benign cases, but there still remained a high proportion
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of oases, which could be classified only as ’typical* 
obstructive Jaundice, i.e. uncomplicated by involvement of 
liver cell damage, in which the S-XCD showed some increase* 
Xn many cases this was only minimal and values above 20 
units/ml. wore infrequently encountered.
Uncomplicated Obstructive Jaundice.
These cases consisted of l4 with malignant obstiruotion 
and 20 with benign biliary retention caused by stone in the 
bile duct, with or without chronic cholecystitis. The 
cases were all proven at operation and had no concomitant 
evidence of liver cell damage, e.g. clinically, there was 
no evidence of hepatomegaly or chronic liver damage, and 
biochemical tests of 3.iver function gave a picture of 
obstructive jaundice with, usually, a raised alkaline 
phosphatase and, in every case, normal thymol turbidity and 
flocculation and zinc sulphate turbidity tests. Further­
more, the serum transaminases, where estimated, always fell 
within the accepted range for obstructive Jaundice, no 
values for either S-GOT or S-GPT above 400 units/ml. being 
found. Cases which showed adverse liver morphology at 
operation were exc3-uded from this group.
It can be seen from Table 6 (p.38) that there was not a 
statistical difference between the S-ICD results obtained 
from the malignant and non-malignant gx’oups, and the 
distribution of S-ICD values in the two groups was very
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similar (Table 2 , p*29). Okumera and Bpellberg (i960) 
found only two abnormal S-XCl) values in 17 cases of acute 
and chronic cholecystitis, but 4 out of 5 cases with 
malignant obstruction had raised S-XCB values; Kerppola 
©t al * (1959) claimed that the S-IGl) could be used to 
differentiate malignant from non-malignant obstructive 
jaundice, but they based this on only a small number of 
cases. It is obvious from the present results that no such 
distinction can be made.
Considering the malignant and non-malignant cases 
together I there were only 9 of the 34 oases ( 26ÿ») which had 
normal S-IGD values. Twelve cases (35fo) had piinimal rises 
(below 15 units/ml.), a further 26fo had moderate elevations 
(l5"20 units/ml. ) , and 4 cases ( 139") had higher values, but 
all were below 30 units/ml. These results support data 
put foxmrd by Cohen et al. ( 1963.) who found 4 of 6 cases of
obstructive Jaundice xirith raised S-ICD va3,ueaf Saad et al.
A ™
(1963) who found only 6 normal results in 21 S-IGD 
estimations on uneompl1cated malignant and non-malignant 
obstructive cases. Hargreaves et al. (196^) quoted an 
incidence of 30^ for abnormal S-XCl) values in their 
obstructive jaundice group, but Bell et al. (1962) pointed 
out that these cases included biliary cirrhosis xvhich would 
produce raised values. However, in this present xfork, case; 
of biliary cirrhosis have been treated separately* Bell
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et aX # (1962) claimed that the S-ICD xfould be normal in
cases of obstructive jaundice uncomplicated by liver cell '
damage. It must be stated that they classified their I9
cases in this xvay with the aid of liver biopsy. This was
not possible in the present study except in a few isolated
cases where liver material was taken at operation and
histology was compatible x^ rith biliary retention. Hoxfever,
Bell et al. (I962) also stated that they found normal S-ICD
values in obstructive jaundice cases only xdien they were of
short duration, and that long-term obstruction leading to
liver cell damage produced raised S-ICD values up to 30
unlts/ml. They did not define, however, xfhat constituted
short and long-term duration of biliary retention. It can
be seen in this study (Table 7» p#42) that the duration of
symptoms did not appear to influence the distribution of
S-ICI) values. The time of onset of symptoms x^ras taken
with a liberal viexir, i.e. in each case, the duration was
timed from the first indication of jaundice, v^ rher© stated,
or abdominal symptoms, however vague or non-specific.
Whi3.st it must be accepted that liver cell damage can, and
probably does, occur with prolonged biliary retention, this
cannot be put forward as the reason for increases in S-ICD
activity in these cases, particularly as there was no other
■-C.
evidence, clinical or biochemical, for the existianc© of 
concomitant liver cell injury. It should also be noted 
here that the S-XCD could not be related to the severity
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of the obstruction when using the serum foillruhin and 
alkaline phosphatase as independent indices of this (Fig.
11 and 12, p.65,66).
If what Bell ©t al» (1962) say is true, that the S-ICD 
will he normal in uncomplicated short-term obstructive 
jaundice, then those present results can be explained only 
by the fact that liver coll damage occur© to some extent in 
the majority of cases of obstructive jaundice and is not 
related to the duration or severity of the obstruction.
This may be so, but can be ascertained only to any extent 
by knowing the state of the liver parenchyma in each case, 
and this xfould involve obtaining liver biopsy material.
Since the S-XCD is being considered as a potential test for 
the differential diagnosis of jaundice, the results must be 
able to be interpreted without having to r©so3?t to this 
technique. It ivould appeax*" from these results that 
abnormal S-ICD values (below 30 units/ml.) may be expected 
in uncomplicated obstructive jaundice, and the ©nzyme will 
not necessarily yield specific information as to severity, 
cause or liver cell complication© of the obstructive lesion.
The increases in S-XGD in these cases were poorly 
correlated with the transaminases. There was a significant 
correlation between the S-XCD and S-GPT (r « 0.43, P ^0.03), 
but this was much lower than that found in acute and chronic 
hepatitis cases. This could be explained by the fact that 
in acute hepatitis, both enzyKies are reflecting active liver
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cell daBiage g la chronic hepatic lapsat they are probably 
responding to changée a In the liver at the cellular level p 
whereas in obstructive jaundicep it is likely that the 
©nîsyme increases could be due, in part* to interference with 
their biliary ©ircretion. There is evidence that the 
transamlnaoe© are excreted into the bile (Reichard p 1959)» 
and Wolfson and ¥illlams-Ashman (1957b) stated that S«XCD 
was increased aftex' bile duct ligation in the rat, and 
Okumera and Spellberg (i960) observed moderate elevations 
following ligation of one of the hepatic ducts in the dog.
It cotald well be that removal of S«XOD via the biliary 
t:eact is independent of the px^ooesses affecting tx’ansaminase 
removal, and, therefore, a good correlation between these 
ensjyraes in biliary x'etention would not be expected,
However, this hypothesis Is not suppoi'ted by the results 
obtained in billax^y ciiurhosis, where tîie 8-XCD showed the 
highest correlation with both tx’ansaminases (Fig, 8 , p, 60) • 
The values fox' S-O-OT and S«»GPT are usually higher in biliary 
than in portal cirrhosis (Molander et al*, 1957}• This 
could be due to the composite effect of liver cell damage 
plus biliary retention giving high transaminaae values, but 
it Is difficult to explain why the S«-XGD should follow the 
transaminases so closely when there is such a poox’ 
correlation in extra-hepatic obstruction*
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Obstruotive J^mdlçeAssociBjïocl with Livex* Cancer’#
The presence of metastatic liver involvement in cases 
of obstructive jaundice duo to malignant lesions, tended to 
give higher S-XCl) values (Table 2, p#29) which were 
significantly different from the non-met as t at i c malignant 
cases (P ^0*005# Table 6, p#38)# There was, however, some 
overlap between the two groups, and the B-XG3> was not 
definitive in sepax’ating them# Px^evious authors have 
commented on secondary involvement of the liver in neoplastic 
disease causing raised S-XCÎ) values (white, 1958î Korppola 
et al# É 1959) • Sterkel et al# (1958) concluded that S-ICl) 
could be useful for detecting liver métastasés in malignancy# 
Others have found S-XCD raised in a high proportion of cases 
of livex’ cancers Cohen et al# (196I) reported an incidence 
of 70/ls Bell et al. (1962) found raised values in I9 of 23 
cases, and Tan et al. (I963) found increases in S-XCD in the 
majority of 289 patients with liver métastasés, although 
only 20^ 0 had values above 20 unit s/ml # All the cases 
reported here had raised values with over 50^ above 20 units/ 
ml# However, Okumera and Spellberg (i960) reported that the 
rise in B-'XCB was governed by the extent of liver involveBnent, 
as normal S-XGB values wore found in cases where there were 
minimal small metastatic lesions in the liver# Although it 
was not possible to grade the present cases according to the 
extent of metastatic deposits in the liver, none of them 
could be said to have minimal lesions, and three of the cases.
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which were reported as having huge liver secondaries, 3iad 
high S-IC3) values (28, 32 and 57 units/ml#)*
The 8-ICI) seems to respond in a more specific way to 
metastatic liver involvement in obstructive jaundice than does 
the S-GOT and B-GFT. No significant differences could be 
seen between the transaminase results in the metastatic and 
non-metastatio groups (Tables 10 and 11, p#46,4?), and Fig.
9 shows that S-XCl) gives comparatively higher values in the 
metastatic group, whereas the 8-GPT does not. These facts 
agree with those of Tan et al# (1963) who stated that S-XCD 
was raised in a greater proportion of cases with liver 
métastasés than were the transaminasea, and Cohen et al. (196I) 
found an incidence of 64^ for raised transaminases compared 
to yofo for S-XCÎ) in cases of liver cancer.
These same authors also ©itated that the S-XOl) api^roachod 
the alkaline phosphatase in sensitivity as an index of 
hepatic Involvement In malignancy. This present study also 
shows that the alkaline phosphatase gives significantly 
higher results in the presence of liver métastasés (Table 13t 
p «52 ) , which agrees with previous findings for this enssymo 
(Shay and Siplet, 1954). Mendelsohn and Bodansky (1952) 
stated that there appeared to be a relationship between the 
degree of hepatic involvement and rise in alkaline 
phosphatase. Olcumera and Spellberg (1960) suggested this 
applied also to S-IGB, but when comparing the two ©nsymes 
in this study, no correlation was found between them, (Fig.
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11, p.65)* Therefore, although both enzymea produced 
raised values in every case of liver métastasés, which were 
significantly different from the results on cases of 
obstructive jaundice without liver métastasés, it cannot be 
said that the two enzymes were comparable indices of liver 
involvement* The alkaline i>hosphatase tended to give higher 
rises in activity than the B-IGl) in the majority of these 
cases, but for both enzymes there was an overlap in results 
obtained from the non-metastatic and metastatic groups, which 
decreased the specificity and, therefore, the usefulness of 
these enzymes in diagnosing liver métastasés in the jaundiced 
patient *
Obstructive Jaundice Complicated by Acute Inflammation*
On reviewing the cases of non-malignant obstructive 
jaundice, it was found in three of them with high S-ICD 
values, that they showed signs of having had acute 
inflammation near to the time at which the blood specimen 
was taken* Consequently, all the cases were classified 
inflammatory or non-inflammatory using the criteria for 
acute inflammation mentioned previously (p*37), excoi^t for 
three cases whose classification was equivocal * It was 
found after separating the cases on the above basis, that 
S-ICD values wore much higher in 7 of the 8 inflammatory 
cases* There was a high degree of significance between 
the two groups (P ^ 0*001, Table 6,p*38)*
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Kxoept for one cas© discussed below, the inflammatoiy 
cases presontod with a history suggestive of obstructive 
Jaundice with acute cholecystitis* They had no clinical or 
biochemical evidence of active liver cell damage oocuring 
along with the biliary retention. Norborg (196I) reported 
essentially normal S-XOB values in patients with symptomless 
gall bladder dysfunction, but raised values occurred in some 
patients with symptoms of acute cholecystitis, Only 7 of 
30 cases had very high values in the latter group. The 
author did not, however, give any criteria for classification 
into this group. At least 8 out of 34 patients did not 
have clinical Jaundice and 17 of 31 cases had only normal 
or moderate rises in alkaline phosphatase* It is, therefore, 
likely that some of the cases in that series would not have 
been classed in the inflaïumatory group in the present study. 
Olcumera and Spellberg (1960) found two abnormal values in 17 
cases of benign obstructive Jaundice. One of those, with an 
S-IGB value 4 times the upper limit of normal, had acute 
cholecystitis, diabetes mollitus and acute pancreatitis.
Saad et al. (1963) also found a very high S-XCD (approximately 
lO times normal) in a case shown to have a stone in the 
common bile duct and acute cholecystitis, but liver biopsy 
shoimd a high degree of focal necrosis which may have been 
responsible, in part, for the very high S-ICÎ) activity.
The other case in the present study, was a women diagnosed 
as having cholangltia -associated with stones in the common
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bile duct of approximateJ,y two weeks duration. She had 
very high S-IGD values, up to 6 times the upper limit of 
normal, on fx^equent oocas^ions, pro- and post-oporatively.
Xn addition to this case, was the patient who developed a 
post-operative infection with jaundice, and whose S-ICD 
activity rose to a high value. This man ivaa thought to 
have a post-operative cholangitis. Wolf son and WiJ-liams- 
Ashman (1957b) reported that cholangitis gave.raised B-IGD 
values, although the^ r gave no detail©. The second cas© 
in the benign obstructive jaundice series of Okumera and 
Spellberg (i960) which showed a high S-XOD value, had 
chronic cholec^retitis, pericholecystitis and intra-hepatic 
cholangitis, and Cohen ©t al. (1961) stated that the patient 
with the highest B-XCI) value in their obstructive jaundice 
group (4 times the upper limit of normal) .had ascending 
cholangitis.
There is a distinct possibility in cases with ascending 
infection that large marabors of hepatic cell© may become 
damaged, and might produce high S-XCD value©. This would 
be expected to give high transaminase values too. This 
was shown in the man with post-operative infection, whore 
the sharp increase in S-XCD activity coincided with peaks of 
transaminase activity. However, there was also an equally 
©harp and impressive.rise in alkaline phosphatase which 
would indicate an acute exaberation of biliary retention, 
and it is, therefore, Impossible to say if the rise in S-XCD
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and transaminases was due to liver cell damage. The woman 
with cholangitis \\fho produced vory high S-ÏOD values, did 
not show such a pronounced increase in transaminaae valuesî 
the S-GPT never went above 200 units/ml., and th© highest 
recorded value f 03? S-GOT was only 110 unit s/ml. The thymol
turbidity and flocculation and zinc sulphate turbidity testa 
did not show any abnormal results, oven after a prolonged 
period of infection, and liver biopsy showed only small foci 
of acute liver cell degeneration. From this, an increased 
S-XCD value would be expected, but perhaps not to such a 
degree as was found.
There was no reason to suspect hepatic cell complications 
in the other oases with acute inflammation of the biliary 
tract. If the high S-XCD values are not explained by 
liver cell damage, there is the possibility that the enzyme 
is released in large amounts at areas of inflammation where 
there will be a large influx of mononuclear, polymorph and 
lymphocytic cells. High S-XCD values have been reported 
in many cases of infectious mononucleosi©. Xn this condition 
liver histology shows only a small degree of focal parenchymal 
damage, but with intensive invasion of the liver by mono­
nuclear and polymorph cells (Sherlock, 1963)* Bell et al. 
(1962) reported that S-XCD values in infectious itiononuoleoois 
covered the same range a© those found in infectious hepatitis. 
All their cases showed raised S-ICD values at some stage of 
the disease, the highest values being seen in cases with
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biochemical or other overt clinical evidence of liver 
involvement, but some cases showed raised S-XCB values with 
no other evidence of liver damage. Xt may well be that 
raised S-ICI> values are a reflection not only of hepato­
cellular dysfunction but are associated with the presence 
in the liver of large populations of inflammatory cells.
S-XOD values in the inflammatory group were not 
reflected to the same extent by the transaminase©, where no 
significant differences could be shown between the 
inflammatory and non-inflammatory groups for both S-GPT and 
S-GOT (Tables 10 and 11, p.46, 4y). Two of the cases did 
have high S-GPT values (300-400 units/ml.), but the other 
cases showed only moderate increases as might be expected in 
simple cases of obstructive jaundice. This would lend 
weight, therefore, to the hypothesis that S-ICD activity in 
these Inflammatory cases may have arisen, in part, from 
extra-hepatocellular sources#
XSOCXTHATIC BDHYDHOGISKASE COMPARED WITH SBEDM THAN B AM IM ASICS .
In previous studies where the S-XCD has been compared 
with on© or both of the serum transaminases, the opinions of 
various authors have differed in the final assessment of 
their relative value of their estimation in the jaundiced 
patient. Sterkel et al. (195B) indicated that the S-ICD 
yields more specific information than S-GFT because of normal 
values seen in obstructive Jaundice. Bell et al. (1962)
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©tàtôd that S-XCB was a more si^ecific test of liver cell 
necrosis than 8-GOT fox' the ©am© reason, and Baron (1963*
1964) has also suggested S-XCD has advantages over the 
transaminases because of normal values found in obstx’uctive 
Jaundice. Opposed to this are the vi©v/a of Kerppola et al.
(1959) who, on considering the clinical significance of 
B-XCÎ), did not think that it provided any more useful 
information than the combined use of S-GOT and alkaline 
phosphatases Cohen et al. (196I) said that, although S-ICD 
was a sensitive and x* at her specific indicator of hepato­
cellular damage, but ©lightly less so than S-GFT, it had no 
significant diagnostic advantages compared with the ©erum 
transaminases.
Sterkel et al. (1958) proposed that S-ICD had some 
advantages over the transaminases in acute hepatitis because 
of its ease of measurement, whereas Bodansky et al. (i960) 
preferred S-GOT to S-ICD because of the former’s higher 
increases in acute hepatitis, and the latter’s relative 
instability on storage of serum specimens »
The results of this present investigation support the 
view of Cohen at. al. (196I) that S-ICD does not have any 
significant diagnostic advantages over the serum transaminases 
in the differential diagnosis of jaundice. Raised S-ICD 
value© are to be expected in obstructive jaundice and, 
therefore, the premise of Bell et al. (1962) and Baron (1963, 
1964) cannot be upheld by this work.
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There Is no doubt, however, that S-ICD Is a sensitive 
Indicator of acute liver cell damage, is comparable with both 
transamiîiases in this respect, and is, perhaps, somewhat 
superior to the S-GOT ao indicated by Boll ot al. (1962)#
The conclusions of Bodansky et al. (1960) are not supported 
as, firstly, the sensitivity of S-XCD in detecting acute 
hepatocellular damage was assessed here by its time of responae 
and not the overall magnitude of the increase in activity, 
and secondly, the stability of S-ICD on storage was not 
considered to bo a px^actical problem or make S-ICD inferior 
to S-GOT or S-GP.T. The practical estimation of the enzymo 
was in some ways better than that for transaminases which 
agroes with Sterke1 et al. (1958).
In cirrhosis, the transaminases, expressed as the S-GOT/ 
S-GPT ratio, had distinct diagnostic advantages over the S-XCD, 
the latter having no real value in this condition as it could 
not be related to the clinical state of the patient. Rises 
in S-ICD activity with liver métastasés were more pronounced 
than with either transaminase, and supported Tan et al. (1963) 
who found raised S-XCD values in a greater proportion of 
cases than élévation© of S-GOT and S-GPT.
In making an overall assessment of S-ICD compared with 
the serum transaminases, it can be stated that S-XOD can be 
readily used as a useful adjunct to the transaminases, but 
it is not likely that the enzyme would over supersede them.
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XSOCITHAT30 DBHYDROaîSNASB COMPARED BITH OTHER TESTS OF LIVER 
FUNCTION.
S-ICl) was compared with ©,lkalin© phosphatase only in 
cases of obstructive jaundice; there was no correlation 
between the two enzymes. Acute inflammation affected only 
S-ICD results and did not %)roduce higher alkaline phosphatase 
values* The presence of liver métastasés tended to give 
higher values for both enzymes. Cohen et al. (I961) stated 
that S-ICD was cOmpax’able with alkaline phosphatase as a 
sensitive index of secondary liver involvement, but it is not 
possible to reach the same conclusion from the present worîc, 
as increases in S-ICD in malignant obstructive jaundice were 
not specific for secondary liver involvement, although S-ICD 
values obtained in the metastatic group were significantly 
higher thaai the non-metastatic group. The same can be said 
of the alkaline phosphatase results, but increases in this 
enzyme activity with liver métastasés were comparatively 
higher than those of S-XCD.
S-ICD cou3,d not be correlated with serum b 13.1 rub in in 
any of the groups of patients studied. Xn acute hepatic 
damage, peaks in enzyme activity usually i^rocede that for 
bilirubin, and it has %)reviously boon observed that S-XCD 
and transaminases are more sensitive than standard tests of 
liver function in detecting acute breakdown of liver cells 
(Bell et al.. I962). Results obtained in the case showing 
liver damage caused by p-aminosalicylic acid indicated the
—superior sonsitivlt^r of S-XCl) and the tran©aminase© over 
the bilirubin in detecting minimal damage to hepatic tissue.
Xn chronic liver damage, there was no correlation between 
S-ÏCB and degree of hyperbilirubinaemia, which agrees with 
Sterkel et al. (1958). This also applied to cases of 
obstructive jaundice.
The protein turbidity and flocculation tests used in 
the diagnosis of acute or chronic damage to the liver cell 
were not directly comparable with 8-XCD. These testa usually 
show abnormal values at a later stage, and remain abnormal 
for a longer period, than serum enzymes in acute hepato­
cellular upset. This is illustrated by the data in Table h 
(p»33)« Xn chronic liver damage, the turbidit^r tests were 
a more reliable index of cell damage than the variable 
results encountered with S-ICD and serum transaminases.
CONCLUSIONS.
S-XC3) is an enzyme which can be easily measured in 
serum, and may bo of some use in the diagnosis of hepatic 
disease. Xt is a very sensitive indicator of liver cell 
damage and shows very high results in conditions involving 
acute breakdown of liver cells. Because of its aonsitivit^'*, 
it will be useful in detecting subclinical hepatic damage 
caused, for example, by hepatotoxic drugs. Xn those respects 
it compares favourably with the serum transaminases.
It is of little or no diagnostic value in chronic liver
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oomlitions, where ©xtremoly variable ami non-specific values 
are found, S-XCÎ> results are again related to transaminase 
values, but the B-GOT/S-C?FT ratio coupled with other tests of 
chronic cell damage, e,g, turbidity and flocculation tests, 
are to be preferred.
Raised values are sometime© seen in obstructive jaundice 
which cannot be related to severit^^ or duration of symptoms, 
and the enzyme cannot be used to differentiate malignant from 
non-mallgnant cases. High S-IGD value© are to be expected 
when secondary liver invasion occur© in malignant obstructive 
jaundice. High value© occurring in benign obstructive 
jaundice are associated with an acute inflammatory condition 
of. the biliar^r tract.
The enzyme will give essentially similar information 
as the serum tranaaminases for most important diagnostic 
uses, differing only in some detail© which are pirobabl]^ not 
of great practical consequence. S-XCD may be used as an 
adjunct to the tran©aminases without difficulty and may yield 
more specific information in those conditions mentioned above 
which produce high S-XCD values. Its sensitivity as an 
index of active liver cell damage will be an asset in 
detecting subclinical hepatic dysfunction*
- J.UU-
. PART 2.
studies o n B-GLUCUR0NII)ASE in cervical GANGER
in tr od uct io n.
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The enzyme, (3-gluciironlda@© (E.G*. 3»2#1,31) hydrolyeee 
aliphatic, alieycliophenolic and eater p-D-gluoosiduronic 
acids (Marsh and Levvy, 1958). Xt has a wide rang© of 
specificity and will split a large number of natural and 
synthetic substrates* The basic reaction may he summarised
as GOOH COOH
O.QR--------------------------------------- J-----------  O OH
+ H^O  -----  ^ /  \ |  + ROH
[3-3)-glucosiduronic p-I)« glucuronic
acid ' acid
Xt seems likely that more than one protein complex may 
exist with p«^glticuronidase activity in a given tissue (Mills, 
Paul and Smith, 1953) * but most of the mammalian p-gluc^- 
uronidases from different species have a pM optimum, between 
4 *5""5 # 3# There are no known co enzymes or oof actors, but the 
purified enzyme can be activated by a number of substances 
including protamine, bovine sermm albumin, DHA from various 
sources, gelatin, lysine and ornithine ; it is inhibited by 
other substances, e*g# hydroxycarboxy3.io acids, ascorbic 
acid and heparin*
The enzyme can readily be assayed by using a p-B-gluco-
■*
aiduronic derivative of a substance which can be measured 
colorimetrically after being liberated by enzymic hydrolysis; 
the one most commonly used is ph©no3.pht1ialein-mono-{3- 
glucuronic acid and estimation of released phenolphthaXein*
FHTSXOLO01CAL FUNCTION OF • 0-CILtrOUHQMXBABB,
Although this enzyme has such a widespread distribution 
in animal tissues, and a great deal of investigation has 
been done on the in vivo, action of the enzyme, its exact 
rSle in living tissue is still not fully understood#
Fishman (1940) observed an increase in ^-glucuronidase 
activity of liver, kidney and spleen in dogs fed a terpen© 
alcohol (borneol) and in mice fed menthol, both compounds 
being excreted in the■ urine as glucuronidee• Xt was thought, 
therefore, that the enzyme might in some way be related, in 
these tissues, with detoxication processes involving the 
formation of glucuronide excretion products. However, the 
equilibrium of the enzyme reaction lies far in favour of 
hydrolysis (Levvy and Marsh, I963), and it is not conceivable 
that the enzyme could play a major rôle in the synthesis of 
gluouronide©• The enzyme has, however, been shown to possess 
a transferase activity of gluouronyl radicals in vitro 
(Fishman and Green, 1957), but as a route of ©ynthesia of 
glucuronidea in vivo this cannot compare in efficiency with 
the established pathway employing TOP-gXucosyluronic acid and 
the very different enzyme, glucuronyl transferase (Dutton and 
Storey, 1954)*
In most mammalian tissues, the enzyme activity appears 
to be related t© the preeenoe or function of various steroid 
hormones* This is particularly evident in tissues of the 
female reproductive tract which come under the influence of
sex hormones, mainly oestrog.ons,, and which have, in general, 
a high p-glnouronidase content which is sensitive to hormone 
stimulation*
Harris and Cohen (1951) showed.that the uterine 
p-glucuroniclase of ova3?iectomisod mice ■ was significantly less 
than that of normal mice, and a return to normal levels could 
fo© brought^ about by oestrogen administration* This effect 
of oestrogen ux>on the tissue p-glucuronidase was stated to bo 
a specific one and not to have resulted from oestrogen- 
induced tissu© proliferation, as progesterone inhibited.the 
oestrogen stimulation of f3-gluouronidase but not the growth 
of the tissue*
Boyler and Szego (1934) discoverod that the preputial. 
(clitora.l) gland of the rat was rich in p-gluciironidase and 
this fluctuated during pregnancy, apparently in response to 
circulating hormones* Androgens have been found to increase 
the activity of p-gluouronidas© in renal tubule cells and 
its excretion in urine (Riotten and Fishman, 1953)•
Xn human studies, the p-glucuronidase activity of tissues 
from the female reproductive tract have shown variation 
associated with changes in oestrogen production* Alterations 
in tissue p-gliicuronidas© show a cyclic variation relative 
to events of the menstrual cycle (Fishman and Mitchell,1959)5 
higher (3-gluouronidase activities ar© found in pregnant cervix 
taken at term than in normal cervix (Odell, Burt and Bethea, 
3.949) $ Those tissue findings are reflected in elevated
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aerum p-glucuronidas© values found in pregnancy (McDonald 
and Odellt 194?)# and were Interpreted as ahowing enhanced 
conjugation of oestrogens and other hormones* Fishman, 
KasdoUi» Bonner, Fishman and Hamburger (195X) showed that 
serum {3-glucuronidas© was sensitive to oestrogens, e.g. the 
serum values doubled in post-menopausal women treated with 
as little as 5 mg.,, atilboestrol per day*
It appears,, therefore, that the enzyme is closely 
connected with the presence or functioning of steroids in 
tissues and must be concerned with either the synthesis or 
hydrolysis of steroid glucuronide compounds, but its ultimate 
rôle is not as yet known.
DISTRIBUTION OF 6-CtLÜCUHONXDASE *
The enzyme is widely distributed in living organisms, 
mainly in the animal kingdom, but it has been reported to 
exist in certain plants (Lewy, 1954), and is fairly widely 
distributed in bacteria (Beuliler, Katzman, Doisy and Doisy, 
1949 ; Jaoox, 1953) * In the animal world, the enzyme is 
widespread and is found in birds, fish, amphibia, insects and 
molluscs* It is found in the majority of mammalian tissues 
and has been extensively studied in man, rat, mouse, rabbit, 
dog and cat tissues*
It occurs in moat species in largest amounts in liver, 
kidney and spleen, and is also found extensively in tissues 
of the reproductive and endocrine systems; the richest known
source is from the female rat clitoraX gland (Beyler and 
S z e g o ,  1 9 5 4 ) $
Seligiaan, Ta on, Hiitenbiirg and Cohen (1954) undertook a 
comprehensive Investigation into the distribution of the 
enzyme in rat tissue-, using hlstochemioaX techniques* They 
concluded that p-glucuronidase was confined, in general, to 
cells of epithelial origin; mesodermal cells showed a poor 
staining reaction for the enzyme# The greatest concentrations 
were seen in liver, spleen* epithella of the gaatro-intestinal 
tract and uterus, thyroid and white matter of nervous tissue*
The distribution of the enzyme did not vary from on© rat to 
another, but the intensity of the staining reaction did, and 
this was not related to sex, age or size of the animal*
Fishman"and Baker (1956) also described a histoohemieal study 
of p-glixcuronidas© in 30 tissues of the adult rat, and showed 
that epithelial tissue was the most active* ICawakatau and 
Mori (1963), again using histoohopiical te cliniques, showed 
that p-gluouronidas© was distributed throughout the cells of 
normal mucosae and In squamous epithelium of normal uterine 
cervix.
Besides these histochemloaX étudiés, there have been a 
few quantitative assessments of various normal tissues by 
determination of p-glucuronidas© activities of whole tissue 
homogenat©©* Talalay, Fishman and Huggins (1946) gave 
comparative figures for 12 rat tissues and found p-gluouronidase 
in all the homogenatea, with the highest activity/mg* wet
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weight of tissue in spleen, liver, ovary and uterus.
Fishman and Anlyan (1947) assayed homogenised human tissues 
and found the highest p-glucuronidase activity in liver, 
colon, rectum and endometrium*
The enzyme can, therefore, he detected in most tissues 
from mammalian sources and is found with highest activity 
mainly in epithelial cells*
INTRACELLULAR LOCALISATION OF B-aLÜGURONXDASE.
B-Glucuronidase in the Nucleus.
The histochemical studies of Seligman et al. (1954) and 
Fishman and Baker (1956) showed that only the cytoplasm* of 
normal epithelial cells stained for (3-glucuronidase, with no 
reaction in cell nuclei. Fishman, Baker and Borges (1959) 
found that cell nuclei of neoplastic cells from human tumours 
were negative or only weakly positive, and Oka, Okamoto, 
Omaohi and Mori (1964) found the enzyme confined to the 
cytoplasm of cells from oral neoplasms. Fishman, Mitchell, 
Dimitrakis and Hayashi (1963), however, found Intensely 
staining nuclei in some histological sections taken from one 
case of adenocarcinoma of the human endometrium. Siebert 
(1963) stated that isolated nuclei from rat cancer ceX3.s 
showed considerable p-gTucuronidas© activity which was not 
due to cytoplasmic contamination of the preparations. The 
author did not state, however, what proportion of the tissue 
enzyme was found in the nuclear fraction*
—X07**
Xn most tissue fractionation'procedures, tlie nuclei are 
centrifuged down from homogenates along with cell debris and 
unruptured cells, and in studies on the B-glUcuronidaso 
dietribu11on in suboellular fractions, this is usually 
referred to as the ’nuclear* fraction* Various figures have 
been quoted for the percentage of the total p-glueuronldase 
activity of a tissue homogenat© which resides in the ’nuclear* 
fraction, and depends, naturally, on the homogenisation 
condition© which will influence the number of unruptured 
cell© and other tissue debris (Levv^ r and Conchie, 1964) .
When Using recognised fractionation techniques, the p-gluc- 
uronldas© activity in the * nuclear* fraction rarely exceeds 
20^ of the total tissue activity (Plaut and Fishman, I963). 
Cytoplasmic B-Glucuronidase#
The greater part of (3-glucuronidase of most cells, normal
and neoplastic, would appear, therefore, to lie in the
cytoplasm of the cells* The distribution of the enzyme in
the cytoplasmic fractions of the cell - mitochondria,
microsome8, lysoaomes and free soluble enzyme «• can be variable
from one tissue to another. Nearly all the work on the
intracellular localisation has been done on rat and mouse
tissues, mainly liver and kidney cells (deDuve, Wattiaux and
Baudhuin, 1962). Fishman (i960) indicated that the enzyme
was found in cellular fractions as follows :-
Nucleus Mitochondria Lysoaomes Microsome© Supernatant 
- V ©  not stated f à
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Walker (1952) stated that ±n mouse liver ooils, the 
greater part of p-gliicuronldae©'was located In the cytoplasmic 
granules (mitochondria and miorosomes) and assumed there was 
little in nuclei and the soluble fraction of cytox>lasm* 
deDuve, Preeeman, Giahetto* Wattiaux and Appelmana,(1955) 
put forward the hypothe^sis that p-giucuronldase. was bound, , 
along with various other hydrolytic enzymes, in separate 
discreet cytoplasmic organelles which they termed lysosomes.
The particles would separate out along with mitochondria and 
microsomes in most tissue fractionation procedures# Microsemes 
were also found to b© h ig h ’in (S-glucuronidase^ .activity•
p-Glucurohidase has, thorefofe, been regarded as , 
primarily a cytoplasmic enzyme, bound mainly - within particles* 
The distribution between the various particulate fractions 
and supernatant can, however, vary with the tissue (Levvy 
and Conchie, 1964)* Xn mouse kidney cells, Conchie and 
Levvy (1959) found approximately ZX% of the total activity 
in the non-partiouiat© cytoplasmic fraction (supernatant), 
with 22% in the mitochondrial and 21 o^ in the microsomal 
fractions* Roth, Bukovsky and Eichel (1962) found a vastly 
different distribution in rat spleen with approximately 70%j 
supernatant, ll^ y mitochondrial, 5$ microsomal and 9^ in the 
nuclei* The lysosomal p-gluouronidase would be included 
with the particulate fractions, probably Biainly with the 
mitochondria* There appears to he no data on cells from 
human tissues *
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There is a suggestion that cancer cells may have a 
different distribution of p-gluciironidas©, although there is 
slight evidence of this - Conchie and Levvy (1959) found that 
in mouse S3? tumour, over half of the enzyme activity of the 
cytoplasm was free and not confined to particles. Levvy 
and Conchie (1964) reported similar findings in Bhrlich and 
T2146 tumours$
B-0LUCUHON1DASB XN CANCER TISSUES.
Fishman, Anlyan and Gordon (194?) compared p-gluc- 
uronidas© activity of homogenates of various human carcinomas 
with corresponding uninvolvod tissue and found higher 
activities of the enzyme in nearly every malignant tissue. 
Striking elevations were found in malignant neoplasms of 
breast, stomach, colon, uterus and lung. Fishman and 
Anlyan (3*94?) compared p-gluouronidas© activity of normal, 
tumour and lymph node tissue of surgical patients, and found 
higher p-glucuronidase in cancer tissues than ih non-involved 
tissues. Fishman and Bigelow (1950) compared the histology 
and j3-glucuronidase of 44 gastrointestinal neoplasms, and 
although they found consistently increased B«glucuronidase 
in these neoplasms, they cou3.d not correlate the activity 
with a single morphologioal characteristic. Their impression 
was that increased (3-glucuronidase might be associated with
greater eelXularity of the lesion, and to a slight extent
©
with mitotic activity, but this was not definitely
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established* They stated that tissiie changes, only 
secondary to malignancy, e*g* inflammation, necrosis, and 
formation of fibroids stroma, could be excluded as causes of 
increased (3-glucuronidase activity.
This work on tissue homogenatos has been supported by 
various histochemical studies. Fishman et al* (1959) found 
consistently^ that neoplastic cells of human tumours stained 
for ^-glucuronidase in the cytoplasm with little or no reaction 
in the nuclei. 0?hey stated that neoplastic cells were good 
sources of p-glucuronidaso, that these cells were the major 
contributors to the (3-gl%%curonidase activity of the whole 
tumour tissue and not non-malignant elements such as leucocytes, 
fibroblasts and fibrocytes* Honis, Banks and Rutenbux'g (i960) 
investigated ^-glucuronidase activity in 121 human tumours,
100 of which were epithelial in origin* They found 
activities varying from low to very high in the epithelial 
tumours, while very low or negative reactions were found in 
tumours of mesodermal origin. The (3-gluouronidase activity 
could not be correlated with histological grades of 
differentiation. Oka ©t al. (1964), in an investigation
into oral neoplasms of epithelial origin, found that the 
tumour parenchyma reacted more intensely for 0-glucuronidase 
than the surrounding healthy tissue ; the activity in the 
tumour cells was confined to the cytoplasm. Lehrer (I962) 
investigated a number of enzymes in glial tumours and found 
that (3-glucuronidas© was the only one which showed a consistent
•inl­
and marked elevation in all tumours*
0-Gluouronidase is found, therefore, in a wide variety 
of tumour tissues and usually with increased activities over 
corresponding normal tissues. It is found mainly in tumours 
of epithelial origin and by histochemical techniques is 
found only in thq cytoplasm*
B-GLUCUHONIDASE IN CERVICAL CARCINOMA*
Great interest has centzed upon 0-glucuronidase in 
malignant and. benign lesions of the female genital tract since 
Odell and Burt (1950) and ÎCasdon, Fishman and Homburger (1950) 
indicated that the determination of p-gluouronidas© in 
vaginal fluid was a useful diagnostic aid for uterine 
malignant growths, especially of the cervix uteri, where 
elevated values were found in over 80’}^ of cases with cancex’* 
Odell et al * (1949) undertook 0-gl\tcuronidase assays on 
whole tissue homogenates in water of various female genital 
tumours $ They compared 13 non-malignant cervices with 6
squamous cell cervical carcinomas, and found that the range 
of p-gluGuronidase activity as units/g* wet weight of tissue 
of the latter group was very much higher than the non- 
malignant group* Fishman, Kasdon and Horabux’ger ( 195d) 
compared 22 specimens taken from untreated cervical cancer 
and found the mean activity for the group was over 10 times 
the moan obtained from 46 spocimens of non-malignant cervix, 
Fishman and Mitchell (1959) studied the distribution of
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p-^luotaronidas© in normal specimens of vagina# cervix and 
nterus by histoehemioal techniques, and described p^ -gluc-* 
uronidase "as showing strong activity alivays in the basal 
layer of epithelium and of^ten in several layers of cells 
above, whilst there was variable activity in the superficial 
layers. There was little or no reaction in the stroma of 
the tissues* The same group (Fishman, Mitchell, Borges, 
LaDu© and Hayashi, 19^3) then studied the ©nssymorphology of 
cervical cancer and described results on three cases - on© 
carcinoma in situ, one early invasive, and one advanced 
epidermoid carcinoma* Xn the carcinoma in situ* gluc­
uronidase was found in healthy gone© confined to basal and 
superficial layers of the epithelium, while in the 
carcinomatous areas, the basal epithelium reacted strongly, 
and 80 did the stroma* Similar findings were described for 
the early invasive carcinoma* Xn the epidermoid tumour, 
the distribution of the enzyme was more %fi do spread and 
generalised, with a highly active stroma* They concluded 
that in non-invasive epithelium, the p-gluburonidase remains 
localised more or less in the basal layer, whereas in 
invasive neoplasm many more of the cancer calls are positive* 
Starisewski, Waronski and St ©pi ew ski ( 1963) # in a study on 10 
cervical cancer specimens, stated that (3-glucuronidase and 
acid phosphatase are high in the border areas of the cancer 
and low or absent in the centre of the tumour * Kawakatau 
and Mori (I963) found in squamous cell carcinoma, that
p^^glucuronidase activity was more marked in the invasive and 
peripheral areas of epidermoid oancer than in necrotic or 
karatinised portions*
The intensity of (3-glncuronidas© staining in histo­
chemistry of cervical neoplasms may vary greatly, and attempts 
to correlate enzyme activity with the degree of malignancy 
have not been very successful* Hatzimichaol (I962) compared 
vaginal fluid and cervical mucus in relation to cancer of the 
cervix and uterus and found high 0-glucuronidase activity in 
the mucus of 20 out of 21 proven cancer patients. Although 
it could not be established, the author*© general Impression 
was that 0-glucuronidase activity of the cervical mucus 
paralleled the degree of malignancy* On the other hand, 
Eauramo (1959)• although finding high g-glucuronidase in 
most cases of cervical carcinoma, could not correlate the 
activity with the spread of cancer (cf. Fishman and Bigelow,
3.950, p. X09).
p-Gluctironidase is, therefore, found with increased 
activity in cervical carcinoma* This is associated with 
increased en%:yme activity in vaginal fluid and cervical 
mucus of tumour patients* Increases appear to occur mainly 
in the squamous cells of the carcinoma, although stromal 
enaym© has been described* There doe© not seem to be a 
definite relationship between enzyme activity and severity of 
the malignant lesion*
There have been no reports on the intracellular
dlstrilmtioîi of the enzya© 'In cervical carcinoma, other than 
histochesialca3- studies stating that the enzyme is confined to 
the oytopiaam of malignant cells (Hopman, I96I g Kawakatsu 
and Mori, 1963). Xt ie not known if the large increases in 
enzyme activity detected in homogonates of cervical cancers 
are due to increase© in soluble oytop3.a©mic enzyme or in the 
particulate enzyme within the cell *
TISSUE B-GLÜCUEONXBABB AMD RADIATION,
A©'0-glucurohiclas© shows à high activity»- in malignant 
cervical tissues and the treatment consista of irradiating 
the lesion, it i© of intoreat to know how the enzyme in the 
tissue responds to this procedure, Little data are 
available 03^  this subject,
Odell and Burt (1950) stated that after irradiation of 
cervical tumour tissue with radium and'roentgen rays, the 
tissue 0-gXucüronidase tended to decrease in the absence of 
a recurrence of malignaiit growth, ' Odell et al, ( 19^9) and 
Odell, Priddl© and Burt (1950) stated that radiation treat­
ment also caused a reduction in p-glucuronidase activity of 
vaginal fluid a© well, as tissue removed from the tumour sit© 
These observations, however, were made on sî)ocim©nG removed 
approxiaiately two months after therapy, and it is probable 
that the reduction in activity was due to malignant tissue 
being replaced by fibrous tissue comparatively weak in 
0-gluouronidas© activity. Kasdon ( 1950) made
observations on tissue specimens following irradiation of 
two months and longer, and could produce no evidence that 
radiation caused a decrease in 0-giiicuronidase, Hauramo
(1959) studied 10 patients and observed chiuiges in 0-gluc« 
uronidase of whole tissue homogenates after treatment of the 
cervical lesion with a single radium implant, This author 
found that in two of the specimens there xiras increased 
0-glucuronidase activity and in eight a decrease occurred. 
Hatzimichael (I962) made observations on cervical mucus from 
eight patients receiving radium treatment# Xn four of these, 
the mucus became negative for 0-glucuronidas© activity, and 
the other four remained positive.
Xt is difficult to ascertain from these facts if the 
0-glucuronidase in cervical tissue is affected in a uniform 
way by radiation treatment, ©specially on a short-term basis. 
Reduction in 0-gluoxaronidase over a long period probably 
reflects the reduction in malignant cells in the tissue 
specimen.
Studies on radiation of other tissues, mainly from 
animal experiments, have been reported, though their 
relevance to the condition# pertaining during therapeutic 
radiation of the human subject is hard to assign.
Pellegrino and Villani (1957) studied the effect of whole- 
body x-ray irradiation on 0-glucuronidase activity in 
lymphatic tissues in rats. They found that the activity/ 
g . wet weight of tissue increased following radiation, but
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this was associated with decrease in weight of the tisane 
duo to loss of protein, and the effect was probably secondary 
to radiation, as the same result could be produced by other 
experimental conditions, e.g. fasting. Roth et al. (1962) 
carried out similar experiments on rat spleen, but determined 
0-glucuronidase activity of various tissue fractions - nuclei, 
mitochondria, raiorosomes and supernatant. They found an 
increase in tho percentage of the total activity in the 
supernatant fraction 64 hours after giving a 700 rad whole- 
body dose. This was accompanied by an increase in specific 
activity of 0-glucuronidase which was attributed to loss of 
non-enzyme protein nitrogen which occurs in the spleen after 
irradiation. Rahman (I962) obtained similar results which 
were interpreted on the basis of selective nitrogen loss.
The author also indicated that the enzyme was not released 
from lysosomes by the radiation dose, Baoq and Alexander
(i960) stated that a dose of 10,000 rads was required before 
leakage of hydrolytic enzymes from isolated lysosomes could 
be detected. Bottocasa, Glass and do Bernard (1965) showed 
that when lysosomal preparations (contaminated with 
mitochondria) from beef heart xmre Irradiated in vitro xvith 
massive radiation doses up to 440,000 rads, there v;as no 
release of enzymes from the lysosomes. Hox^ever, when heart 
tissue slices,with lysosomes intact in the cell, were 
irradiated with doses from 10,000-440,000 rads, there was an 
increase in homogenat© specific activity which was shoxvn to
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be a true increase in p-glucuronidase and not due to loss of 
nitrogen; this was caused by release of enzyme from lysosomes. 
There x^ as not, hoxyever, an iaaorease in homogenat© activity 
with radiation doses beloxt? 10,000 rads.
URINARY EXCRETION OF B-GLTJCÜRONXDASE BY CANCER PATIENTS.
The excretion of 0-gluouronidaao in the urine has been 
shpxm to bo increased in some patients xfith various malignant 
lesions (Boyland, Gasson and Williams, 1957)• Cases of 
cancer of the larynx, bronchus* oesophagus, prostate and 
testis tended to show the moat significant increases. The 
excretion of this enzyme has been investigated most fully, 
hoxvever, in patients with bladder carcinoma, where increased 
values have been found in the majority of those patients 
(Boyland, Wallace and Williams, 1955 ; Lewis and Plaice, i960 ; 
Helicow, Uson and Lipton, 1961; Haije and van dor Werf-Messing, 
1962 ; Kerr, Burkin, D*Aloisio and Menczyk, I963)• Interest 
has arisen in these patients as it was thought that 0-gluc­
uronidase might play a vital rSl© in the genesis of bladder 
tumours by its hydrolytic action upon gluouronide conjugates 
of carcinogenic substances in urine, e.g. ortho-amines 
(Boyland, Wallace and Williams, 1957)«
Although the urine enzyme has been found to be increased 
in a wide variety of malignant lesions, there has been little 
evidence put forward that the malignant lesion itself is the 
primary source of this increase. Kerr et al♦ (1963)»
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investigating bladder tumour, showed that surgical removal 
of the.tumour resulted in a fall in urine enzyme from 
previously high values to normal values# Haijo and van der 
Worf-Messing (I962) did not find elevated values in a group 
of bladder carcinoma patients xdiQ, after radiotherapy, showed 
no evidence of tumour at follow up, whex'eas patients xfith 
active bladder tumour showed increased 0-g’lucuronidaee 
excretion# ..There-"'have been no reports on the effects of 
treatment of other malignant lésions upon urinary 0-gluc- 
uronidase excretion* A study by Takiguchi (1963) on the 
activity of p-g3.ucuronidase in serum of patients with cervical 
cancer who underwent radiotherapy is tho only report 
I>ortinent to this question# The author stated that serial 
deteroiinations of serum 0-glucuronidase and lactic 
dehydrogenase might permit an estimation of the radio- 
sensitivity of cervical cancer*
QUTLXME OF THE PRESENT INVESTIGATION#
An opportunity existed for obtaining tissue specimens of 
cervical carcinoma. Xt was decided to investigate their 
0-glucuronidase activity and study the distribution of the 
enzyme in the cytoplasmic subcellu3-ar fractions of tissue 
homogenates# The results were compared with a series of 
non-malignant cervical specimens# In some cases, changes in 
the tissue g-glucuronidase of the tumours following 
irradiation of the lesion by radium implantation were
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inveat igat ed•
The excretion of p-glucuronidas© in the urine of patients 
with oeir'Yical cancer, undergoing radiation treatment, was 
studied to. see if the urine enzyme responded to destruction 
of the lesion. It was expected that this would give an 
indication if tho enzyme in the urine was produced by the 
cervical tumour or was a secondary systemic effect.
Concomitant studies on serum 0-gluouronidase activities were 
also carried out on these patients. The urinary excretion 
of p-glucuronidase was studied# for comparison# in two groups 
of patients receiving radiotherapy on other malignant lesions ■ 
patients with bladder carcinoma# and a group of patients with 
lesions in the thoracic region.
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PART 2.
MATERIAL AND METHODS.
«* XæX—■
For this investigation, biopsy material was obtained 
from patients with carcinoma of the cervix uteri who under­
went a course of radiotherapy involving radium implants and/ 
or a period of deep x-ray irradiation* For comparison, 
normal cervical tissue was obtained from patients undergoing 
surgical repair for prolapsed uterus *
Investigations into the excretion of 0-glucuronidase in 
urine during a course of radiotherapy were imdertaken in 
selected patients with cervical, bladder and thoracic tumours *
TISSUE SPECIMENS*
Carcinoma of the Cervix Uteri *
Nineteen specimens were obtained from patients with 
proven cervical carcinoma, taken under anaesthesia just prior 
to insertion of the first radium implant. After removal, 
the specimens were placed immediately into iced water, blood 
clots and inflammatory exudate carefully dissected away, and 
the specimen washed, dried on adsorbant paper, weighed and 
stored at -20^ until further processing*
It was possible to classify each tumour from histology 
obtained from biopsy material taken prior to radium treatment* 
There were two adenocarcinoma© and the others were squamous 
carcinomas of the cervix*
* Normal* Gervical Tissue,
Twelve ©ample© of cervical tissue were obtained at 
operation on patients undergoing repair of uterine prolapse*
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The speclmons were taken in such a way as to inc3.ude as much 
of the epithelial layer as possible with minimal amounts of 
underlying fibrous tissue # Although these specimens wore 
classed as normal, microscopic evidence of varying degrees 
of chronio cervicitis were -seen in some of the specimens, but 
this was unavoidable*
Pro- and Post-Eadiation Specimens *
In 12 of the patients in the Carcinoma Series, further 
biopsy specimens were taken after radium had been implanted 
for about two days* They were obtained at the time of 
insertion of the second radium implant. These 12 specimens 
constituted the Post-Radiation Series, and the specimens taken 
before radium treatment on those 12 patients made up the 
Pre-Radiation Series* '
URINE STUDIES *
Gorvical Caroinoma Group*
Twenty-four hour collections of urine w©3?e taken 
periodically throughout a full course of radiotherapy on 
selected cases with carcinoma of the cervix uteri*  ^ These 
were patients who could, and would, readily co-operate with 
collection of specimens, were not incontinent of urine, 
showed no signs of urinary infection, and had good renal 
function at the time of presentation*
Two 24-hour collections were mad© befoz^e commencement 
of treatment, followed by collections while radium implants
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wore In aitu# collections taken 2-3 days fo3.1owing radium 
witîidrawal, and further collections taken 2-3 times per week 
over a course of supervoltage therapy which lasted usually 
3-4 weeks *
Blood samples %mre also taken during therapy on days 
corresponding to Urine collections# They were withdrawn 
early in the morning with the patient in a fasting state.
Two further groups of patients receiving radiotherapy 
were also studied by taking 24-hour urine collections before 
and during therapy. Thoso were;-
Bladdez* Carcinoma Grotip - patients receiving radiation of 
the renal tract, comprising 8 cases (3 males, 5 females) 
who had not received previous radium therapy#
Thoracic Carcinoma Group - these were patients receiving 
radiation away from the urogenital tract. They consisted 
of 5 patients with carcinoma of the bronchus (3 male, 2 
female), one female with carcinoma of the oesophagus, one 
with epiglottal carcinoma and one with carcinoma of the 
breast•
RADIATION DOSAGE.
Patients with carcinoma of the cervix uteri received 
total radiation doses ranging from 3000-8500 rads# Those 
were given, in part, as radium implants inserted for periods 
of 48 to 100 hours as one or two insertions, follov/ed by a 
course of supervoltage therapy from the A ,E ,I # Linear
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Aooelarator ,or■ OrbitroH Unit administered 'over a 3-4
week period. .
-Patient® in the Bladder Carcinoma Group received doses 
ranging from 3500-7000 r a d s . Radium implants were not used 
in this group# and, all doaes were given by supervoltage 
therapy. . This also applied to the Thoracic Garcinoam Group 
where ,the-tumour radiation dose ■ranged from 2500-7000 rads.
TISSUE FRACTIONATION.
All, tissue specimens,, normal and cancerous# which had
opreviously b ee n  washed and .weighed and -stored at -20 , were 
fractionated ,b.y the following method.
Homogenates of 1 i n  10 or 1 in 20 (w/v) in isotoiiic 
sucrose were made depending on the type and weight o f  the • 
tissue specimen. The frozen tissue was sliced into sections# 
10-40 microns thick# on a freezing microtome ; these were then 
placed in an appropriate volume o f  ice-cold 0.25M-sucrose ..and 
homogenised in an H.S.E. Blender for 3 minutes# using crushed 
ice as the refrigerant. The homogenate was then spun at 
500 g for 10 minutes in an M.S.E. *Minor* centrifuge at 4^ 
to remove cell debris and nuclei. The non-sedimented 
fraction was then spun at 5000 g for 20 minutes in an M.S.E. 
Superspeed 17 Refrigerated Centrifuge at 4^. The remaining 
fluid fraction was pipetted o f f  from the sedimented 
particulate fraction and centrifuged at 35t000 g at 4^ for 
60 minutes. The supernatant layer was removed from the
second, particulate fraction and both particulate fractions 
were washed with approximately 10 ml. of ice-cold 0 .25M- 
sucrose and centrifuged dotm again.
The three cytoplasmic fraction© obtained by this 
procedure were designated - Supernatant# and Ml and M2 
particulate fractions. It was not possible to ascertain the 
precise composition of each fraction# but reinvent information 
was obtained from electron micrographs of similar fractions 
obtained from thyroid tissue fractionated under identical 
conditions (Goldberg# I965)* It has been assumed that 
fractions of cervical tissue would produce a similar picture. 
The three fractions were described ass- 
Supernatant - an optically clear solution cojitaining 
predominately cytoplasmic or soluble cell material with 
minimal contamination by intact particulate material.
Ml Fraction - particle© centrifuged down between 500-5000 g. 
These were mainly well-preserved mitochondria. Some 
microsomes were seen# but there were few J.ysosomes.
M2 Fraction - particles centrifuged down between 3000-35#000 g. 
These were predominately microacmes but occasional mitochondria 
and mitochondrial-like fragments were seen. There appeared 
to be about twice the lysosomal contamination seen in the Ml 
Fraction.
It was estimated by visual study of the electron micro­
graphs# that the mitochondria were distributed approximately 
759^  in the 'Ml Fraction and 25^ in the M2 # with the ^reverse
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for the microsomes*
The two particulate fractions were suspended in ice-cold 
water of known volume (usually about 3 ml.) and the peirticles 
disrupted by sonicatlon at 20Kc/seo. under refrigeration in an 
M.B.B# Ultrasonic Disintegrator Model ,60¥. A eoagulum of 
mitochondrial membranes was formed in the Ml Fraction which 
was removed to leave an opalescent solution* The M2 Fraction 
formed a clear solution wlthoiat formation of a coagulum.
It was not possible to obtain particulate fractions on 
some of the specimen® due to the small amount of material 
available* This applied especially to normal cervical tissue 
where the particle yield was very small# In some of these 
cases# the particles centrifuged do\m at 5U00 g were combined 
with the fraction sedimented at 35#000 g| the particulate 
material was then teroied * Combined Particles* *
There were certain technical complications regarding the 
separation of particles from normal cervix which wear'© 
unavoidable# These arose from the large amount of collagen 
fibres in the normal tissue tirhich were spun down with cell 
debris and nuclei at 500 g. This matrix of fibres would 
trap some particles and prevent their recovery# and might 
account for the small yield of particles obtained from normal 
cervical tissue * There was comparatively little collagen 
material in the carcinoma specimens and paarticle yields were, 
on the whole# satisfactory#
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ESTIMATION OF B-aLUGUHQMIDASE.
In T is s u e  Fractions and Serum.
The method need for the estimation of the enzyme in 
test material other than urine# was essentially that described 
by Talalay et al* ■(1946), but using a different %)reparation 
of enzyme substrate# and an 80^ reduction in volumes of 
substrate and test solution to allow an economical assay of 
th e  ©nzypie*
This method involves the photocolorimetric measurement 
of phenolphthalein in allcaline solution# liberated by the 
enzyme from phenolphthalein mono-p-glucuronie acid. ■
BeagâBÈE
0*lM-acetat© buffer# pH 4.5 as aeacrlbed by Talalay et al♦
0.4M-glycine buffer#pH 10*4 - * * ** " *'
0 .01M-phenolphthalein-glucuronic acid substrate* ■ 50 mg, of
*
phenolphthalein mono-p-glucuronic acid were dissolved in 5 ml* 
water# neutralised with 0*lN-Na0H# and diluted to 10 ml.
The solution was stored in a dark bottle at 4^ with one drop 
of toluene as preservative *
^ Obtained from the Sigma Chemical Company Ltd* A3.though 
the suppliers stated that variation in hydrolysis rates by 
p-gluouronidas© might occur with different batches of this 
substrate# this was nevei* found to be a coHîplioation when 
changing from on© lot no, to another*
—120—
Fhenolphthaleisi Standard. 25 mg* 'A n a la r* phenolphthalein 
were diseolved in 100 ml * o f  80ÿ ethanol * 1 ml* contained
250 |.tg* phenolphthalein*
Procedure »
0.8 ml * acetate buffer and 0*1 ml * o f  test soliution were 
pipetted into two conical c e n t r i fu g e  tubes - test and control 
and placed in a water bath at 0*1 ml* o f  substrate was
added to the test'and the mixture incubated f o r  a kno%m. time. 
Four ml * of g ly c in e  w ere them added to each tub® followed by 
0.1 ml. o f  substrate to the -control* The tubes were 
centrifuged to remove small amounts o f  precipitated pi^otein 
and the supernatant decanted into 1 cm. cuvettes* The test 
was re a d  against th e  O o n tro l on a Urnicam S.P.600 spectro­
photometer at 550 Bip.
A phenolphtlialein calibration c u rv e  %fas made using 0*1 
ml * o f  various dilutions of th® phenolphthalein standard 
with 0.8 ml. acetate buffer# 0,1 ml* water and 4 ml. glycine 
buffer, These were read against a re a g e n t  blank* The 
calibration curve was linear o v e r a w id e  ra n g e  o f  extinction*.
Precis© reaction conditions for different t e s t  material 
weres —
Serum - 0*1 Bal * serum with an incubation o f  24 hours «
Tissue fractions - 0.1 ml* o f  s u i t a b le  dilutions o f  th e  
various fractions with incubation times varying between 1-6 
hours.
A unit o f  0-gliicuronidaa© activity 1© expressed as th e
fo r m a t io n  o f  1 jag. p h o n o Ip h th a lo ih  in 1 hour a t  37^ under 
the test conditions. Results are expressed ae u n i t s / m l . 
f o r  tiaaiie f r a c t i o n s , and unlt©/lOO m l. f o r  serum . To
convert to  1.0./litre at 3?^# the tissue results must be 
multiplied by 0.03# and th e  serum.results fey 0.0003•
The excretion o f  p -g lu o u ro n id a s e  in u r in e  was estimated 
u s in g  tho m ethod d e s c r ib e d  by Malicow et al. (196I)# b u t with 
s l i g h t  m o d i f ic a t io n s . The m ethod a ls o  in v o lv e s  th e  
measurement o f  liberated p h e n o lp h th a le in  fro m  p h e n o lp h th a le in  
m o n o -0 -g lu o u ro n ic  a c id  s u b s t r a te ,
Urin© coXleotiona.
Twenty-four hour urine specimens were collected by th e  
patient voiding the bladder at a known time# u s u a l ly  early 
morning, and collecting e v e ry  specim en  fro m  then up to and 
including a specimen passed  at _the same time 24 h o u rs  later. 
All specim ens passed  in the 24 h o u rs  w ere com bined in a
I
Winchester bottle containing 10 ml. c h lo ro fo rm  as a 
preservative. The collections w ere kept at room te m p e r a tu r e .
.Th© 24-hour collection was thoroughly mixed and the 
volume m easured* The pH was recorded and an a l iq u o t  o f  th e  
collection taken and spun v ig o r o u s ly  for 10 minutes. The  
clear .supernatant urine was pipetted o f f  and s to r e d  i n  a 
refrigerator at 4^ until analysed.
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1, Acetate buffer# pH 4*5« 5*783 g» sodium acetate
(CH^COONa,3HpO) and 3,25 ml* glacial acetic acid were made 
up in 430 ml. water# the ,pH adjusted to 4 ,3 and the f i n a l  
voXtam© made to 300 'ml,
2, 0 .OlM-plienolphtlialein-glucuronic acid substrate. This 
was the same aa that t^eed in the tissue and serum method,
3* IO9G (w/v) sodium carbonate* 10 g, anh yd ro us  sodium 
carbonate were dissolved in 100 ml, water,
4, Phenolphthalein Standard - as In the tissue and serum m etho d . 
Procedure•
,w IIIIPW '•i kmUkWiM»
TUo Id ml, g ra d u a te d  tubes were s e t up - teat and c o n t r o l . -  
To 1 l'iîli o f  urine ‘in each tube ifOT® added 1,1 ml, a c e ta te  
buffer. The tubes were placed in a water b a th  a t  37^ and  
0.1 ml. substrat© added to the teat. Th© tubes were then 
incubated for exactly 18 hours, when 1 ml. lO^ i sodium carbonate 
was added to b o th  test and contfol# followed by 0.1 ml. 
substrate to  the control. The volum e was then made to 10 m l. 
with water and the e x t in c t io n  o f  the test read against th e  
c o n t r o l  on the^Unloam  S.F,600 s p e c tro p h o to m e te r  at 530 Bp 
with a 1 cm. l i g h t  p a th .
A calibration c u rv e  was made by using O.O5 # 0.1 and 0.2 
ml. vo lum es o f  th e  phenolphthalein standard and adding 1 ml. 
buffer# 1 ml, urine# 1 ml. sodium  carbonate and making to 
10 Bil. with water* The extinction was read against a reagent 
plus urine blank. Mollcow et aX. (1 9 6 1) stated that a
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calibration curve should bo mad© for each uz’ln© specimen, but 
in practice this was not found necessary as th© calibration 
curve did not alter appreciably iirith different urines of 
normal.i>H* Only when urines with a high pH above 8 were 
encountorocl, was a special calibration curve made using that 
particular urine.
, lilhen urines of high 6-glucuronidase were suspected or\
encountered, 0,5 ml, of urine was used in th© estimation. 
However, 0.5 m3_. of boiled urine was also added to the 
incubation mixture so as to coimteract effects due to dilution 
of heat-stable Isihlbltors or activators caused by using a 
reduced volume of urin©.
One unit of enzyme activity was defined as that amount 
of ©nzyme which liberates 1 jig. pheno 1 %)htha 1 ein at 37^ under 
the test conditions and is essentially the ©am© as that used 
in tissue and seruol studies. The results are expressed as 
units/ml. urine or units excreted/24 hours. O'hese results 
are to be multiplied by 0.05 to convert them to X.U./litre 
at 37®.
TXSSme PROTEIN.
Protein in tissue fractions was measured by the method 
of Lowry, Mosebrough, Farr and Handoll (1951)p with a slight 
modification by Ayr© (3-965) to increase the sensitivity of 
th© reaction•
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PART 2
RESULTS
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The estimation of sertm and urine 0-glucuronidase 
presented no problems# and reproducible results wesre readily 
obtained.
In the tissue studies# however, it was expected that 
wide ranges of 0-glucuronidas© activity would be encountered# 
and it was felt necessary to undertake preliminary experiments 
to ensure that variation in reaction conditions# to cop© with 
high enzyme activities, would still produce reliable results.
First, the effect of dilution of tissue fractions was 
investigated to observe possible effects due to dilution of 
activators or inhibitors of 0-glucuronidase. Fig. 13 shows 
results obtained from various dilutions of an active 
preparation of a supernatant fraction from cervical carcinoma. 
The supernatant # mad© up in 0.25M**suoroso, was diluted with 
water. It can be seen that dilution of the fraction had an 
effect upon the observed 0-gluouronidase activity only at the 
1 in 2 dilution, and further dilution produced linear 
reduction in 0«glucuronidas© activity. This effect would be 
due # presumably, to dilution of inhibitors j^resent in th© 
undiluted sample but vdiich would not be effective on increased 
dilution. It might also be caused by inadequate substrat© 
concentration at the high enzyme activity of the undiluted 
sample, but it was found that increasing th© concentration 
of substrate did not Effect the result obtained on the 
undiluted sample. The effect of dilution is again shown in
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BFPECT OF DILUTION OF A CERVICAL SUPBRNATAMT FKACTIOW 
OH ITS 6-GLUOUROMIDASE ACTIVITY,
3-GLUCURONIDASE 
units/ml.
120 -,
undiluted
supernatant
100 -
80 -
1 in 2 dilution
60 -
40 -
1 in 5
20 -
I in 10
1 in 20
5 15 20 2510 30 35
PROTEIN CONCENTRATION (mg. /m l. )
The protein concentration of each dilution was calculated 
from the protein concentration estimated in the undiluted 
sample.
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Table l4, where it can be seen that dilution of supernatant 
from another cervical carcinoma produced slightly higher 
0-glucuronidae© activity. This effect was not seen in the 
particulate fractions made up in water and^ if anything, 
dilution caused slight inhibition of the enzyme. It is 
possible that the sucrose in the supernatant causes this 
slight inhibition, but the effect is not as pronounced as 
that stated by deDuve (I963), who claimed that 
caused a 30^ inhibition of ^-glucuronidase.
The effect© produced by dilution of supernatant.and 
particulate fractions are only minimal and would not 
appreciably affect measured p-gXucuronidaa© activities.
To minimise any of the above effects, fractions obtained from 
different specisnen© were diluted wherever possible at least 
1 in 2, and the variation in reaction conditions achieved 
mainly by change© in incubation time (see below). Some 
specimens of normal cervix, however, could not be diluted due 
to low p-gluouronidase activity.
The second factor considered in the estimation of tissue 
p-gluouronidas© was linearity of the enzyme reaction with 
time. Talalay et al. (lp46) showed that the reaction was 
linear with time using different tissue homogenates, but it 
%^ a© felt that a check should be made using the tissue fractions 
being studied in the present work.
The supernatant and particulate fractions of a cervical 
caroinoma, at 1 in Z dilutions, were used to follow the course
TABLB 14.
EFFBOT OF DILUTION OF TISSUE FRACTIONS UPON
B-GLUCUEOHXDASE ACTIVITY.
T i s s u e C e r v i c a l  Carcinoma
Tissue
Fraction
Dilution Observed 
u n i t s / m l .
B-Gluo.corrected 
for dilution
units/ml.
SDFBHHATAOT 
(in 0 .25M™ 
eucroseT
0
1 in 2 
1 in 4
150
77
39
150
154
156
Ml FRACTION
(in water)
O
1 in 2 
1 in 4
32
15
7
32
30
28
M2 FRACTION
(in water)
O
1 in 2 
1 in 4
36
16
8
36
32
32
All dilutions were made in water.
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of the eaiayme reaction with time. Fig. 14 illustrates that 
the enzyme reaction linear over at least a 6 hour period
for the supernatant and Ml fractionst and for the M2 fraction, 
the reaction was linear at least up to 5 hours ; it was not 
tested beyond this because of the high (3-glucuronidase 
activity of the M2 specimen.,
■Xt Was possible, therefore, t.o vary Incubation times 
quite safely from.1 to :6 hours, but in practice it was found 
that incubation times in excess of 4 hours were not required.
By varying the dilution of the tissue fractions and 
incubation times, it was possible to estimate specimen© of 
low and very high (3-glucuronidase activity and produce reliable 
results.
6-0LUOURONXDASE ACTIVITY OF NORMAL AND CANGBHOUS CISRVXCAh 
TXSStJE.
The enzyme activities of the tissue fractions were 
expressed in two ways, (a) as p-gluouronidase units/g. wet 
weight of tissue «• units/g.w .w . «• and (b) as specific 
activities, i.e. units/mg. tissue protein as measured by the 
method of Lowry et al. (1951)•
Normal Cervical Tissue.
The (3-glucuronidase activities recorded on 12 specimens 
of cervical tissue classed as normal but Including, in some 
cases, non-malignant changes consistent with chronic cervicitis,
yjms.j-.iLt.
LimSARIYY OF YlflS RAYE Og HYDROLYSIS OF SUBSTRATK BY 
B-OLÜGUROHIDASXii XW THRXSE CYTOPLASMXC FRACTIONS OF
— r— i y~^r“‘Titrn~'i^i«rfrTTuTT*triirrt'~ Tin i*i*i#mn nnniiiTirr i%mwn iorii#i #i m rmii rrm^ rrm
GFRVICAL CARCINOMA.
|iG. PHENOLPHTHALEIN 
FORMED
30 T
M2 FRACTION
SUPERNATANT
25 -
20 -
Ml FRACTION
15 -
1 0 -
2 3 64 5 71
INCUBATION TIME IN HOURS
The Slabstrate was phenoIphthaXein mono-p-^liiciironic acid 
the arsnount of phenolphthalein liberated was measured and 
plotted a^'alnst time of incubation at 37*^  •
'“1,39“*
are shown in 15 as units/^«w*w, and Fi^* l6 as specific
activities, and the data pertaining' to normal cervix from 
these Figures is summarised in Table 15 # Particulate 
material was obtained in only 7 of the 12 specimens, and this 
could be divided into HI and M2 fractions in only 4 of these* 
Consequently, the 'Combined Particle' fraction in Fig. 15 and 
16 and Table 15 includes the results obtained on throe specimens 
with Ml and M2 fractions combined before onssyme analysis, 
together with aummated Ml and M2 results on the other 4 
specimens•
The p-gluouronidase activity was low in the majority 
of these tissues. On a unit/g.w.w. basis, the measured 
activity appeared to be mainly in the supernatant fraction 
in these tissues in which particles ware obtained (Table 15)• 
However when the results were expressed as specific activities, 
the particles appeared to be more active than the supernatant.
Three of the specimens with supernatant p-gluouronidase 
activities of 235» 115 and 114 units/g.w.w. xmro much higher 
than any of the others (range 10«*55 units/g.w.w. ) . There 
\ms no histological feature in these three specimens to 
account for their comparatively high enzyme values. Comparable 
findings were obtained when the activity was expressed as 
specific activity, indicating that this was a real increase 
in tissue enzyme in these specimens and not due to increased 
soluble tissue protein. Combined particles were obtained on 
two of the specimens with a higher g-glucuronldase activity,
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B-OUJCimONIDASIS CONTEOT OX!' SUPISRWATAMT AND PARTICULATE 
FRACTIONS OF MALIGNANT ANB NOH-MALIGNANT CERVICAL TISSUES.
U N IT S /G . W ET W EIG HT TISSUE
6000
5000
4000
3 0 0 0 -
2000-
1000-
5 0 0 -
4 0 0 -
3 0 0 - 
200 ■
1 0 0 -1
50
2 5 -
1 0 -
SUPERNATANT
5 0 0 -
4 0 0 -
3 0 0 -
200-
100-
50 - 
4 0 -
3 0 -
20 -
10 -
5 -
CARCINOMA NORMAL
COM BINED PA R TIC LES
/•
• •
••
CARCINOMA NORMAL
Results are plotted on a semi-log scale
14.1-
FiaURlS 16
B-G]AJOX;Rü NIDASE s p e c i f i c a c t i v i t i e s i n SUPERNATANT AND
l - rr ' t rn—* U   .................... n r '——" ' - '— — ' i i ii ‘ i i ( i i fm u iiiimnmi* ii^ ' i 'i i#mr|MWi#xi,« # *  iiniirnv ini i ■n n ipinMiiiii*>iim.u n i nrT»i i i nfTw»w n M MiM. i^ ^ ni»ui i in i r auiWm n ii«irn» ■■i wijM iimipwnMrttrTtfTiiTf iT nm rufi i i r j w iw ^^W»
PARTICULATE FRACTIONS OP MALIGNANT AND NON-MALIGNANT
CERVICAL TISSUES.
w- W.H'
S P E C IF IC  A C T IV IT Y
60
50
40
30'
20 -
10 -
5
4
3
2 -
1 . 0  -
0 .5  -
SUPERNATANT
##
V
••
CARCINOMA NORM AL CARCINOMA NORMAL
COM BINED PA R TIC LES
& ••
••
# #
Results are plotted on a semi-log scale.
e-GLUCUROKIUASB ACTIVITY OP CYTOPLASMIC FRACTIONS 
OP NORMAL CERVICAL TISSUE.
«àikMjri<d9ai;kKW:WKnh«Mcu
Tlasuas- Normal Cervix
Tlsstie 3“glucuronldaso
SUPERNATANT (lJ>) 
Ml FRACTION (4) 
M2 FRACTION (4)
COMBINED (7)
PARTICLES
unita/g. wet 
weight tissue
Mean a- 8 .D.
60 ± 65 
6 ± 1,7 
B dr 3.5 
18 ± 11
activity
Mean ^ S.D, 
2.1 ± 2.0 
9 ± 4,1 
10 ± 4.2 
10 ± 3,3
SUPERNATANT (?)
Ml FRACTION (4)
M2 FRACTION (4)
COMBINED (7) 
PARTICLES
of total 
activity
Mean j: S . D .
71 ± 10,3 
13 ± 2,0 
19 ± 9.3 
28 ^ 7,7
Figures in parenthe a i 0 d eno t e numb 0 r of s amplea.
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and their activity/g#w*w. xvas higher (35 and 30 unita/g*w.w. ) 
than that recorded on the othejr particulate specimens ( 6-18 
unita/g.w.w.). However this was not mirrored by the 
spécifie activities and would indicate a higher particle 
yield in these two specimens than in the others*
dervical Oaroinoma#
The p-glucuronidase activities obtained in the 19 
carcinoma specimens are shown also in Fig. 15 (p.l4o) and 
Fig. 16 (p.l4l), and the data on these specimens are 
summarised in Table 16. Ml and M2 particulate fractions 
were obtained in l4 specimens ; in one, the particle fractions 
were combined.- The'total activity* presented in Table 16 
was calculated by combining the supernatant and particulate 
results. Xt is, therefore, an assessment of the total 
cytoplasmic activity obtained from the tissue, and not a 
representation of the total p-gl'ucuronidase activity of the 
tissue, aa no account has been taken of nuclear or residual 
p-gluouronidase left in the cell debris after homogenisation.
As can be seen, a wide range of p-gluouronidase 
activities was obtained. Values for the total activity 
ranged from 211-2590 units/g.w.w. and 5-44 units/mg. protein.
The activity was mainly in the supernatant fraction (?4^ o^  13.l); 
the distribution of activity was very similar to that found 
in normal cervical specimens. The particulate activity was 
fairly evenly divided between the Ml and M2 fractions, the M2
“l44"»
TABLE 16.
B-GLHCURONIDASK ACTIVITY OP GYTOl’LASMIC FRACTIONS
OF CERVICAL CARCINOMA TISSUE.
Tissues- Malignant Cervix
Tissue p-glucuronidaso
u©
spécifie
SUPERNATANT (19)
Ml FRACTION (l4)
M2 FRACTION (l4) 
TOTAL ACTIVITY (15)
Mean ^ S.l). 
855 A 669  
114 A 56 
142 A 69
1190 A 809
Mean ± S.D. 
22 A 18
l4 A 7.0 
16 ± 8,8
IB + 11.8
SUPERNATANT (15) 
Ml FRACTION (l4) 
Î12 FRACTION (l4)
activity 
Mean ± S«D.
74 A 13.1 
12 A 6.7 
14 A 8.2
Obtained by combining the Supernatant and Particulate 
results, including one additional case which only 
yielded Combined Particles on fractionation.
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fraction showing a slightly higher activity in all but 4 of 
the specimens when the results were expressed as units/g,if$w. 
or as specific activities*
There was not such a strikli^ difference between the 
supernatant and particle fractions when the p-glucuronidase 
of each fraction was expressed aa specific activity instead of 
units/g*w*w* This is because there 1© approximately three 
times the amount of soluble protein in the supernatant as in 
the particulate fractions*
Oomparison of Normal Cervix with Cervical Carcinoma*
Xt is clear that tissue from carcinoma of the cervix 
uteri, whilst having great variability in p-glucuronidase, 
usually has higher enzyme activity than normal cervical tissue 
(Fig* 15 and 16, p*l40, l4l)* The results on HI and M2 
fractions from the carcinoma specimens have been combined for 
purposes of comparison with the normal specimens. There was 
a large difference between the normal and carcinoma series 
with only one normal case lying in the carcinoma range of 
supernatant p-glucuronidaae activity, and there was no overlap 
in the particulate enzyme results• Statistical analysis of 
these data is shown in Table, 17 with the results aa units/g*v/.w* 
and Table 18 as specific activities. The differences for 
both supernatant and particle fractions on a unit/g*w*w* basis 
ax'e highly significant (Table 1?), but the specific activities 
of the particle fractions of the two aeries are very similar
X46*"
TABLE 17
OOMPARISON OF B-GLUCURONIBASB ACTIVITY OF NORMAL AND 
MALIGNANT CERVICAL TISSÜ1S.
Tissue
NORMAL
CARCINOMA
Ne. of 
samples
12
19
SUPERNATANT
p-glucuronidase 
(units/g.w.xj. )
Mean,A S.U.
60 A 65
855 A 669
t P
4.052 <0.001
NORMAL
CARCINOMA 15
COMBINED PARTICLES
h iaipuk.ii ii>. i [iwuiiiiiw ffin»WinB- f m w *w  wn' * A # ,
18 A 10.8 
242 A 126
4.671 <0.001
—xHy—
TABLE 18.
COMPARISON OP B-GIlJCURONinASE SPEÜXPXC ACTlVIOrlES OF 
NORMAL AND MALIGNANT CERVICAL TISSUE.
Cervical
tissue
Ho* of 
samples
Mmrnx### *# *6  nm  vtmnrnmiim
SUPKIiHATANT
p-glucuronidase 
(units/mg. protein)
Mean ± S.D . P
NORMAL
CARCINOMA
12
19
2.1 d 2.0 
22 ± 18
3.805 <0.001
COMBINED PARTICLES
NORMAL
CARCINOMA
7
15
10 i 3.5 
± 7.3
1#802 n* s.
•ï*X48—
and there was no demonstrable difference between them 
(Table 18)* This indicates that the differences in 
particulate p*^glnotironidas©/g.w«w. between the normal and 
cancer specimens are due to differences in particle yield, 
and are caused, in part, by the poor yield of particles from 
normal tissue for the technical reasons previously mentioned
(p.126),
DISTRIBUTION OF CYTOPLASMIC B-GLUCURONIDASE IN CERVICAL
CARCINOMA.
On comparing the results on the tissues with high 
p-gluouronidase and those with low, there was a difference 
in the distribution of the enzyme between the supernatant 
and particulate fractions. Consequently, the specimens were 
split into two well separated groupas those with a total 
cytoplasmic p-glucuronidase of over 1000 units/g.w.w. - 
the High-Content Group, and those with a total activity of 
under 500 units/g.v/.w. - the On this
basis, only one case with a total activity of 7^9 units/g.v/.w. 
was not placed. The distribution of ^-glucuronidase in this 
case was 71^ in the supernatant, 13)^  in the Ml and l6fo in the 
M2 fraction.
The pearcentage of enzyme activity occurring in each of 
the three fabactions in both groups is shown in Table 19» and 
it can be seen that there is a highly significant difference 
in the distribution of the enzyme in the two groups.
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DISTRIBUTION OF fô-GLÜCUHONXDASB ACTIVITY IN CFHVXCAL 
CARCINOMA OF HIGH AND LOU BN5ÎÎYME CONTENT.
Percentage of Total Activity 
in each Fraction
High-Content 
g r o w
n j )
Mean ± S.I).
Low-Content 
Groui
Mean ^ S.D,
SUPERNATANT 82 ± 5•3 61 ± 13.4 4.038 <0.005
MX FRACTION 8 ± 2.3 18 ± 7.4 3.645 <0.005
M2 FRACTION 10 + 3.3 21 i 10.5 2.810 <0.025
Figures in pasrenthesis denote number of cases in each group.
t and P values were obtained by comparing the equivalent 
fractions of the two groups.
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Xn the High-Content Group, a greater proportion of the enzyme 
activity is found in the supernatant fraction than in the 
Low-Content Group* This indicates that most of the increase 
of p-glucuronidae© in these tissues was in soluble 
cytoplasmic enzyme rather than in particulate ^-glucuronidase, 
However there could be an alternative explanation of this 
finding in terms of variation in particle yield in the two 
groups. This could be due to (a) tissue specimen© in the 
Low-Content Group giving a higher particle yield than the 
High-Content Group, (b) the particles in the Low-Content 
Group having more p-glucuronidas© activity than the High- 
Content Group or (c) differences in the fragility of the 
particles in the two groups resulting in particulate 
contamination of the supernatant in the High-Content Group.
However, the most likely explanation can be arrived at 
when the specific activities and the protein content of the 
specimens in the two groups are compared. Table 20 shows 
the protein content as mg./g.w.w. of the two groups. There 
is not a great difference in particulate protein between the 
High-Content and Low-Content groups. The particulate 
protein/g.w.w. can be taken aa an index of the yield of 
particles from the tissue, and it is clear, therefore, that 
there is not a great difference in this respect between the 
groups. There is in fact, an indication of a slightly 
smaller particle yield from the Low-Content Group which is 
the reverse of what would be needed to ©xj^lain the difference
TABUS 20.
PROTEIN CONTENT OF 0J5RVICAL CARCINOMA SPECIMENS
OF HIGH AND LOU 6™GLUGUIU)NXDABE CONTENT,
Protein Content of each Fraction 
(mg,/g.w 6 w ,)
!?h-Content Low-Content
Group Group
Mean ± S.l). Mean ± S.D. P
SUPERNATANT 56 ± 13.0 36 + 8.1 4.146 <0.001
Ml FRACTION 9 A 3.2 8 ± 5.4 0.663 n.'s.
M2 FRACTION 11 ± 3.8 7 i 2.0 2.143 n.s.
— 3.3'^ ’**
in P-glucuronidas© distribution on this basis.
Table 21 shows the specific activities found in the two 
groups. From this, it can be seen that there are no 
pronounced differences in 0-glucuronidase activities of the 
particulate material in both groups and, if anything, the 
High-Oontent Group was more active in this respect than the 
Low-Content GroupI this finding is again the opposite of that 
required to account for the different distribution of the 
enzyme in the two groups by difforenoes in particle activities.
Xt is also shown in 'fablo 21 that the supernatant 
specific activity in the High-Content Group is considerably 
higher than the particulate specific activities. Xt is not 
possible, therefore, to explain the increase in supernatant 
0-gTucuronldase in this group in terms of breakdown of 
particles during fractionation, to release the enzyme into 
the supernatant. There would have to be a selective release 
of 0-glucuronidase-rich protein from the particles to give 
such large increase© in supernatant specific activity in view 
of the fact that protein released from particles would be 
greatly diluted due to the very large protein content of 
supernatant relative to particles.
From these considerations, it can be concluded that 
increases in the majority of specimens of cervical cancer are 
due mainly to increases in soluble cytoplasmic enzyme with 
only slight increases in particulate 0-gluouronidas©.
Another fact to be observed from Table 20 ( p . 131) is that
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TABLE 21
SPBGIPIG ACTIVITIES OF FRACTIONS OF CERVICAL CARCINOMA 
SPECIMENS OF HIGH AND LOW B-GLUCUROMIDASK CONTENT.
Specific Activity of Each Fraction
-Content Low-Content
  — -MWuW# mgiiiiMifPi i.iiiiH inm jiilW H iiM w iiii mi*
GroupGroup
Mean ± S.D. Mean ± S.D.
SUPERNATANT 30 ± 13.0 7 A 4.6 3.761 <0.005
Ml FRACTION 17 A 8.2 10 ± 2.0 1.860 n.s.
M2 FRACTION 19 A 10.1 11 A 4.1 1.647 n.s
"•X54—
there was signifieantly more supernatant protein/g.w.w. in 
the High-Content Group. This could be a reflection of more 
epithelial tissue being obtained in these specimens than in 
the Low-Content Group, where it is likely that there was more 
stromal material which would not yield cytoplasmic protein. 
This would also explain the higher p-glucuronidase content 
of the tissues in this group, as the enzyme is usually 
confined mainly to epithelial cells with little or no 
activity in the stroma.
6-GLUCUR0KXDASB AND THE DEGRBB OF MALIGNANCY OF CERVICAL 
GAHOXNOMA.
Because there was such a wide rang© of 0-glucuronidas© 
activities in the carcinoma series, it was felt necessary 
to see if this was associated with the clinical and 
histological assessment of the severity of the disease.
V
The cases were graded into the following three groups using 
the clinical staging of the disease together with histology 
reports; Severe cases', with a widespread, highly malignant 
lesion; Mild case©,' with an early lesion? Intermediate 
group comprising those cases which could not bo placed with 
certainty in the other two groups* This classification 
must needs be arbitrary, but the main purpose was to separate 
the distinctly advanced oases from those with early lesions. 
The clinical and histological classification was made 
independently by a colleague with no knowledge of the enzyme
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results. On this basis, 9 of the 19 cases were classed as 
Sever©, with 3 Mild and 3 in the Intermediate group. The 
supernatant p-glucuronidnso activity of the specimens 
obtained from these patients in each of the groups is shown 
in Table 22. There was a significant difference between the 
Mild and Severe oases with the results expressed as units/ 
g.w.w. and as si>ecific activities. This difforenc© was due 
to all 3 cases in the Mild group having very low p-gluc-
i
uronidase activities with none higher than 230 units/g.w.w., 
whilst cases with higher activities wore spread over the 
Severe and Xntersnediate groups. There was no difference 
between the Severe and Intermediate cases. Particulate 
material was obtained on only three of the oases in the Mild 
group. The combined particle activity for those three oases 
138, 73 and 48 units/g.v/.w. - were very much lower than for 
the Severe group - 198-487 units/g.w.w. This difference was 
not apparent, however, with the results expressed as specific 
activities and was, therefor©, probably due to a small 
particle yield in the Mild cases.
Table 23 shows the protein content of normal and 
malignant cervical;,specimens• Comparing these values with 
those in Table 20 (p.131), it is seen that the carcinomas 
with low 0-glucuronidase activity approach the normal tissues 
in their supernatant protein content. Also it is shown 
that those specimens classed as Mild in Table 22 lie perhaps 
even nearer to the normal group. This does not apply to the
156-
T A B L Î5  2 2 .
SUPERNATANT B-QLUCURONIDASE RESULTS ON CASES OF CISHVICAL
CARCINOMA CLASSIFIED BY SEVERITY OF THE MALIGNANT LESION.
B-GXucuronidase (unite/g.w.iir. )
tMean ± S.D. t P
Severe it (9) 1044 ± 675 2.739 <0.02
*Intermediate (5) 1159 A 625 3.378 <0.01
Mild (5) 212 ± 46
Speoiflo Aotlvlty
Sever© 24 + 16.1 2.469 <0.05
Intermediate 33 ± 21.7 2.510 <0.05
Mild 6 ± 1.1
t t values obtained by reference to the Mild Group,
* The Severe and Intermediate Groups were not statistically 
different,
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t a b l e  23.
PROTEIN PONTKNT OP NORMAL CERVIX AND CERVICAL CARCINOMA.
SUPERNATANT 
COMBINED PARTICLES
NORMAL CERVIX 
Samples Mean ± S.I>
12 27 A 7.9
7 1.8 ± 0.9
«UPBRNATANT
COMBINED PARTIC1,,ES
SUPERNATANT 
COMBINED PARTICLES
SUPERNATANT
COMBINED PARTICLES
CERVICAL CAHGINOMA 
19 43 A 17.6
15 17 ± 6.9
MILD GASES*
33 ± 6.5 
11.0, 4.0 and 10.0
3
SEVERE AND INTERMEDIATE 
'CASIOS
*
14
12
47 ± 18.9 
19 A 6.8
^Cervical carcinoma cases divided as in Table 22 (p.156)
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partiel© fractions where th© protein in the normal specimens 
is very much lower than that of the cancer specimen©; this 
reflects the much lower yield of particles from normal 
cervical specimens.
EFFECT OF RABIATXDH ON TISSUE B-GhUCUHQHXl)ABF.
Specimens of cervical cancer tissue were obtained before
and after radiation in 12 patients; particulate material was
compared in 10 of these.
There was not a uniform change in 0-glucuronidase in
these tissues following treatment by radium, with the results
expressed as units/g.w.w. or as specific activities. Three
cases showed large increases in supernatant 0-glucuronidase,
while four showed large decreases. The remaining five cases
*rshowed small vaiations which probably arose from tissue 
samj^ling techniques.
Changes, in particulate enzyme were also very variable, 
and they did not correlate with changea in supernatant 
enzyme «
The increase© and decreases seen following radiation 
could not be correlated with the classification of the 
cases into Severe, Mild or Intermediate with respect to the 
degree of malignancy?*, or with the response of the patient to 
the radiation treatment.
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BLOOD 
URXNB STUDIES.
Result3 on the urinary 0-gIucuronidase excretion in the 
three groups of patients studied - those with cervical, bladder 
or thoracic carcinoma - were expressed as 24 hour excretion 
and as urine enzyme activity in units/ml*
A normal range for urine 0-glucuronidase was obtained by 
taking 24-hour urine collections from 20 healthy subjects, 
aged 19-67 years. These gave a mean excretion of 1520 units/ 
24 hours, S.D# 4lO, with an observed range of 950-2450 units/
24 hours, and mean urine enzyme activity of 1.29 units/ml.,
S.D. 0 .36, with an observed range of 0.74-1.93 units/ml.
Patients with Carcinoma of Cervix.
Xn order to group the results on all the patienta 
together for statistical analysis, the scheme of radiotherapy 
treatment for each patient was divided into phases, and the 
mean 0-glucuronidase excretion and activity was taken from 
the results on all 24-hour urine specimens collected in each 
phase. These phases were as follows;-
1. Pre-treatment - comprising two consecutive 24-hour 
collections taken before treatment commenced; the average of 
the result© was taken as a baseline for 0-glucuronidase 
excretion for each patient.
2, Radium treatment - in five of the patients, these comprised 
four collections, two following insertion of the first and
— X60 —
second radium implants# and tim following withdrawal of these; 
in the remaining four patients# there was only on© insertion 
of radium and# therefore# only two collections were made 
following radium insertion and withdrawal * The moan was
taken of the results on all speoiraens from each patt^nt over
\
this periodi
3i Supervoltage therapy - this was divided into three separate 
weekly periods; the mean of the 0-glucuronidas© results on the
2-3 Gollections taken in each week on each patient were used*
The collective data on the 9 patients in this group are 
shown as 24 hour excretion of 0-glucuronidase in Table 24, 
and as units/ml 4 in Table 25* As can be seen from the 
standard deviations on the results during each treatment# 
there was a large patient variation in 0-glucuronidase output 
before and after radiotherapy# The difference between base­
line values and those obtained during different treatments 
were analysed statistically# and it is shown in Table 24 
that there was a significant increase in 24 hour excretion 
of enzyme which occurred during and following radium 
treatment* The same was found with urine 0-glucuronidase 
expressed as units/ml *, indicating a true increase in enzyme 
output and not simply increases in urine volume*
There was, however, variation between the patients in
the group* The larger increases in 0-glucuronidase output 
occurred in patients who had an abnormally high 24 hour 
excretion of enzyme before radiotherapy* This is shown in
— l6X'
T A B L E  24.
24-h o u r mixmt b-glitouhonibase pimim r a b i o t h e h a f y of
PATIENTS WITH CAKCXNOMA OF CERVIX.
Daily B-gluouronldaae excretion 
(unita/24 hours)
Mean ± S.D. ib P
Before treatment 2270 ± 1216
Radium treatment
Supervoltage 
Week 1
Week 2 
Week 3
3577 ± 1975 
4310 à 3070 
3360 ± 3400 
3380 à 4310
3.644 <0.01
3.107 <0.02
1.286
0.948
n. s •
n.s •
Number of patient
t values were obtained by comparing the means for each period 
of treatment with the before-treatment value.
1 6 2 .
TABU5 23.
aLUCUROWIBASlî ACTIVITY DURING RADIOTHERAPY OF
........................aoMm;*! * # I Wktf iATiv x i iniM ii iin nifii I-,rKTirT0uwacgeaA:6 #*»mM W % *Km *m TmmKei«Lm#3c.w )6@w * % 'iK »
PATIENTS WITH CARCINOMA OF CERVIX
B-GlMcugonldaae activitv
(units/ml. urine
M © a n ± S  • 3>é
eetio*MaiV*i=a4aeît**ià*cr2<¥ti#*eA»6.'jt4#*Aitio6#»
Before treatment 1.66 ± 0.76
t
Radium treatment 8.71 * 1.1
Supervoltage 
Week 1
Weols 2
Week 3
2.84 ± 1.52
2.33 ± I.
1.86 j; 1.
3.841
2.725
1.478
0.645
<0.01
<0.05
n. 8.
n. 8.
Number of patients  ^9
*»X63“
Figure 17* The cases were divided into those with a high 
pre-treatment p-glucuronidas© excretion and those with normal 
p«glucuronidaae values* All 4 cases in the high-excretion 
group showed pronounced increases in 24 hour enzyme output 
occurring during radium treatment and over the period directly 
following* This was reflected in the urine activity aa units/ 
ml * The large increases in 24 hour p-glucuronldase excretion 
in Case G *2 were accompanied by a diuresis occurring in the 
second and third %fe©ka of supervolt age therapy. There was # 
however, an increase in enzyme activity in units/ml. in the 
third xmek* Collections were taken on this patient for a 
further two weeks of radiotherapy, and it was found that the 
enzyme excretion fell over this period to approximately 
7000 Units/24 hours*
Of the 3 patients with normal pre-1 re at ment p-glucuronidase 
excretion, two (Cases G *5 and 0*6) showed a definite increase 
in enzyme output occurring over the same period as the 4 high- 
excretion cases* Case 0*7 appeared also to show a slight 
increase in enzyme excretion, although not to values far 
outside the normal range* The other cases - G *8 and C*9 - 
showed no response to radiation and produced remarkably 
constant urine values over the whole course of therapy*
It is clear that 7 of the 9 cases showed increases in 
p-glucuronidas© excretion which in 6 were very pronounced*
The increases occurred during implant at ion of radium into 
the cervical carcinoma and extended for some time afterwards
l64-
FlGWiUS 17.
EXCRETION OF B-OUJCUROKIDASlii IN URINK OF PATIENTS WITH
CERVICAL CARCINOMA RECEIVING RADIOTHERAPY.
HIGH - EXCRETION CASES
units / 24 hours u n its /m l.
12,000-1
1 0 ,0 0 0  -
4 0 0 0 -
2000 -
C .3
6 .0-1
C.4 2.0-
LOW - EXCRETION CASES
C. 2
C .3
6000-1 . 0-1
4 0 0 0 -
C.5C.5
2000 - 2.0-
.♦C.7
.« C .3
C.O
C .9
P re - radium  
radiation
P re - radium  
radiation
Weeks supervoltage therapy Weeks supervoltage therapy
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during ^upervoltage therapy* The enssyme output usually 
fell thereafter by a varying extent. The largest increases 
in enayme excretion were associated with those case© which 
had an abnormally high glucuronidase exoretion prior to 
radiotherapy•
There was not a direct correlation between the severity of 
the disease and (^"glucuronidase response. The 4 patients 
in the high"excretion group were all classed as Severe by 
previous criteria (p.154). However* in the low-excretion . 
group* Oases 0*5 and 0.6 which showed the largest response 
were Mild cases* and Case 0.8 which produced no response was 
Severe.
Patients with Bladder Carcinoma.
Urine collections were taken at intervals over the whole 
period of supervoltago therapy* and the results on the 
collections grouped into three separate week3-y periods as 
previously described with the cervical carcinoma patients.
A statistical difference between the baseline values 
and those for each period of treatment could not be found. 
Results on individual cases are èhown in Fig.18. It can bo 
seen that there was not a consistent response of the patients 
to supervoltage therapy* even though 5 of the 8 patients had 
very high p-glucuronldaae excretion before radiotherapy,
Only two cases « B*1 and B.2 ™ showed pronounced increases 
during radiation* while the others shov/ed only alight or
166-
Fxaumc 18.
EXCRETION OF B-OUJOXmONXDASF IN URINE OF PATIENTS VITH
BLADDER CARCINOMA RECEIVING RADIOTHERAPY.
HIGH - EXCRETION CASES
units/ 24 hours
8000 -
6000 -
4000“
2000-
6000-1
4000-
2000 -
B.5
B.6
B.2
B,3
B.7
8.0 -
6,0 -
4 .0 -
2.0
LOW - EXCRETION CASES
units/ ml.
B.7
B.2
B.3
B .l
B.4
B.B
 1 1 1 1---
Pre- 1 2 3
radiation
Weeks super voltage therapy
4 .0 -
2.0-
B.4
321Pre­
radiation
Weeks super voltage therapy
non-specific changes.
Patients with Thoracic Carcinoma.
Urinary p-glncnronidas@ results on this group were 
obtained in a similar way to those in the bladder carcinoma 
group. A statistical difference between the results on 
different stages of the treatment could hot be shoxm.
Fig. 19 shows the individual cases. Only two, both 
xirith carcinoma of the bronchus, had high pro-treatment 
p-gluouronidase values ; both showed increased enzyme output 
over the first two weeks of treatment which fell to initial 
values during the third xfoek. Of the other 6 cases, only 
Case T.7 (cai’cinoraa of oesophagus) showed increased excretion, 
this in spite of the patient developing oliguria clue to 
poor fluid intake during treatment.
Urine B^Glucuronidase and Radiation Dosafge.
The pattern of p-glucuronldase excretion was not related 
to the total radiation dose given to the tumour tissues in 
any of the three groups. In the cervical carcinoma group, 
however, the radium implants appeared to be tlie major cause 
of the increases in enzyme excretion.
SERUM 6-GLUCURONIDASE IN CERVICAL CANCER PATIENTS.
Blood specimens were taken along with urine collections 
in the cervical carcinoma group, and serum p-gTucuroniclase
168'
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EXCRETION OF B-OI.’IJOIJRONIDASR IK 8RIHE OP PAYIENYS WITH
THORACIC CARCINOMA RECEIVING RADIOTHERAPY.
HIGH - EXCRETION CASES
units/ 24 hours
8000-
6000-
4000-
2000-
6.0 “
T .5
T.B
2.0 “
units/ ml.
T .5
T .8
LOW - EXCRETION CASES
6000- 6.0- T.7
4000- 4 .0 -
T.l 
^  T .7  
j#  T .6  
"* T .3
T .4
T .2
2000 2. 0- T .3
T .4
^  T.6- 
-# T .2
1 2 3Pre-
radlation radiation
Weeks supervoltage therapy Weeks supervoltage therapy
analyses carried ont. The results on these patients were 
^^ roupO^ i in the same way as the urine results and, therefore, 
the values for serum p-glucuronidase in eaoh patient during 
the different periods of treatment are the mean of 2-3 or 
sometimes 4 analyses of p-f-glucusronidase in different serum 
samples. All except one case showed an increase in serum 
(3-glucuronidase during radium treatment ; the results are 
shown statistically in Table 26. "thereafter, results were 
Unpredictable, but in three cases there were further increases 
to high values over the course of supervoltage therapy.
Four of the other case© showed subsequent decrease© in 
enzyme activity. These results are shown in Fig.20.
Ho connection could be found between the serum and urine 
p-glucuronidase over the whole course of therapy in the 
majority of these patients. One fact that emerges, however, 
is that during radium treatment, increases in urine enzyme 
output were accompanied by increases in serum (3-glucuronidase 
in 7 of the cases. Case C.B which did not produce an 
increase in urine activity, also failed to produce a rise 
in serum p-glucuronidase during radium implantation.
Two cases, shoi\m in Fig. 21, showed a reciprocal 
relationship between serum and urine (3-glucuronidase. Both 
cases showed a coincident increase in urine and serum enzyme 
during radium therapy. Case C.5 then produced a dramatic 
fall in urine enzyme output to low values of 200-400 units/
—X 7 o—
TABL35 26.
SERUM 6-aLUCm^ONXDASID ACTIVITY DURING RADIOTHERAPY OF 
PATIENTS WITH CARCINOMA OF CERVIX.
Supervoltage 
Week X
Week 2
Week 3
Serum O-glucuronldas© 
(units/100 ml.)
Mean ± S.Î).
Before treatment 6k6 * 1?4
Hadlum treatment 794 a 128
662 ± 220
701 ± 252 
676 i 254
No. o f  p a t i e n t s  = 9
3.552 <0.01
n. s.
n .  8
n . S .
171.
FIGURE 20.
SERUM B-GLUCURONimSE IK PATIENTS WITH CERVICAL 
OARCINOMA RECEIVING HADIOTHICRAPY.
SERUM
p-GLUCURONIDASE
u n i t s / 100 m l. GROUP 1 GROUP 2
1200 H
C .3
1000 -
800 -
6 0 0 -
4 0 0 -
200-
4 5 P r e -  ra d -2 3P r e -  rad 1
C.
C.
ra d . ium  ra d , lum
W eeks supervo ltage  therapy
GROUP 3
C .6
C .8
I 1--1--1--1--r
P r e -  ra d -   ^ 2 3 4
ra d . lum
0roup 1 « casea showing increased en^ym© activity over 
aupervoltag©
0roup 2 •» cases showing no specific change
Group 3 cases showing decreases over supervoltag© therapy 
Cas© nnmbers refer to those in Fig. 17 (p.l64).
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FIGURB 21.
HECX.PROCAL RELATIONSHIP OF BLOOD AND
IN TWO PATIENTS WITH CERVICAL CARCINOMA.
SERUM
P”GIjUC . 
units/ 100 ml.
1200 -1
1000-
800 -
600 “J
CASE C.5
Serum URINE 
p -G LU C . 
u n its / 24 hours
4000
-  2000
Urine
CASE C. 31200 -1 “ 10, 000
Serum
800 - -  6000
400 - - 2000Urine
P re - radium 21 3 4 5
radiation
Weeks supervoltage therapy
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24 hours in the fourth and fifth weeks of deep x-ray therapy 
which was accompanied by a rise in serum activity to abnormal 
values. Case 0.3 also showed a sharp fall in urine excretion 
of p-glucuronidase$ with the serum values rising in a 
correspondingly sharp manner.
OQMPAHISOH OF TISSCB AND tJHXNB B-CUJCURONIDASIS STUBIBB IN 
PATXIDNTS WITH CBHVICAL CARCINOMA *
aa;l'^ W^rnwda^#lËmmwllll#WbW ilr * l 'l ii*mi mv
There were on3,y 5 patients with cervical carcinoma on 
whom biopsy specimens were obtained, who subsequently had 
urine studies porformed. This was due to difficulty in 
selecting patients suitable for the urine studies. A post­
radiation tissue specimen was obtained in only one of the 
3 cases.
Biopsy material was taken on Cases 0.1,2,3,5, and 8 
shown in Fig. 17 (p. 164). Of the cases with a high initial 
excretion of (3-glucuronidase, Case C.2 had a very high tissue 
supernatant g-gluouronidas© - 2300 units/g.w.w. and specific 
activity of 44 - and produced a good increase in urine 
eiig;yme excretion following radiation; Cas© C.3 had a moderate 
tissue supernatant enssymo activity of 6^0 units/g.w.w. , but a 
high specific activity of 46, and also produced a good 
response in urinary ^-glucuronidase following irradiation of 
the tissue.
In the cases with normal p-gliicuronidase excretion,
Case 0.3 had a moderate to high supernatant p«glucuronidas© -
- 1 7 4 -
1000 units/g.w.w. with a specific activity of 17> and showed 
an increase in urine (3-glncuronidase excretion following 
radiation, although not so marked as Oases C.2 and C.3.
Case G.B, which showed no change in urine enzyme output 
following irradiation, had a very low tissue supernatant 
enzyme activity - 220 units/g.w.w, and a specific activity 
of 7 # A post-radiation specimen was obtained in this case, 
and this showed no significant change from the j^re-radiation 
specimen.
From a consideration of the results on these 4 cases, 
there appears to he a definite relationship between the output 
of enzyme in the urine following radiation of the tissue by 
radium implants, and the (5-glucuronidase activity of the 
carcinoma tissue being irradiated. However, Case C.l does 
not apx>ear to uphold this hypothesis. This case had a high 
initial excretion of {3-glucuronidase in urine which increased 
after radium therapy. The corresponding tissue specimen, 
however, showed only a low supernatant (3-glucuronidase - 
290 units/g.w.w. with a specific activity of 6. The total 
cytoplasmic activity was much higher - 490 units/g.w.w. - 
due to a high particulate enzyme content. This anoioaXi^ty 
might b© explained by the tissue specimen obtained at biopsy 
having a high proportion of fibrous material and not being 
truly repre s ont at ive of the carcinoma. This view is 
supported by the fact that the case was c3-assed from clinical 
and histological considerations as a Severe one, but the tissu©
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enzyme results were more oonsiatent with those obtained 
from the Mild cases where tissue speoimena were likely to 
contain a higher proportion of stromal material than the 
Severe" oases.
% / 11
PART 2.
DISCUSSION.
6-aLHCTOOHXDASE XH CBRVIGAL TXSSm.
Normal Cervical Tia.siae.
The 12 speoiiBon© of non*»malignant cervix showed low 
p-gluotsronidase activity* The observed range for the 
supernatant p-glnouronidage 10-235 (mean 6o) nnita/g.w.w* - 
compares with values quoted by Odell et al. (1949) of 23-330 
(mean l42)_units/g*w.w* for aqueous preparations of cytoplasmic 
contents of non-malignant cervical speoimena. Fishman et al * 
(1 9 5 0) used tissue homogenates in 0*1M-acetate buffer and 
quoted a irange of 0-533 (moan 1 5 3) imite/g*w.w* for non- 
malignant cervix uteri* Rauramo (1959) found a range of 
2 0 -2 7 0  units/g.w.w. using tissue homogenates in water.
The homogenatos used by all those authoirs are likely to 
give a higher range than that quoted for supernatant (B-gluc­
uronidase In the proaont work* Their figures will include 
particulate enzyme, and from this study, It can be estimated 
that this would 'give at least a further 30^ increase over the 
supernatant figures (Table 15® p# 142). Furthermore, 
homogenisation in water or O.lM-acetate buffer is likely to 
cause disruption of particulate material and perhaps nuclei 
by osmotic effects; the homogenatea in this atudy were 
prepared in isotonic sucrose solution to maintain the integrity 
of particulate material and, therefore, this will lead to 
lower values for particle-free stipernatant fractions than 
crude tissue homog©nat © a.
Although these cervical specimens were classed as normal
there were in some cases, benign changes characteristic of 
chronic or acute cervicitis. However, the severity of these 
changes in no way influenced the p-glticuronidas© activity. 
This was borne out by Odell and Burt (1950) who found low 
p-gXuciaronidase activity in specimons with cervicitis, 
nabothian cysts and cervical erosion, which did not differ 
from normal.
Cervical Cancer Tissue.
rh iia .^ m te ;" i.ir .W - i i*»inn» i ' iiw>. i n.n'i mi in nn j >i»m *— n f m i
The rang© of (3™gluciironidas© activity of the cervical 
cancer specim©2is was ve.ry much higher than that of non- 
malignant specimens. Supernatant |3-glucuronidase values 
ranged from 138-2300 (mean 855) miits/g.w.w., which compare 
with results on x^ ihole tissue homogonates of 543-2790 (mean 
1274) units/g.w.w. obtained by Odell and Burt (1949) and 555' 
5950 (mean 164?) tinits/g.w.w. by Fishman et al. (l950). 
Rauramo (1959) doacribocl a range of 140-2820 units/g.w.w. 
with 50^ 0 of the cases having values above 600 imits/g.w.w.
If the particulate results are included with the supernatant 
results in this work, the range becomes higher - 211-2600 
units/g.w.w. (mean II90).
THE NATURE OF INCREASED B-OLHCUÎiONXBABB IN GANGER SPECIMENS.
The cervical carcinoma group aa a whole shows a much 
higher p-gluctaronldaae/g .w.w. than the normal cervical 
specimens* The precis© nature of the increased activity
has not, as yot, been explained. Two poBsibilities 
present tiieiîiselvee3- 1* an increased activity of (B-gluc- 
uronidas© in the malignant cells, or 2. as cervical carcinoma 
:la. mainly due to a proliferation of the epithelium of the 
cervix, the increase in p-gTucuronidase in the tissue may bo 
ciu© to more cells, with approximately the same p-g3.iicuronidase 
activity as .normal cells, being found in the biopsy speoiraeii 
of tumoi.sr, than in normal samples.
Fishman et al. (1959) reported that cancer cells contain 
P-glucuronidase In an amount that exceeds the activity seen in 
non^neoplastic oe.lls# On the other hand, Hopman (I961) 
upholds suggestion 2., by stating that the marked 
quantitative increase in p-glucuronidase in cervical carc'inoma
in eitu was duo to a greater amount of epithelium in the
malignant tissue, and that the cancer cello did not stain 
any moro- strongly than basal cells of normal epithelium*
The results from this present study indicate that both 
possibilities contribute to the increased (3-glucuroîiidase 
activity of cervical carcinoma* The amount of soluble 
protein obtained in the supernatant fraction of the tissue 
homogenates can be taken as an indication of the collularity 
of the specimen, as this protein will be derived mainly 
from soluble IntraceJ-lular protein and not from structural 
proteins of fibrous connective tissue. Xt can be seen from 
Tab3.0 23 (p* 157) f that the carcinoma group had a higher 
supernatant protein content/g.v/.w* than the normal group,
—XBO*»
indicating that th© malignant specimens had more epithelial 
tigsue tn the biopsy specimens than normal and, therefore, 
upholding the views of Hopman (196I)#
However, when the supernatant enzyme activity is 
expressed as apeoiflc activity, i.e. with,reference to the 
supernatant protein content, the carcinoma group is again 
very much more active than the normal group (Table 18, p.14?). 
This substantiates the view of Fishman et al. (1959) that 
cancer cells have a higher p-gltaouronidase activity than 
normal epithelial colls.
THE XHTKAC31iLLyi.AR DISTRIhm'IQN OF 6-GLVCURONIDASE IN CERVICAL 
TISSUE.
The total activity of p-gluotironidas© obtained from the 
tissue hoEiOgenates in this wmrk is,, in rea3.ity, the cytoplasmic 
activity, aa no account has been taken of any enzyme that may 
be present in nuclei * Levvy and Conchi© (1964) have shown 
that the time of homogenisation and method employed will 
rlrifluenc© the distribution of the enzyme in the sub cellular 
fractions. They deiBonstrated that a blender device, as used 
here, tends to disintegrate granules, and a better means of 
homogenisation was the Potter-lOlvejrlhJem, homogenisor. However, 
this Is suitable onl^ r for soft tissues and could not be used 
with oer’vioal specimens. Levvy and Conchi© (1964) also 
showed that in some tissues studied, if the homogenisation 
time was Increased from one to three minutes, there was a
reduction in the percentage activity in the nuclear fraction 
and, in some cases, small reductions in the mitochondrial 
and microsomal fractions, with corresponding increases in 
the supersiatant p-glucuronidase activity. They suggested 
that the prolonged homogénisation disrupted nuclei and other 
cytoplasmic particles. However,the reduction in p™gluc- 
uronidase of the eedimented nuclear fraction can equally be 
explained- by a decrease in the numb ear of unbroken cells 
found in this fraction on further homogonisation.
When fractionating tissue specimens, conditions must be 
selected which v/ill give adequate breakdown of cellular 
material, and snmst be a compromis© between this and an 
attempt to keep disruption of particles to a minimum. The 
conditions selected for the cervical tissue were based on 
these considerations.
Xn interpreting the distribution of p-glucuronidase 
botwooil the supernatant and particulate fractions of the 
normal and malignant tissues, two factors must be considered. 
First, particles can be trapped within the fibrous network 
formed from disrupted connective tissue of the specimen.
These will bo centrifuged down with the nuclei and cell debris 
and rendered unobtainable. Xt is probable that this occurred 
extensively in the samples of normal cervix where fibrous 
material formed a high proportion of the total specimen, and 
accounted for the poor yield of particles. Xn the malignant 
tissue, however, this factor was very much loss, due to the
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high cellialarlty of tha canoar speoimena. Secondly, 
disruption of particles, with release of their contents into 
the oupernatant fraction, can occur during tissue fractionation 
due to (a) mechanical disruption of particles in the blender, 
and. (b) disintegration of particles as a oonseqiîenco of the 
freezing and thawing of the specimen during storage and ■ 
subsequent slicing of the tissue on the freezing microtome*
This factor will be common to both normal and malignant tissue 
preparations•
Xt is difficult to assess the extent to which the 
disruption of %)artiol0B interferes with the distribution of 
(3-gluciaronidase in the cytoplasmic fractions. It la unlikely 
that this would invalidate the observed distribution to a 
notable degree for the following reasons* In the first place, 
the specific activity of the supernatant In the carcinoma 
group is considerably higher than that of the particles 
(Table 16, p*l44), whereas the specific activity of the 
normal supernatant ia only one-fifth that of the corresponding 
particles (Table 15, p. 142)* If the distribution were 
affected by factors common to both groups of tissues, one 
would not expect such a remarkable difference betxireon the 
supernatant/particle specific activity ratios * Xn the second 
place, the protein content of the cancer supernatant was 
approximately 30^ o higher than that of the normals (Table 23, 
p* 157)§ the specific activities of the particulate enzyme in 
the two groups was not widely diff©rent• If it was assumed
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tîiat all the supernatant ©nzym© was derived from the particles 
in both tissues# it can be calculated from the mean values of 
specific activity and pirotein content of each fraction, that 
3/4 of the normal particles/ and 4/5 of the cancer particles 
would need to be ri.^ ptt^ r©d to give the observed results*
Idiile the former possibility cannot be excluded on 
theoretical grounds, in vieiv of doubts about the recovery of 
the particles, the latter ia quit© unacceptable,' ae this 
would require that approximately 85 mg. of particulate protein/ 
g* of tissue had escaped into the supernatant, the entire 
protein content of which ia considerabl3r lower than this 
(mean 43 mg./g.w.w*)* From these considerations, it seems 
likely that the supernatant ©nzym© ia a separate entity from
the particulate enzyme, and that only small modifications of
this distribution occurred as a consequence of the techniques 
employed.
It can,, therefore, be stated that, while the distribution 
between supernatant and particles for the normal specimens 
will be far from the true intracellular distribution in vivo 
due to loss of particles in the stroma, the distribution in the 
maligh^b^ group tirill be more reliable. Xt is obvious from 
the literature,' that the distribution of p-glucuronidase in 
the cytoplasm can vary from tissue to tissue (Oonchie and
bevvy, 1959; deDuve '©t aï.. 1962)* Values as low aa l4^ for
the percentage of total, enzyme activity to be found in the 
supernatant from mouse liver (Lewy and Gonchle, 1964) to
—3.84—
70-90^ lia rat spleen (Roth et al*. 1 9 6 2), have been reported.
Tlhen the spécimens of cervical carcinoma were divided 
into those with high (B-gluouronidasc (above 1000 unlta/g.w.v/. ) 
and those with Idw p-gluourpnldas@ (below 50 0 tmits/g.w.w. ) ,- 
it was shown that th© increase in 0-gl%%ouronldaee was mainly 
in the soluble supernatant fraction (Table I9 , p.149)I the 
supernatant specific activities were also greatly increased 
(Table 21, p.3*53)* ' The partielea from the two groups did
not show any differences in enzyme activity, and also th© 
yield of partio3.es in the High-Gontent and Low-Content Groups 
were not significantly different when the particulate protein 
was used as an index of this (Table 20, p. I5 1 ). From this, 
it appears that the raised p-gluouronldase in malignant 
cervical tissue Is primaril^r due to soluble enzyme free in 
the cytoplasm and not bound to particles. The particles in 
the malignant specimens with different total oytop3.asmic 
{B=»glueuronldas0 activity do not show pronounced differences 
in enzyme activity, and indeed, the particle© from malignant 
cervical cells do not vary greatly from normal cervical celle 
in their specific activltiea.
These findings would seem to support those of Gonchle 
and Levvy (l959) who stated that in S3? mouse tumour, a large 
percentage of (3-gluoiironidase was free in the cytoplasm of the 
tumour cells, and Levvy and Gonchle (1964) reported similar 
results from Ehrlich and T2146 tumours.
The estimation of (3-gluouronidase activity in vaginal
—XBS®'*
secretions has proved to be the most profitable olinical 
application of the enz^ niae in the diagnosis of cervical cancer. 
Fishman and Mitoho11 (1939) stated that there were a number 
of possible sources of p-glticuronidase in vaginal fluid, 
including vaginal mucosa, utorihe cervix and endometrium, 
bacterial flora, protozoa, blood, lymph or tissue fluids, and 
cancer cells. Watkin© and Lawson (1963) stated that the 
source of the enzyme in vaginal fluid was unknown, and they 
were doubtful If cervical carcinoma contributea directly to 
the enhanced activity observed in the majority of these 
patients. From their work, it appeared that the ©nzyiie was 
partly free in solution and partly bound in an insoluble form 
in the vaginal fluid, although whether this is due to being 
confined within cells or bound to mucopolysaccharide©, 
insoluble under 'the conditions used, ia not known. It is 
uncertain whether the inereaaea in cervical caroinoRia patients 
are in th© free or bound forma.
It is, therefore, of interest to note in the present 
investigation, that the increased (3-glticuronidaae activity of 
malignant cervical cells occurred in the cytoplasmic 
supernatant and not bound within particles. Xt is feasible 
that, with this distribution, the enzyme could more readily 
escape from th© malignant cells and enter vaginal secretions, 
than if th© ^-glucuronidase had been enclosed within cytoplasmic 
particle#.
Uhen comparison was made between the particulate
p-gliicuronidaBO of normal and carcinomatouB cervical specimens, 
there was a far higher p-glucuronidase content in the particles 
from the carcinoma cells* This has already been explained 
part ly in terms of poor particle 3^ 1 eld from the normal 
specimens due to technical difficulties# However, one fact 
should be borne in mind when considering those results; Leubel, 
Saunders and Ashworth (3.960), in a study of carcinoma in situ 
and invasive carcinoma of the cervix uteri, with the electron 
microscope, described the'cancer cells as being 'richer-.in 
mitochondria than the normal- epithelial cell. O^ 'he differences 
between the normal and cancer cells seen in this present work,
, therefore, in part bo due to a higher content of 
mitochondria from the tumour specimens.
Xn the particle fractions of the tumour cells, the 
p-glucuronidaoe appears to be evenly divided between the Ml 
and M2 fractions (Table 16, p. l44). The enzyme has been 
referred to as a •lysosomal* ©nzyme by doDuve et al. (1953), 
although they found comparable activity in microsomes.
Levvy and Conchie (1964) have shown that it is present in 
mitochondrial and microsoBial fraotions. During any tissue 
fractionation procedure, cross-contamination of the particle 
fractions ia difficult to avoid, and l^raocornea will 
contaminate both Ml and M2 fractions* Levvy and Conchie (1964) 
showed that mitochondrial and microsomal fractions from various 
tissues prepared by a method similar to the present one, had 
sroughly equal p-g.lucuronidaso activity*
X s *7
Xt ±8 likely that are s S’--coîit amination of tho partiale 
fractions occurred and, therefore, as the ^-glncnronidase 
activity was found to be, very similar in the Ml and M2 
fractions# .nothing could be deduced about the particulate 
distribution of the ensiyme in these tisaucss. The fact that 
the M2 fraction had slightly higher activities than the Ml 
fraction In most speolmeno# ©an be explained by the likelihood 
that the former would contain more lysosomes than the latter 
under the conditions of centrifugation employed*
TISSUE 6«GLUCUhONXDA8K AND BEVBHXTT OF THE MALIGNANT UOSXON*
Xt waa hoped that the wide range of p«-glucuronida©e 
activities of the cervical carcinoma specimens might be 
explained in terms of degree of malignancy of the lesion or 
clinical aasesament of the disease * Previous authors have 
not been able to relate j3-«gluctironidas© activity of tumour 
tissue to the histological appearctnco (Monis et al., i960) • 
'Eauramo (1959) stated that the spread of a malignant cervical 
lesion did not seem to affect the ^-glucuronidase content of 
the tissue to any notable degree. He did, however# find a 
higher incidence of normal values (below 300 imits/g*w*w.) 
in Stage 0-1 incipient cases ( 3B^) than in Stage 2 (X35^ ) and 
Stages 3 and 4 (7%)* Xn this present work# the Mild cases 
had ©Ignifleantly lower p—glucuronidase than the more advanced 
Intermediate and Severe cases.(Table 22# p,lg6)* Rauramo 
(1959). explained the low values seen in early cases by the
—IBB"®*
fact that normal cervieal tie sue would b© ^removed readily
along with tumour tissue in the biopsy specimen* The results
found here confirm that this is the most likely explanation*
The result's on the Mild cases do# in fact# fall between those
of the normal cervical apociniens and the more advanced
malignant specimens. For example# although they have a low
supernatant (3-glucuronldase# the range is still somewhat
higher than that for the normal group (ef. Table 15# p.142
and Table 22# p..1 5 6 )4 The supernatant protein of the Mild
cases approaches# but is still a little higher than# the
supernatant protein of the normal group. The protein content
of the Intermediate and Severe groups was much higher (Table
2.3# p. 1 5 7 ) « This would indicate the higher cellularity of the
specimens from the mm re advanced cases# and would fit in very
'
well with the concept of normal tissue# containing less 
epithelial cells, being taken along with tumour tissue in 
the spocimena from early lesions. There is no evidence 
from the present data to suggest that carcinoma colla from 
an early lesion would have lea© p-gluoiîronidas© activity than 
cell© from a more advanced ©aae.
EFFECT OF RADIATION UPON TXS!
Results obtained from the Pro- and Poat-Radiation Series 
did not shov; a specific pattern of response by tissue 
p-gliicuronidase t© radium treatment.
One of the major dlfficultlea in comparing results on
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two scuiiploa taken from the same tissue siwh as malignant
cervix after a specific'treatment# is the heterogeneous nature
of the lesion* Because of this# a wide variation in results
on the two specimens may arise from tissue sampling. Xt must
bo accepted that in a tissue of multiple histological elements
where p-glucuronidase activity is ooiined mainly to one cell
A
type - epithelium - there is liîcely to be an appreciable 
difference in p-gluouronldaso/g.w.v;. from on© sample to another 
depending on the aiBOtmt of epithelial tissue obtained in the 
biopsy* Xt is impossible to assess to what extent this will 
occur without examining a carefully controlled group of samples 
taken from patients receiving no treatment. This was not 
possible in the present work and# therefore# no Esieans was 
available for determining to what extent tissue sampling 
had caused the very variable alterations in p-glucuroniclas© 
activity following radiation*
X'hoae variable results agree xirlth those reported by 
Rauramo (1959) on 10 pre- and post-radiation specimens taken 
from patients receiving a single radium implant. The author 
found that (^-glucuronidase/g .w*w. from whole tissue homogonates 
fell in eight cases and increased in two. Hartlala# Nanto# 
Hinne and Savola (196O) found that the j3-gluouronidase activity 
of rat gastric mucosa and liver increased up to three days
after a 400 rad radiation dose and then returned to normal 
values. Sottocasa ©t al. (I965) also produced increases in 
(3“gluctironidase 8%)0cifIc activities of heart tissue slice
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Iiomogenates after large doses of irradlationg this was shown 
t o  be a true increase in enayme and not a consequence of loaa 
of protein.. I t  ç o n ld  well be# therefore# that in c e r v ic a l  
tiasii© tivo simultaneous processes occur - stimulation of 
p-glU€uronidas© within the cell to give in c re a s e d  activity 
in the tissue# and death of neoplastic cells tending to reduce 
the p-gXucuronidase activity* V a r ia b le  results would then 
arise depending on the relative extent of the two processes*
From cytologioal studies# it is known that there is a variation 
in response of different lesions to radiation.(Cfraham and 
Graham # 1955)•
It has been suggested that radiation of tissues results 
in damage to lysosomes w ith  concomitant release of their 
enzymes (Errera, 1959)# However# it has since, been 
demonstrated that very large radiation doses are required t o , 
cause leakage of hydrolytic ©nssymes from lysosomal preparations | 
Baoq and Alexander (i9 6 0 ) stated that a dose of 10,000 rads 
was required on in vitro preparations, and Sottoeaaa et al. 
(1 9 6 3) found doses of over 10,000 rads were needed to release’ 
enzymes from lyaosomes in vivo. There was no evidence from 
th e  particulate result© on the P r e -  and Post-Radiation 
specimens i n  this work to suggest that there had been any 
damage to lysosomea or o th e r  particles.
EXCRETION OF 6-GLUGUROMIDASE IN URINE OF PATIENTS RECEIVING 
RABIOTHKRAPY.
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There are no similar studies on the urinary excretion of 
p-glucuroniclase following radiation with which to compare the 
present work. Although p-glncuronidaae has been found to be 
elevated in the urine of patients with various malignant lesions 
(Boyland et al#■ 1957)i there la little evidence that the 
malignant lesion is the major contributor to the increased 
p-glucuronidase in the urine* Kerr ©t al. (1963) showed that 
bladder carcinoma was a direct source of p-gluouronidase in the 
urine, aa surgical removal of the tumour resulted in fall of 
,p-gXucuronldaao excretion to normal values* This Is not 
unexpected due to the location of the sBalignant lesion* Xt la 
of interest to know if other lesions outwith the urinary tract 
are the primary source of increased p-gluouronidase found in 
the urine of some of these patients* An alternative 
possibility Is that these increases aria© from a systemic 
reaction of the patient to the carcinoma# aa the enzyme can 
show increased activity in the urine in some systemic body 
reactions such as pyx'exla ( Boy land and Williams, 1956).
The results obtained in the present study on patient© 
with cervical cancer receiving radiation indicate that the 
lesion in the cervix is the source of increased p-gluctironidas© 
in the urine of some of the patients* Insertion of radium 
into the lesion was followed by increase© in the excretion 
of (3™glucuronldaa© In 7 of the 9 patients (Fig* 1?p P* 164) # 
which lasted for approximately 2-3 weeks and fell back to# 
and often below# the pro-radiation values* Furthermore# the
— 3.92—
patienta with an abnormal excretion of p-gluoisronidaa© before 
radiotherapy produced the most pronounced Increasae*
The rises in p-gluouronidaae excretion in the urine were 
accompanied by increase© In serum p-glucuronida$e activity* 
This suggest© that the enssyme la liberated from the cancer 
tiasti©# enter© the circulât ion, and ie then cleared by the 
kidneys* Xt ha© been suggested that a proportion of the 
p-glucuronidaso found in normal urine is derived from the 
urethra and bladder mucosa (Kerr et al»,1963). but the results 
found in the cervical caaea In this work cannot be explained 
other than a© a renal clearance of the enssymo. In two cases, 
the reciprocal relationship between serum (3-glucuronidase 
and excretion of the enssym© in the urine (Fig*21 # p* 172) 
can also be explained as an inadequate r©na3. clearance of the 
enîsyme causing an increase in circulating ensyrae in the blood* 
In this respect # it is of interest to note that in some 
independent studies on on© of the oases# the patient's renal 
function#as assessed by the Van Slyke urea clearance# fell 
from a pre-radiation value of 59^ of normal to 4o^ after the 
full course of radiotherapy«
The group of patients with bladder carcinoma v/er© studied 
to investigate the effect of radiation of a tumour known to 
be rich in p-g3.ucuronidas© and having direct access to the 
urinary traot* The patienta were not# however# receiving 
radium implants* Suprisingly# the results within the group 
were not consistent and a regular pattern of p-glucuronldase
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©xcretion# as seen in the oervloal carcinoma group# was not
shown* Five of the 8 patients had very high (3-glucuronidase
excretion before radiotherapy, but this was not increased to 
A
any noticable degree except in one casa* The other 
A
anticipated affect may have been a decrease of enzyme excretion 
towards the end of the therapy due to death of the malignant 
cells by radiation, but a decrease in enzyme output waa not 
detected• However, decrease© mmy have occurx*ed at a mmch 
later date, as the effects of radiation upon tissues are not 
always immediate (Errera, 1959)#
The third group of patients were studied with a view to 
observing any changes which might occur in urinary gluc­
uronidase excretion in patient© with malignant lesions 
recoiving radiation distant from the urinary tract. Two of 
the patients, both with carcinoma of the bronchus, had
yv
abnormall.y high .p-glucuroidas© excretion before therapy, and
A
both produced a pronounced increase in urine activity 
following radiation by supervoltage therapy (Fig,19# p, 168), 
Seligman et al,(1954) have described bronchial ©pithelia as 
having a high (3-glucuronidase activity and Fishman et al,
(1 9 4 7) have Indicated that lung carcinoma has high p-gluc- 
uronldase activity, O'h© other patient who showed increases 
in p-glucuronidase excretion had an oesophagal carcinoma,
Monis et al. (i9 6 0 ) showed that epidermoid carcinomas of the 
oesophagus war© very rich in p-glucuronicias© activity.
These results on this group, therefore, support the idea
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that radiation of oarolnomas rich in p-glweiironidas© activity 
can causa an inoreaaqd excretion of the enzyme In the urine of
theae patients.
It is' unfortunate that tissue epeolmene could not be 
obtained from the thoracic and bladder carcinomaa# particularly 
as- the results from the cervical group indicate a connection 
between the glucuronidase activity of the malignant lesion 
and' the excretion of urinary (^-glucuronidase following 
Irradiation of the tumour. Two patients,with a high pre­
radiation p-glucuronidase excretion and showing a large 
increase'in enzyme excretion following radium therapy, had 
high {3-glueuronidase activity in their tissue biopsy speciaiens, 
one case t^ ith a moderate tissue activity showed urine increases 
slightly less pronounced, while one of the oases which 
produced a normal pre-radiation excretion and no radiation 
response, had low tissue (3-glucuronidase activity, Thus^
4 of the 5' patients In which such an assessment was possible 
auî>port the hypothesis of the cance^r tissue being the source 
of the abnormal amounte of (3-gluourenldaee in the urine.
Taklguchi (1963) studied (3-glucuronidase in serial blood 
specimens taken from patients with carcinoma of the cervix 
receiving radiotherapy, The author found variable patterns 
of response during radiation treatment, similar to those 
shown In Fig,20 (p, 171) , which he related to the clinical, and
<at 19 5®*
radiation reeponso of the patient. It was not possible, 
however# in this work to correlate the serum enzyme pattern 
with the patient’s progress*
CONCLUSIONS.
The results of this study have ©gtabliahed that the 
malignant cells of cervical cancer tissue have higher 
^-glucuronidase activity than normal cervical epithelial cells, 
and that this increase occurs mainly in the free soluble 
fraction of the cytoplasm and not in the particles. The 
nature of this increase could well account for Increased 
amounts of this enzyme which are found in vaginal secretions 
in the majority of these patients.
The estimation of p-gXueuronidas© activity of cervical 
biopsy specimens would be of no diagnostic advantage over 
histology, however, a© there was such a wide scatter in 
results in the carcinoma series which could not be related, 
except In early lesions, with the severity of the disease,
Tho effect of radiation upon the malignant tissues of 
the cervix clearly seems to mobilise p-glucuronidase from 
the cells into the patient’s circulation fi'om whence it is 
eventually excreted in the urine. This seems to be caused 
mainly by implantation of radium into the tissue, Xt is 
possible that this also occurred in two patients with cancer 
of the bronchus and one patient with carcinoma of the 
oesophagus. However, radiation of bladder carcinoma, a
lesion lasually associated with high p-gluouronidase activity 
and in close contact with urine, did not result in pronounced 
Increases in enzyme content of the urine, even though there 
was a high pre-radiation excretion of the enzyme. This 
anomalous finding cannot be readily explained, but specific 
changea occurring In the bladder could not b© assessed. Xt 
has been reported that inhibitors of p-gluouronidase are 
excreted in the urine of moat subjects, including patients 
with bladder carcinoma (beivis and Plaie©, i9 6 0 ) • The source
'and nature of these inhibitors is not known, but it is within
■ ' ' ■ .
the botmds of possibility that radiation of the bladder 
mucosa could cause release of inhibitors of p-gluouronidase 
along with the enzyme. Future worlt could be readily 
undertaken to test this.
Changes in tissue g-glucuronidaae in malignant cervical 
specimens following radiuai treatment did not produce any 
fruitful information. Results wez^ e very variable, and it may 
well be that this arose from taking the poet-radiation 
specimen too soon, before specific changes in enzyme activity 
could be detected.
Odell ©t al. (1 9 5 0) stated that (3-glucuronidas© activity 
of vaginal fluid tended to decrease following radiation 
of the cervical lesion. Hatzimlchael (1 9 6 2) claimed that 
malignant tumours of the cervixj which responded to radiation^ 
were associated with decreased activity of the enzyme in 
cervical mucus. Unfortunately, In this present work, there 
were no facilities for obtaining vaginal s©or©tiona to study
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along with tissue biopsy materia.!. Similarly, there was no 
means of assessing the radiation response of the lesions and, 
therefore, the tissue, urine and serum p-gluouronidase results 
could not be considered from a prognostic viewpoint.
Takiguchl (1963) claimed that serial serum p-glucuronidase 
and lactic dehydrogenase determinations might yield an index 
of radiation response in patients with cervical cancer. It 
is hoped that, in the future, a controlled study of comparative 
p-glucuronidase activities of vaginal secretions, tissue 
biopsies and excretion of the enzyme in the urine of patients 
with cervical cancer, before and after radiation, may be 
undertaken, with a view to assessing the response of the 
patient to treatment and ultimately arriving at a j^rognosis. 
There is every reason to believe that useful data might be 
obtained from further studies in this direction.
SUMMARY.
«=*» X9 9***
Separate -studies on two enzymes have been included in 
this thesis
%n Part.1. the activity of isocitrat© dehydrogenase 
was measured- in tho serum of patients with various diseases 
of tho liver or 'biliary tract. The usefulness of this 
enzyme as a diagnostic aid waa aseossod by comparing the 
results with established biochemical tests'of liver function» 
namely » serum bilirubin, protein turbidity and flocculation 
tests, serum alkaline phosphatase, and especially serum 
glutamic-oxalac©tic tranaamlnae© (S-GOT) and serum glutamic- 
pyruvic tranaaminase (S-GFT)•
Cases of hepato-biliary disease were divided into five 
groupas- (a) acute liver damage due to infectious 
hepatitis, (b) drug-induced jaundice, (c) chronic liver 
disease - portal and biliary cirrhosis, (d) cancer invasion 
of the liver, and (©) obstructive Jaundice due to malignant 
and benign lesions.
(a) witlh acute damage of liver cells, very high values
for serum isocitrate deh^rdrogenase (S-ÏGÏ)) were found in 
every case* These high values coincided with very high 
transaminase va3,ues, and the three enzymes responded in a 
similar way. They were - very sensitive'in showing the onset 
and progression of infectious hepatitis.
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(b) Two oases of acute liver cell damage caused by the
drug', p-amlnoaalicylic acid, gave very high S-XCI) value©. 
Further investigations on on© of these cases showed that 
S-XGB was extremely sensitive in detecting subclinical liver 
ttpsei,. and waa probably ©lightly euperior to the trans- 
aBinases in this respect* The enzyme could be usefully 
employed as a screening teat in patients receiving drugs 
which may cause toxic damage to liver cells. Ghlorpromazine 
and promazine jaundice produced only small variable increases 
in S'^IQD*
(o) Xn portal cirrhosis, 2B% of the patients had normal
S-ICB values* increases in .activity, where seen, t^ ere only 
moderate and could not be related to the clinical ©tat© of 
the patient. The S-XCB results were significantly 
correlated with both serum transaminase©•
Patient© with biliary cirrhosis produced generally 
higher S-ICGÎ) values than those from patients with p03?tal 
cirrhosis g these values were closely correlated to S-GOT 
and S-GFT values.
(d) Fifteen, cases of invasive cancer of the liver all
gave S-XOD values | large increases were associated
with widespread secondary deposits in the liver.
(©) Xn obstructive jaundice of different types, variable
2 0 X '*
S-XC3) value© were found| inoreaaod value© were found in 83^ 
of caaee and were not related to the severity or duration 
of the obstmiotlon*
Xn cases with malignant obstructive Jaundice, the presence 
of secondary liver involvement caused significantly higher 
S-XÜD values than tîioae found with non-metaBtatic patients.
In oases with benign obstructive Jaimdice, the presence 
of an aout©’inflammatory process in the biliary tract 
produced high S-XCD values which were not necessarily 
associated with damage to liver cells.
There was no significant difference in S-XGB results 
from non-m©tastatic malignant cases and benign obstructive 
jaundice oases uncomplicated by acute inflammation.
S-XCD was not closely correlated with the transaminases 
in cases of obstructive Jaundice, and neither the S-GOT‘?vor 
S-0FT reflected the high S-ICî? values seen with liver 
métastasés in malignant eases and inflammation of the biliary 
tract in benign cases.
It was concluded that, while the S-ICB did not offer 
great diagnostic advantages over the serum transaminases,
A
it could be a useful complimentary or alternative test 
them. It was an enzyme, easily estimated, very sensitive 
for detecting acute damage to liver cells, and could provide 
useful Information in some cases of biliary obstruction.
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Part 2 consisted of investigations on p-gluouronidase
activity of specimen© of cervical tissue, urine and serum
/
taken, from patient© xirith cervical carcinoma.
Tisau© apeclmans of oarcinoiaa of the. cervix uteri were 
fractionated by homogenisation and separation of cytoplasmic 
Contents into cell sap (supernatant) and two particulate 
fractions designated Ml - consisting mainly of mitochondria, 
and-M2 - consisting mainly of microsomes. p-Glucuronidase
was measured in each fraction, and the result© compared xfith 
those from similar.fractions prepared from non-mallgnant 
cervical specimens.
p-Glucuronidas© activity of the malignant cervical 
specimens xvas, in general, miach higher than that of normal 
or non-malignant cervix. There was a xvide range of 
activities in the malignant series, but values could not be 
related to the degree of malignancy, ©xdept In apecimena 
from an early lesion which alx^ ays gave low p-glucuronidaa© 
activities approaching those found in non-maXignant specimens.
From the intracellular di©tribution of p-gltscuronidase 
in the malignant specimens, it was found that increase© of 
(3-glucuronidase xfore mainly In free sup ©mat ant ©nzyHi© and 
not in particulate enzyme, although the enzyme has previously 
been described aa located mainly within cytoplasmic particles.
<**20 3*^
This work appear© to be the first study on the intraoellular 
distribution of p-gluonronidase in human tumour tissue| the 
results are supported by similar finding© in certain mouse 
tumours.
In twelve of the patients with cervical carcinoma, 
further tissue specimens were obtained after treatment of the 
lesion by an Implant of radium for approximately two days. 
p-Glucuronidas© activity of those ©pocimena x^ as compared 
with the pr©-radiation value» , No specific change in ■ ■
glucuronidase activity could be detected fo-lloxiririg■ radium 
treatiBent» Xn three cases there were large increases, and 
in four there were large decroaaea in p-glucuronlclas© 
activity. Xn the other cases, smaller variable changes 
occurred x#loh may have arisen from tiasue sampling.
In nine patients, the urinary excretion of p-gluouronidaai
waa studied throughput a full course of radiotherapy.
Results ahoxmd that there was a significant increase In the 
24-hour excretion of the enzyme in seven patients folloxving
insertion of radium. Patients with abnormally high 
excretion of the enzyme before radiotherapy produced the 
most pronounced increases.
Rio©© in urinary enzyme output following radiation 
were accompanied by increases in serum p-glucuronidaae.
Results indicated that there was probably a renal clearance
** 2q4— 
of the .enzyme*
. I,t was seen on comparing the urinary excretion of 
p^gluoiirpnidase and the activity of the enzyme in the tissue 
specimen from the same patient# that radiation of lesion© 
with high p-glxicuronidase .activity psrociuc.ed large responses 
in urine output of the enzyme. Results suggested that 
increased {3-g’lucuronidas© in the urine of those patients 
was derived directly from the malignant lesion, and did, not 
result;from a systemic reaction of the patient.
(3-0Xi^curonidaso excretion was also studied in patients 
with,bladder carcinoma receiving radiotherapy. These were
studied as. a group with a lesion usually described aa having 
high p-glucuronidas© content and oXosel^^ asaoclated with the 
urinary tract. Suprlsingly, there was not a uniform responseA
in urine {3™glucuronido.a© following radiation of the lesion.
Another group of patients receiving radiation of 
malignant lesions imll away from the urogenital tract were 
also studied. Some patients showed increased ^-glucuronidase 
excretions the most pronounced responses were found in two 
patient© who had high pre-radiation enzyme excretion. This 
group offered further evidence that radiation of lesion© high 
in §-gXuouronidase could lead to increased excretion of the 
enzyme in the urine. ' ■
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